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ABSTRACT 
 
Background: Diabetes is a metabolic disorder characterised by chronic 
hyperglycaemia, with Type 2 diabetes being the most common form. Over time, chronic 
lower limb complications such as peripheral neuropathy and arterial disease can 
develop. Approximately one in twenty people with diabetes will then go on to develop a 
foot ulcer every year, and more than one in ten ulcers will progress to leg or foot 
amputation. Investigating the impact of plantar pressure on peripheral blood flow, and 
in particular endothelial dysfunction is an important element in increasing our 
understanding of the mechanisms which contribute to foot ulcer formation. However, to 
date no studies have simultaneously investigated the interaction of elevated plantar 
pressure and endothelial dysfunction. 
 
Aim of the study: To develop and validate a pressure delivery device and utilise this 
equipment to investigate the impact of plantar pressure on endothelial dysfunction of 
the superficial blood vessels supplying the plantar aspect of the forefoot.  To devise and 
utilise protocols for measuring blood flow, both during post-occlusive reactive 
hyperaemia (PORH), and when the vessels are stimulated to dilate with an endothelium-
dependent and an endothelium-independent vasodilator under 50% and 100% of 
simulated walking plantar pressure on the feet of subjects with diabetes mellitus. 
  
Methods: A pressure delivery system was developed and tested for repeatability in 
normal healthy volunteers. The system consisted of a stainless steel spring housed in a 
metal casing to allow unimpeded movement of the spring. Iontophoresis of solutions 
xxii 
 
with different possible vehicles were investigated, and a suitable protocol for the 
delivery of an endothelium-dependent vasodilator, acetylcholine (ACh) and an 
endothelium-independent vasodilator, sodium nitroprusside (SNP) utilising a 
methylcellulose thickening agent was developed. Laser speckle contrast imaging (LSCI) 
in conjunction with PORH was tested for suitability of use on the plantar aspect of the 
foot and a comparison with laser Doppler flowmetry (LDF) carried out for the 3rd 
metatarsophalangeal joint (MPJ) area. Endothelial dysfunction was assessed with 
vasodilation via iontophoresis of ACh and SNP with the simultaneous delivery of 50% 
followed by 100% of simulated walking pressure applied by the developed pressure 
delivery system on the 3rd MPJ.  
 
Results: The required equipment and protocols were successfully developed which 
would allow the simultaneous investigation of the interaction of plantar pressure and 
endothelial dysfunction. On utilisation of the equipment, the post occlusive peak flux 
was significantly higher in the subjects with Type 2 diabetes than in the control subjects 
in all areas under study except the 1st toe. A significant positive association was found 
between the utilisation of LSCI and LDF measurements obtained at the plantar aspect of 
the 3rd MPJ. With vasodilation of the superficial vessels on the plantar aspect of the 3rd 
MPJ using ACh, the main impact of reduction of blood flux occurred when only 50% of 
normal walking pressure was applied to the area. When delivering the vasodilator SNP 
with iontophoresis to the same area of the foot, increase in pressure was found to have a 
greater impact of reduction of blood flux on the group with Type 2 diabetes than the 
control group. 
 
xxiii 
 
Conclusions: Investigation of the interaction between peak plantar pressure and 
endothelial dysfunction was achieved with the utilisation of the equipment and 
protocols developed. With PORH the subjects with Type 2 diabetes displayed a 
significantly higher post occlusive peak flux in comparison to the control group. A 
strong, significant positive association was found between the LDF for resting flux 
under the 3rd MPJ and LSCI, thus, LSCI was found to be suitable for assessing 
endothelial function in superficial vessels. Reduction in blood flux when pressure was 
exerted under vasodilation with ACh occurred with 50% of normal walking pressure. 
Increase in pressure with SNP delivery was found to have a greater impact on blood 
flux for the subjects with Type 2 diabetes than the control group i.e. the group displayed 
a greater reduction in blood flux with simulated normal walking pressure delivery. 
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Chapter One 
Introduction and aims of the thesis 
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1 INTRODUCTION 
 
1.1 BACKGROUND TO THE RESEARCH 
Diabetes mellitus has been defined as a metabolic disorder with multiple aetiology 
characterised by chronic hyperglycaemia and manifests with carbohydrate, fat and 
protein disturbances resulting in insulin secretion and/or defects. Type 2 diabetes is the 
most common form of diabetes and is characterised by problems with insulin action and 
secretion (WHO 2011). A recent estimation of worldwide prevalence for 2011 indicated 
that there were 366 million cases of diabetes, with an expectation of this rising to 552 
million people by 2030. In the UK there are currently 2.9 million people who have been 
diagnosed with diabetes, with an estimation of around 850,000 people undiagnosed. In 
Scotland in 2011, the prevalence was 4.3% which was 223,494 diagnosed adults, with 
90% having Type 2 diabetes and of that group more were men than women, 55% being 
male and 45% female (Quality and outcomes framework (QOF) 2011).  
Over time a large number of those presenting with Type 2 diabetes will develop chronic 
complications such as retinopathy, nephropathy, peripheral neuropathy and peripheral 
arterial disease. Lower limb and foot problems are a major cause for concern with 
diabetes, particularly when there is poor glycaemic control, and can ultimately lead to 
lower limb amputations (Abboud 1995; Stratton et al. 2000). Diabetes has been cited as 
the major cause accounting for just under half of all adult lower limb amputations 
(Amputee Statistical Database for the United Kingdom 2007). Around one in twenty 
people with diabetes will develop a foot ulcer each year and more than one in ten foot 
ulcers results in amputation of the foot or leg. It has also been found that up to 70% of 
people die within five years of having an amputation resulting from diabetes (Abbott et 
al. 1998). Many factors have been investigated as having a role in the development of 
foot ulceration in diabetes including peripheral neuropathy, environmental factors such 
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as accidental trauma, especially from ill-fitting footwear, muscle dysfunction, abnormal 
blood flow and endothelial dysfunction, as well as elevated plantar pressures. Overall 
opinion indicates that there is a combination of factors generally involved in the 
formation of foot ulcers (Abboud et al. 2000; Plank et al. 2000; Bowering 2001; Cobb 
& Claremont 2001; Newton et al. 2001; Khan & Newton 2003; Hahn et al. 2007; 
Petrofsky et al. 2009; Tong et al. 2011). The work presented in this thesis will 
concentrate on investigating a combination of two of the factors, namely elevated 
plantar pressures and endothelial dysfunction. 
 
1.1.1 Elevated plantar pressures with diabetes 
There are many factors that can play a role in the alteration and increase in plantar 
pressures found in association with diabetes, with the most commonly associated 
pathology being peripheral neuropathy (Abouaesha et al. 2001; Pataky et al. 2005; Bus 
et al. 2005; Acharya et al. 2011; Tong et al. 2011; Waldecker 2012). Sensory 
neuropathy has been found to lead to abnormal gait, which results in increased plantar 
pressure (Cavanagh et al. 1991; Masson 1992). Kersting & Rosenbaum (1992) noted 
that a loss of sensation could prohibit the feed-back mechanism when overloading of the 
plantar surface was experienced. Thus, the individual would not know that they required 
to alter the load, which would result in high pressures occurring in plantar areas. Motor 
neuropathy causes weakness and imbalance of the intrinsic muscles of the foot which in 
turn allows an imbalance to occur between the long flexor and extensor muscles leading 
to forefoot slap (Abboud et al. 2000; Bowering 2001). This imbalance creates a 
likelihood of the metatarsophalangeal joints bearing abnormally high pressures during 
gait (Bus et al. 2005; Tong et al. 2011). Involvement of the autonomic nervous system 
has been implicated in callus formation with a reduction in sweat leading to anhidrotic 
4 
 
skin (Boulton 1987), and to fissuring with a higher chance of bacterial infection 
occurring, as well as the loss of the peripheral sympathetic vascular tone (Bowering 
2001). Another contributing factor is limited joint mobility (Veves el al. 1992; Masson 
1992).  Subjects with diabetes and limited sub-talar joint mobility exhibiting clinical 
signs of neuropathy were found to display the highest mean forefoot pressures and also 
had the highest prevalence of plantar ulceration in comparison with those without 
neuropathy and healthy control subjects (Fernando et al. 1991). Structural changes in 
keratin in the skin, muscle, cartilage, tendons, ligaments and bony alignment have also 
all been linked with an increase in plantar pressures (Abouaesha et al. 2001; Kogler & 
Shorten 2001; Bus et al. 2005). 
 
1.1.2 Endothelial dysfunction with diabetes 
When diabetes is present, the endothelium has been found to be more vulnerable to 
pathological changes with many mechanisms thought to possibly contribute to this 
(Kampoli et al. 2009). As expected due to the nature of the disorder, hyperglycaemia is 
implicated in endothelial dysfunction (De Vriese et al. 2000). Evidence relating to the 
role of oxidative stress in the pathogenesis of endothelial dysfunction is growing with 
Alp et al. (2003) finding in animal studies that reactive oxygen species (ROS) in the 
form of endothelial cell superoxide was higher in diabetes. Kampoli et al. (2009) 
reported that hyperglycaemia with elevated free fatty acids and insulin resistance acted 
together to target endothelial cells, and this was thought to lead to oxidative stress. 
Advanced glycation end products (AGEs) formation is a natural aspect of ageing, but is 
accelerated in diabetes. Sampathkumar et al. (2005) correlated serum levels of AGEs 
with diabetes and microangiopathy in association with retinopathy and neuropathy, and 
found the serum levels to be higher than in control subjects. There is increasing 
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evidence that protein kinase C (PKC) activation in diabetes leads to endothelial 
dysfunction by several mechanisms as indicated in Figure 1.1 (Khamaisi & Raz 2006). 
 
 
Figure 1.1The process from diabetes to micro-vascular dysfunction with the role of PKC activation 
 (adapted from Khamaisi & Raz 2006). 
 
 
Circulating biomarkers have also been implicated. Caballero et al. (1999) when 
investigating groups who were at risk of developing diabetes, found elevated levels of 
the cellular adhesion molecules in response to inflammation. Endothelin-1 (ET-1) levels 
were significantly higher in those with relatives who had diabetes, subjects with 
impaired glucose tolerance (IGT) and the group who had diabetes when compared to a 
group of control subjects. Von Willebrand factor (vWF) was found to be higher in the 
group with diabetes in comparison to those with relatives having diabetes and the 
6 
 
control group. Soluble intercellular adhesion molecule (sICAM) levels were found to be 
higher in the group with diabetes and the IGT group whereas the soluble vascular cell 
adhesion molecule (sVCAM) levels were higher in the group with diabetes and the 
group with relatives having diabetes than in the control group. It was noted that they 
were being used to aid the adhesion of circulating leukocytes to their surface and this 
was considered to be an early stage in transendothelial migration of leukocytes and the 
subsequent development of atherosclerosis. Von Willebrand factor has been reported as 
a response of the activated endothelium and has been found to be associated with the 
complications found with diabetes (Freestone et al. 2008). Brooks et al. (2008) 
compared blood flow responses to acetylcholine (ACh), an endothelium-dependent 
vasodilator, and sodium nitroprusside (SNP) which is a none endothelium-dependent 
vasodilator, with blood borne biomarkers of endothelial dysfunction including 
plasminogen activator inhibitor1(PAI-1), sICAM, sVCAM and high sensitivity C-
reactive protein (hsCRP) in groups with Type 2 diabetes with and without 
microvascular complications and a control group. They found a significant correlation 
between the ACh and SNP responses with diabetes (r = 0.6, p< 0.0001) which was 
especially strong in those with microvascular complications. Both ACh and SNP 
responses fell progressively with the development of diabetes with microvascular 
complications. Higher hsCRP levels were found across the groups, although this trend 
was not found with the other biomarkers used in the study. They postulated that an 
impairment of the vessels to react to vasodilator stimuli must be present with diabetes.  
The actual effect that insulin has on endothelial nitric oxide synthase (eNOS) and the 
generation of nitric oxide (NO) is under debate. Kashyap et al. (2005) found insulin- 
stimulation of muscle NOS activity to be impaired in well-controlled Type 2 diabetes 
suggesting that impaired NOS activity could be involved in insulin resistance in this 
group. Vehkavaara et al. (2000) found the use of insulin therapy improved endothelium-
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dependent and independent vasodilation which suggests that there was some positive 
impact on vascular function, however their claims could imply that aspects other than 
improvement in the activity of NOS could be involved. For example, Sartori et al. 
(1999) found insulin to have actions on the vasculature by stimulating the release of NO 
and sympathetic neural outflow. However the mechanism by which this occurs is 
unclear and Clark et al. (2003) noted that there was evidence that when there was a lack 
of blood flow to muscles, insulin could act to switch flow from the non-nutritive to the 
nutritive route and suggested that insulin resistance of muscle impaired glucose uptake 
could be due to insulin-mediated capillary recruitment i.e. an increase in the number of 
perfused capillaries in the muscle in response to the stimulus of insulin. 
 
1.1.3 Simultaneous assessment of plantar pressure and endothelial function 
To date no studies have simultaneously investigated the effects of plantar pressure on 
endothelial function and therefore no commercially available equipment exists which is 
capable of carrying out this investigation. Experimental systems have been developed to 
investigate the impact of pressure and blood flow using laser Doppler flowmetry and a 
variety of pressure delivery methods including a weighbridge device with a cantilever 
mechanism around a central pivot (Abu-Own et al. 1995; Fromy et al. 2000). Other 
examples include work with pressure delivery via a piston to the heel, with the piston 
actually acting as a probe for blood flow assessment (Meinders et al. 1996). Finally, a 
shoe based upon an orthopaedic insole with cut out area under the first 
metatarsophalangeal joint was the first to attempt measurement of blood flow on the 
plantar aspect during actual loading when walking (Cobb & Claremont 2001). However, 
movement artefacts prevented actual measurement during the stance and loaded phase 
of gait, and data was only possible during the swing and unloaded phase of gait. 
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1.2 RATIONALE FOR THIS STUDY 
Investigating the impact of plantar pressure on endothelial dysfunction in diabetes is 
vital to increase our understanding of the mechanisms that contribute to soft tissue 
breakdown and ulceration of the foot. Currently, there is no commercial equipment 
available to investigate the interaction of pressure and endothelial dysfunction, thus, the 
purpose of this study was to develop and validate equipment that could simultaneously 
investigate the impact of pressure and endothelial dysfunction, and to analyse the 
possible differences in endothelial dysfunction in the skin blood vessels in a group of 
Type 2 diabetes when compared with a healthy control group. Endothelial function in 
this thesis was assessed using analysis of post occlusive reactive hyperaemia (PORH) 
with laser speckle contrast imaging (LSCI), which is a non-invasive, laser Doppler 
method for assessing microvascular perfusion, providing simultaneously high spatial 
and temporal resolution. This was followed with iontophoresis of two vasodilator 
substances, acetylcholine (ACh) an endothelium-dependent vasodilator and sodium 
nitroprusside (SNP) an endothelium-independent vasodilator which works via liberation 
of NO. Iontophoresis is the process where ionisable substances dissolved in solution 
create an electrolyte solution, which is capable of conducting an electric current. The 
substances can be readily delivered through the skin surface utilising the electric field 
created. External pressure was generated from a pressure device developed specifically 
to apply a given pressure to the local area whilst not damaging or interfering with the 
iontophoresis equipment or the laser Doppler probe used to measure the skin blood 
flow. 
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1.3 AIM, OBJECTIVES AND HYPOTHESES OF THE STUDY 
 
The aim of the study described in this thesis is to develop and validate a pressure 
delivery device and utilise the equipment to investigate endothelial dysfunction of 
superficial skin blood vessels by measuring blood flow, both during post-occlusive skin 
reactive hyperaemia and when stimulated to dilate with an endothelium-dependent and 
an endothelium-independent vasodilator under different plantar pressure on the feet of 
subjects with diabetes mellitus. 
 
The objectives are: 
 
 
1. To develop and validate equipment which will allow the application of 
iontophoresis with ACh followed by SNP, blood flow assessment and 
plantar pressure exertion simultaneously upon the plantar aspect of the 
forefoot. 
 
2. To investigate the possibility of utilising LSCI for PORH assessment in the 
lower limb, as it provides a global perfusion map which affords  difference 
in the perfusion found in areas of the foot to be compared, as well as offering 
high spatial and temporal resolution, and to compare LSCI with the more 
established LDF. 
 
3. To explore the relationship between endothelial function assessed by PORH 
of the lower limb and 50% and 100% of peak plantar pressure when exerted 
upon the 3rd metatarsophalangeal joint (MPJ) area of the plantar aspect of the 
foot in a non-weight bearing position in conjunction with vasodilation of the 
superficial blood vessels. 
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4. To compare this relationship in a group of subjects with diabetes with an age 
matched control group of subjects without diabetes. 
 
The experimental hypotheses under test are: 
1. There will be a significant difference in the maximum peak blood flux (MPF) 
response, the time taken to reach MPF and recovery as measured at 2 minutes 
and 5 minutes following MPF when measured using the LSCI system between 
subjects with diabetes and the control group of subjects without diabetes.   
 
 
2. The LSCI and LDF systems will be comparable when used to measure blood 
flux on the plantar aspect of the foot under the chosen comparison site of the 
mid forefoot area i.e. the 3rd MPJ. 
 
3. There will be a significant difference in blood flow when measuring 
endothelium-dependent vasodilation using ACh, and endothelium-independent 
vasodilation using SNP when delivering 50% of peak plantar pressure between 
subjects with diabetes and the control group of subjects without diabetes. 
 
4. There will be a significant difference in blood flow when measuring 
endothelium-dependent vasodilation using ACh, and endothelium-independent 
vasodilation using SNP when delivering 100% peak plantar pressure between 
subjects with diabetes and the control group of subjects without diabetes. 
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1.4 THESIS STRUCTURE 
1.4.1 Chapter 2 – Literature review 
Chapter 2 provides a review of the literature focused around the topics of plantar 
pressure analysis and endothelial dysfunction. It initially explores the relationship 
between plantar pressure alterations and diabetes as well as plantar skin and pressure 
elevation in diabetes and the role that plantar pressure plays in ulcer formation. It 
outlines the methods for assessment of plantar pressures currently available bringing in 
both platform and in-shoe devices. Endothelial structure, function and physiology are 
discussed to provide the background for dysfunction of the endothelium. The 
endothelium-derived vasodilators and contracting factors are included prior to the 
discussion of endothelial dysfunction specifically related to diabetes. Methods of 
assessing endothelial dysfunction and blood flux are discussed with specific emphasis 
on LDF and iontophoresis, LSCI and PORH. Finally the relationship between pressure 
and blood flux is explored as well as the methods developed to assess pressure delivery 
and blood flow. 
 
1.4.2 Chapter 3 – Design and development methods 
Chapter 3 concentrates on the equipment design and development for the study. Initial 
development of the plantar pressure delivery system is discussed in conjunction with 
repeatability or test-retest reliability data. Development work around the LDF utilisation 
including calibration of the equipment, the choice and rationale for chamber size used in 
the study and the iontophoresis solutions and vehicle are discussed. An appropriate 
protocol for the delivery of iontophoresis and the vasodilators is outlined, as well as 
inter-day repeatability testing for LDF detailed. The LSCI inter-day repeatability is also 
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noted and a pilot for the initial use of LSCI in conjunction with PORH for the lower 
limb is detailed. 
 
1.4.3 Chapter 4 - Application of the developed protocol 
In Chapter 4 the choice of site for the study is discussed and ethical approval outlined. 
Details are provided for the volunteers with diabetes, their invitation to participate as 
well as the details for the control volunteers. The actual protocol for the assessment is 
included with details of the procedure provided. The statistical methods employed to 
analyse the data generated by the study are described and presented.  
The results of the study are set out in relation to the order of completion during the data 
gathering process. The initial sections detail the results of the post occlusive reactive 
hyperaemia assessment utilising LSCI with the findings between the two groups taking 
the parameters individually. It then summarises the correlation between the areas under 
study in the forefoot with the LSCI system and reactive hyperaemia in the two groups 
under study, as well as the impact of pressure on baseline blood flux. The comparison of 
LDF and LSCI when utilised to measure blood flux on the foot in this study is then 
detailed. It then moves onto the results of the effect of the addition of 50% and 100% 
pressure delivery on endothelial function as measured with laser Doppler flowmetry 
(LDF), taking the group as a whole and each of the two groups individually, with an 
account of the differences found between the two groups initially with ACh and then 
followed by SNP.  
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1.4.4 Chapter 5-Discussion 
A detailed discussion of the results of the study is carried out in Chapter 5. This 
includes debate around the findings of the study, and comparisons with other work in 
the area when possible. It follows the format of the results of the study in Chapter 4 by 
starting with the equipment developed specifically for this study, PORH with LSCI and 
possible mechanisms around the reaction and the implications for this study. It then 
follows with the discussion around the comparison of LDF and LSCI for measuring 
perfusion. The discussion then focuses on pressure and endothelial function, taking each 
of the vasodilators and discussing the results of this study in relation to other work in 
the area and the mechanisms for the vasodilation, as well as the evidence for endothelial 
dysfunction with diabetes, and the impact that pressure has on blood flux. Possible 
limitations of the study are also discussed. 
 
1.4.5 Chapter 6-Conclusions  
Chapter 6 brings the main findings of the study together and discusses 
recommendations for future relevant work accordingly. 
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Chapter Two 
Literature Review  
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2 LITERATURE REVIEW 
2.1 PLANTAR PRESSURE ANALYSIS 
2.1.1 Introduction 
Load bearing during bipedal locomotion in combination with adaptation to foot 
structural and functional changes are important functions of the human foot. Apart from 
the natural ageing process, disease dependent pathological changes which alter foot 
function and gait, such as those in  conditions like diabetes, have an influence on foot 
loading (Bosch et al. 2009; Sawacha et al. 2012). One of the issues with the impact 
created by loading the foot during both normal and intensive activity is the repetitive 
nature of that loading itself, so any alterations of the biomechanical behaviour of the 
foot structure and/or soft tissue elements caused by a disorder have a greater impact 
with multiple repetitions (Natali et al. 2010).  Thus, measuring pressure exerted on the 
plantar aspect during locomotion adds an important and dynamic element to evaluating 
foot function. However there are limitations to assessing plantar pressure as it only 
provides an indication of the vertical force acting on the foot ground interface, or with 
in-shoe systems the foot insole interface, but does not measure the shear stresses which 
are thought to impact upon the function of the foot during activity (Rouhani et al. 2010).  
 
2.1.2 Association between diabetes and increased plantar pressure  
The mechanisms for increased plantar pressure found in association with diabetes are 
multifactorial, however, generally the singly most commonly reported pathological 
disorder found with diabetes which has been associated with higher plantar pressures is 
lower limb neuropathy (Abouaesha et al. 2001; Lord et al. 2002; Pataky et al. 2005; 
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Bus et al. 2005; Acharya et al. 2011; Tong et al. 2011; Waldecker 2012).  Caselli et al. 
(2002) found that the plantar pressure at both the forefoot and hindfoot was increased in 
the diabetic neuropathic foot. However, an investigation of plantar pressure distribution 
patterns in non-ulcerated and ulcerated patients with diabetes and neuropathy, found 
that the progression of neuropathy did not influence plantar pressure distribution as both 
groups presented with the same clinical signs and symptoms of neuropathy. Thus 
concluding that while a relationship existed between neuropathy and plantar pressure 
distribution, other predictive elements including vascular deficit, joint mobility and foot 
disorders should also be investigated (Bacarin et al. 2009). High plantar pressures and 
neuropathy were found to frequently coexist with diabetes; however, a direct causal 
relationship was thought to be speculative (Bevans 1992). Plantar pressure distribution 
in patients presenting with Type 2 diabetes without neuropathy was investigated and 
showed similar maximum peak pressures as a control group without diabetes leading to 
the conclusion that either motor or sensory neuropathy had to be present before plantar 
pressures became elevated (Tong et al. 2011). Abboud et al. (2000) found a delay in 
muscle contraction time with diabetes, with the anterior tibialis muscle reaching a 
significant delay. This delay was thought to alter the speed of forefoot contact during 
gait allowing the foot-flat stage to be achieved in a less orderly approach than in control 
subjects. The outcome of this was that the forefoot was subjected to higher plantar 
pressure. The impact of restricted ankle dorsiflexion on plantar pressure distribution 
was investigated by Malloy et al. (1999). They found that when the restriction of 
dorsiflexion was to a neutral or dorsiflexed position, there was no significant impact on 
plantar pressure. However when the limitation in available dorsiflexion was 5 to 10 
degrees of plantarflexion, it produced a significant shift in the distribution of plantar 
pressure laterally and increased the pressure-time integral (impulse) at the forefoot. It 
should be noted that their study was carried out on healthy subjects with no lower limb 
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pathologies utilising ankle foot orthoses to limit mobility and the subject group 
consisted of only 5 male and 5 female volunteers. However, Fernando et al. (1991) 
found that patients with diabetes coupled with limited sub-talar joint mobility and 
exhibiting clinical signs of neuropathy displayed higher mean forefoot pressures and 
had more plantar ulcers when compared with diabetic subjects without neuropathy and 
healthy controls. It should be noted that clinical neuropathy was coupled with limited 
sub-talar joint mobility, so the differences noted between the groups could not solely be 
attributed to the presence of neuropathy. 
In conclusion, while it has been commonly reported that peripheral neuropathy is 
associated with higher plantar pressures, other factors have also been linked such as 
vascular deficit, limitation in joint mobility, foot disorders such as digital deformity and 
delay in muscle contraction, and are commonly found concurrently with neuropathy. 
The evidence would indicate a strong link between neuropathy and elevated plantar 
pressures in association with diabetes, but not a causal relationship as such.  
 
2.1.3 Alterations in plantar skin and pressure in diabetes 
The evidence that connects elevation of plantar pressures with thickening of the 
epidermis and callus formation is contradictory. Abouaesha et al. (2001) studied 157 
patients with diabetes and neuropathy but with no history of peripheral vascular disease 
or ulceration. Subjects who presented with forefoot callus displayed a reduced tissue 
thickness under all of the MPJs with the exception of the first, and an increase in peak 
pressure across all MPJs. Thus they found a strong inverse relationship between plantar 
tissue thickness and dynamic foot pressure measurements. Hashmi et al. (2006) 
attempted to quantify specific glycation products generated in the plantar epidermal 
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proteins in Type 2 diabetes. They found a greater pentosidine (a biomarker for AGEs) 
concentration in the subjects with Type 2 diabetes than in healthy controls. Utilising 
high frequency ultrasonography they measured the thickness of the epidermis and found 
it to be thicker in Type 2 diabetes than in healthy controls and to have decreased 
plasticity. Kogler & Shorten (2001) found that pathologies like diabetes resulted in 
atrophy of the heel and forefoot fat pads caused an increase in plantar pressures. 
Callus was found to be located under high pressure areas and to further increase the 
loading under the feet (Boulton 1987); it was also thought to act as a foreign body 
elevating plantar pressures (Young et al. 1992) meaning that high plantar pressures are 
generally associated with evidence of stress-like callus formation (Abouaesha et al. 
2001; Masson 1992). Peak plantar pressures fall following removal of callus (Pitei et al. 
1999); however others have suggested that callus does not actually cause elevation in 
peak plantar pressure (Woodburn & Helliwell 1996; Potter & Potter 2000).  
The skin pathology which has been widely reported in conjunction with high plantar 
pressures in diabetes is ulceration.  
 
2.1.4 The role of plantar pressures in ulcer formation 
Elevated plantar pressures have been cited as a risk factor involved in the pathogenesis 
of plantar ulceration in diabetes, however most authors would agree that the elevation in 
pressure is found in conjunction with other risk factors such as neuropathy, peripheral 
arterial disease, muscle dysfunction and foot deformities (Meinders et al. 1996; 
Mayrovitz & Smith 1998; Abboud et al. 2000; Lord & Hosein 2000; Plank et al. 2000; 
Bowering 2001; Cobb & Claremont 2001 and 2002; Khan & Newton 2003; Koitka et 
al. 2004a; Newton et al. 2005; Hahn et al. 2007; Tong et al. 2011). Patients with 
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diabetic neuropathy and a history of ulceration were found to display significantly 
higher pressure than those without ulceration (Plank et al. 2000). However, no 
difference was found in pressure at the site of ulceration and the contralateral foot. They 
concluded that while high plantar pressure was important in the development of 
ulceration, additional factors must be involved.  Around 1 in 20 people with diabetes 
will develop a foot ulcer each year (Abbott et al. 1998), and Meinders et al. (1996) 
noted that while the occurrence of ulceration was common with diabetes, aetiological 
factors including neuropathy and micro-angiopathy as well as elevated plantar pressures 
had to be implicated. However the interaction of these factors was uncertain. Mayrovitz 
& Smith (1998) commented that the heel was subject to ulceration in conditions such as 
peripheral arterial disease and diabetes as it had a small surface area of contact with 
fairly high local pressure coupled with a limited basal blood flow. Reduction in blood 
flow and neuropathic factors when associated with the abnormal pressures found in 
diabetes have been proposed as the principal factors in the pathogenesis of ulceration, 
although the precise role of pressure is still unknown (Levin 1995; Jeffcoate & Harding 
2003; Koitka et al. 2004a; Hahn et al. 2007). 
Bacharin et al. (2009) found alterations in plantar pressure distribution in 2 neuropathic 
groups with and without ulceration. Although the subjects presenting with ulceration 
exhibited higher loads, both groups presented with similar clinical signs and symptoms 
of neuropathy, so they concluded that the progression of diabetic neuropathy could not 
be cited as influencing plantar pressure distribution. Thus, concluding that further work 
was required to investigate other predictive factors such as foot deformities, ankle joint 
mobility, autonomic and vascular deficits.  
As well as a link between increased plantar pressures and plantar ulceration, there is 
also a risk with lower pressures, but experienced over an extended duration also adding 
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to that risk. Several studies have concluded that diabetes leads to alterations in gait, and 
one of the main findings has been a significant reduction in walking speed (Brach et al. 
2008; Ko et al. 2011; Volpato et al. 2012; Raspovic 2013). Slower walking in subjects 
with Type 2 diabetes means that the contact time for the plantar aspect is generally 
increased in comparison to that found in subjects without diabetes.  An investigation 
into gait patterns in older adults with Type 2 diabetes by Ko et al. (2011) also found that 
alterations in gait occurred prior to the onset of peripheral neuropathy, with a 
significantly shorter stride during fast walking occurring (p = 0.033). Again the impact 
of a shorter stride pattern would be longer contact and thus extended time when the 
plantar aspect of the foot would experience pressure. Baccarin et al. (2009) also noted a 
cautious walking pattern was present, with decreased speed and an increase time of 
double support, again leading to an increased contact time.  
 
2.1.5 Summary 
Plantar pressure alterations found in conjunction with diabetes have been investigated in 
numerous studies. While it has been firmly established that they play a key role in the 
development of foot problems encountered with diabetes like callus formation and 
importantly ulceration, the evidence for epidermal changes is contradictory and it would 
follow that other risk factors are undoubtedly involved in the pathogenesis of these 
conditions. The association and links between the several risk factors have not been 
fully investigated and in order to obtain a better understanding of the development of 
foot disorders, further research is required. 
When investigating the role of elevated plantar pressures in the development of foot 
disorders like ulceration, it is essential that reliable methods of assessing plantar 
pressures are available. Several commercial systems have been developed to assess 
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barefoot plantar pressures and also those found when the foot is encased in footwear. 
Platform systems are useful for barefoot analysis assessing the foot to ground interface, 
whereas in-shoe insole based systems assess the foot to footwear interface. The 
following section outlines some of the more commonly used available systems. 
 
2.2 METHODS FOR ASSESSMENT OF PLANTAR PRESSURES 
2.2.1 Background 
The foot during locomotion is normally the only part of the body in contact with the 
ground. Foot function is controlled by both intrinsic and extrinsic muscles which allow 
the foot to be both adaptive to deal with the changes in loading patterns during the 
contact phase of gait, and compliant so that walking over uneven ground is possible. 
When the foot makes contact with the ground an equal and opposite force is created 
caused by gravity and the velocity of the body, known as ground reaction force 
(Abboud et al. 1996). During locomotion, pressures are transmitted via the plantar 
surface to the deeper structures of the foot, and measuring plantar pressure provides an 
additional dynamic component to foot evaluation which is clinically important for the 
identification of foot deformities which in turn can impact upon the foot ground 
interface (Natali et al. 2010). In the late 1960’s the majority of neuropathic foot ulcers 
were reported to occur under pressure bearing areas of the foot. This then lead to the 
development of systems to measure the pressures under the foot and the initial system 
utilising instrumented shoes to measure dynamic plantar pressure appeared in the 
1970’s (Alexander et al. 1990). 
Currently there are several systems available to measure static and dynamic forces 
exerted on the foot-to-ground interface, foot-to-shoe and sole of the shoe to ground 
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interfaces. Most systems available measure vertical forces or pressure, but the important 
shear stresses are now being studied. Lord & Hosein (2000) investigated plantar shear 
stresses in a group of subjects with a history of diabetic neuropathic ulceration in 
comparison with asymptomatic adults. Shear was not found to be significantly different 
between the groups, but they did find a medial shift of stress across the forefoot in the 
group with neuropathic ulceration.  
With the variety of systems available and thus types, number and size of sensors utilised 
inevitably leads to variation in measurements and units employed. Davis et al. (1996) 
noted that even when sensor size was standardised, different protocols utilised for 
gathering data could impact upon the results.  Comparison of an in-shoe and a platform 
system found that the data could not be extrapolated from one method to the other; they 
recommended standardisation of collection of data but that the systems should be 
recognised as not interchangeable (Chevalier et al. 2010). 
 
2.2.2 Platform systems 
Platforms enable collection of data in a barefoot state i.e. without the influence of 
footwear which can mask high pressure areas. The whole foot/ground contact can be 
measured and subjects are able to walk naturally without wires or data boxes attached to 
them. They do require a walkway to ensure the plate is flush with the surface and 
targeting of the plate can be an issue (McPoil et al. 1995). Earlier systems tended to 
have few sensors and provided poor resolution but with improved technology higher 
resolution systems have been developed and are widely available on the market. 
 
 
23 
 
2.2.2.1 Musgrave plantar pressure platform system (Preston Communications) 
One of the earlier plantar pressure platform systems was developed in Belfast at 
Musgrave Park Hospital, with the latest computerised system (5th generation) consisting 
of two plates with an active area of 394 x 194mm2 each containing 2048 5 x 
5mm 2 force sensing resistors which are electronically scanned with a speed of 113,777 
sensors/second and calibration is with a hydraulic probe (Preston Communications).  
Some issues had been found with higher levels of pressure and Young et al. (1993) 
found the system saturated above 15kg/cm2 thus preventing use for conditions where 
high levels of pressure could be noted, such as diabetes.  Musgrave system is not 
commonly used now and has been superseded by other more reliable systems.  
 
2.2.2.2 Pedobarograph 
This system follows a very early principle described in 1934 by Elftman utilising a light 
source and dots and squares on a glass plate and recorded on cine-camera, the size and 
density of the dots and squares indicating pressure levels. The system is now made up 
of a contact plate made of thin opaque plastic with a glass plate beneath. The glass plate 
is illuminated with strips of light. Alteration of internal reflections of light occur when 
the force is applied via the foot causing contact between the opaque plastic sheet and the 
glass, so when viewed from below, the light pattern is proportional to the pressure 
applied. A mirror held at an angle of 450 below reflects the light pattern and the data 
generated is connected to a computer, thus the pressure is recorded. The system can be 
calibrated with the application of known loads to the platform, but has the disadvantage 
of not being portable (Abboud et al. 1996; Urry 1999). Again, like the Musgrave system 
it has been superseded by more advanced systems. 
24 
 
2.2.2.3 Tekscan Matscan®and Walkway™systems (Tekscan Inc. Boston, 
Massachusetts) 
Two resolutions of the systems, standard and high resolution are available in multiple 
sizes with associated increase in sensors ranging from 435.9mm x 368.8mm in area 
housing 2288 sensors to 50,688 sensors encased in a low profile mat of 2926.1 mm x 
447.0 mm. Scanning speeds are 100Hz and 440 Hz. As the sensors are compact in size, 
the platform height at 5mm has a profile which allows utilisation of the system without 
the need to embed in a walkway (Tekscan, MA, USA 2013). Utilising the two-step gait 
protocol for measuring the parameters of dynamic pressure, 30 healthy asymptomatic 
adults were assessed on two occasions, one week apart. The system was found to offer 
moderate to good test-retest reliability (Zammit et al. 2010). Two Tekscan 
Matscan® systems were assessed for repeatability along with two Novel emed-
x® systems with 22 healthy participants with 10 walking trials on each system during the 
same visit. The inter-system reliability was found to be good between the systems thus 
allowing repeatable data collection to occur between the systems (Hafer et al. 2013). 
Figure 2.1 displays the Tekscan Walkway™. 
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Figure 2.1 Tekscan Walkway™ 
2.2.2.4 The Emed®system (Novel gmbh Germany) 
Novel currently produces 5 Emed® platform systems (Novel gmbh Germany) illustrated 
in Figure 2.2. They offer a range of size, number of sensors, sampling frequency, 
maximum total force and resolution as outlined in Table 2.1. All systems use calibrated 
capacitive sensors and connect to computers via the USB interface. Hughes et al. (1991) 
found the Emed®–f system, which was an earlier version to be reliable for most force or 
pressure measurements, and when the mean of three or more trials was calculated found 
reliability to be even better. Bryant et al. (2000) found their results utilising Emed®–sf 
also to correlate well with earlier studies. The Emed® ST4 was assessed for repeatability 
when mounted in the centre of a flat 10m walkway with 53 healthy volunteers. The 
mean number of days between repeating data collection for the same individual was 
11.8 days. The coefficient of repeatability was less than 16.9% for the parameters 
considered which included peak pressure, contact area, contact time, the pressure-time 
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integral, force-time integral and instant of peak pressure, thus the system was found to 
be repeatable (Putti et al. 2008). The Emed® ST2 system was also tested for 
repeatability by Maetzler et al. (2010) and found to be comparable with the results of 
Putti et al. (2008) on the earlier system. This study utilised 23 healthy subjects who 
were tested and retested 7 days apart. The parameters were start and end of contact, 
contact time, peak pressure, instant of peak pressure, contact area and the pressure-time 
integral with the coefficient of repeatability being found to be less than 16% for all 
parameters, thus the updated system was also found to be repeatable. 
 
Table 2.1 Current range of Emed® platform systems (adapted from novel gmbh 
Germany 2012). 
 
Platform 
Type 
Sensor 
Area 
(mms) 
Number of 
Sensors 
Resolution 
Sensors/ 
cm2 
Sampling 
Frequency 
Max. force 
(Newtons) 
 emed a50 389 x 226 1,760 2 50/60 110,000 
emed c50 395 x 240 3,792 4 50/60 120,000 
emed n50 475 x 320 6,080 4 50/60 193,000 
emed q100 475 x 320 6,080 4 100 193,000 
emed x400 475 x 320 6,080 1 or 4 100/400 193,000 
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Figure 2.2 Emed® platform system in conjunction with portable walkway 
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2.2.2.5 Kistler® force plate (Kistler Instruments Ltd.) 
The Kistler® force plate (Kistler Instruments Ltd.) utilises piezo-electric crystals which 
generate an electric charge along crystallographic axes, which can be measured via an 
amplifier (Figure 2.3). The transducer consists of four load cells, one located at each 
corner and measures applied forces and moments along three orthogonal directions. It is 
generally considered accurate and reliable; however it is sensitive to temperature and is 
not portable, requiring to be set in concrete (Lord 1981; Abboud et al. 1996). 
Strain gauge sensors have also been used where one or more foils glued to a short beam 
bend on force being applied, causing a change in resistance of the material. Calibration 
of this change in resistance against known applied forces provide the magnitude of the 
force.  
 
 
Figure 2.3 Kistler® force plates sunk into a permanent walkway 
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2.2.3 In-shoe systems 
As technology has progressed, and sensors become smaller with higher sampling rates 
and faster computer systems became available, commercial in-shoe systems have been 
developed. In-shoe systems offer great advantages over platform systems in that they 
enable collection of data in the foot’s normal functioning environment during activities. 
As no area has to be set into the surface to collect data, targeting is prevented and they 
can provide multiple footstep data from both feet during a single walk. However, the 
feet can miss some aspects of the sensing area with the influence of the shoes and unless 
the system is wireless, the positioning of the wires/data box can alter the subject’s 
natural gait (Finch 1999). The material of the insole itself can alter the pressure e.g. a 
stiff insole and the depth of the insole with the sensors may increase pressures and make 
it uncomfortable for the subject (Rose et al. 1992). If the material of the insole itself is 
slippery it may alter the natural gait and bending of the insole to fit the shoe which may 
in turn affect the sensors. 
 
2.2.3.1 F Scan® system (Tekscan Inc. Boston, Massachusetts) 
The system (Figure 2.4) uses an insole with a matrix of 960 force sensing resistors with 
a sensing range of 50.75 to 862 kPa, held in a micro-thin insole of 0.15mm. Insoles are 
available in sizes up to USA 14 shoe size, but can be trimmed to fit the individual shoe. 
While the depth of the insole is useful in that it does not take up space within the shoe, 
they are prone to wrinkling when inserted into the shoe, or when walking. The system 
does also suffer from calibration issues with the sensitivity of the insoles declining with 
use as much as 20.5% with multiple use (Abboud et al. 1996; Urry 1999). As Young et 
al. (1993) found issues with the Musgrave system which utilised force sensing resistors 
at higher pressure levels, McPoil et al. (1995) found that although the F Scan® system 
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displayed a linear correlation with known loads, the system was found to be less 
accurate when pressure levels exceeded 200kPa.  
 
 
 
Figure 2.4 F Scan® system with insoles which can be cut to size 
 
2.2.3.2 Pedar® plantar pressure measurement system (Novel gmbh Germany) 
This in-shoe system (Figure 2.5) is one of the most commonly used in-shoe systems 
(Putti et al. 2007). It uses 2mm deep insoles to house 256 capacitive sensors with a 
frequency of  20,000 sensors/sec. The sensors measure change in capacity with a change 
in distance between two conducting wires which change with loading (Novel gmbh 
Germany). Similar to the equivalent platform system, calibration of the system was 
found to be straightforward to carry out and accurate, and McPoil et al. (1995) found 
less creep than exhibited with the F scan® insole when continuous and constant pressure 
was applied. The system is also available with Bluetooth technology which reduces the 
need for subjects to have wires and a data box attached to them thus preventing gait 
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alterations. A study utilising 53 healthy subjects who were clinically assessed to ensure 
no pathologies were present which might affect their gait, were assessed using the 
Pedar® system. The insoles were placed inside a specific model of shoe and 8 steps of 
data were collected per straight line for 8 walks per session. The same protocol was 
repeated during a second session. The Pedar® system was found to be repeatable for the 
pressure parameters tested (Putti et al. 2007). 
 
 
 
Figure 2.5 Pedar® in-shoe system insoles 
 
2.2.4 Summary 
The development of systems to measure plantar pressure has enabled evidence to be 
gathered about the function of the plantar aspect of the foot in relation to the shoe and 
external environment in health, and more importantly in disorders which impact upon 
the function of the foot such as diabetes. It has provided valuable data useful in the 
expansion of knowledge regarding the development of ulceration, and has provided a 
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method of investigating how useful offloading strategies are in the management of such 
problems. However, as plantar pressure alterations are only one of the risk factors in the 
development of ulceration, further work is required to investigate the relationship 
between the various risk factors. There have been great strides in the development of 
systems to measure plantar pressure, but there is no perfect system available, and there 
are advantages and disadvantages to both platform and in-shoe commercial systems. A 
major issue with any of the systems outlined here is the limitation to measuring vertical 
stresses only, and thus the inability to measure shear stress which also has an important 
role to play in the development of foot pathologies. In addition to plantar pressure, 
blood flow is a critical factor in determining the development of ulceration on the 
plantar aspect of the foot in diabetes. The circulation in the foot in areas of ground 
contact during ambulation was found to be reduced in subjects with diabetes, but it was 
only in the areas where elevated pressures were located such as the metatarsophalangeal 
joint areas of the forefoot that ulceration was found to develop. Thus reduction in blood 
flow and elevation of plantar pressure both were found to be associated with tissue 
breakdown (Proano et al. 1992). When heel skin microvascular perfusion was 
investigated in response to sustained pressure loading during surgery as well as in 
patients who were in long term residential care, it was found to be rapidly as well as 
significantly reduced with loading and to remain so with the duration of the loading 
period thus again leading to a risk of heel tissue breakdown (Mayrovitz & Smith 1998). 
With increase in demands made upon the microcirculation as a result of issues like 
injury, infection or prolonged pressure, the damaged microcirculation associated with 
diabetes may not be able to respond appropriately and resultant tissue breakdown and 
ulceration occurs (Flynn & Tooke 1992). Whilst a relationship between pressure and 
blood flow does exist in the pathogenesis of ulceration particularly in pathological states 
like diabetes, it appears to be a complex relationship and further evidence to provide a 
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better understanding of this relationship is undoubtedly required. This is perhaps further 
hindered by the fact that there are no commercial systems for measuring plantar 
pressure available which can readily be utilised in conjunction with blood flow 
measurement, to simultaneously assess both.   
 
2.3 BLOOD FLOW ANALYSIS 
There are many factors which are thought to play a part in the control of blood flow, of 
which endothelial function is one of the most important. Such elements as endothelium-
derived dilating factors (nitric oxide (NO) and prostacyclin) and contracting factors 
such as endothelin, prostaglandins and reactive oxygen species (ROS) all play an 
important role. Over the past 20 years, great advances have been made for developing 
techniques for assessing endothelial function, and in this review some background to the 
more important factors is presented, and then some of the methods available for 
measuring blood flow are discussed. Each method has advantages and disadvantages, 
and I will provide information on some of the more commonly used methods.  
 
2.3.1 Endothelial structure and function 
The endothelium is made up of a monocellular layer covering all of the innermost 
surfaces of blood vessels (Triggle et al. 2012). Its cellular characteristics are basically 
the same as those in all human cells, with a nucleus surrounded by cytoplasm and 
organelles and held within a membrane. It has long been known as a lining, acting as a 
barrier to intravascular coagulation, but as far back as 1980, Furchgott and Zawadzki 
recognised the importance of the endothelium in the regulation of vascular function, and 
more recently multiple functions regulating blood flow and tissue homeostasis have 
been recognised (Daugherty et al. 1995; Furchgott 1996; Feletou & Vanhoutte 1999; 
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Mombouli & Vanhoutte 1999; Calles-Escandon & Cipolla 2001; Esper et al. 2006, 
Kampoli et al. 2009).  
The cell membrane is a phospholipid structure which is double layered with water 
between the layers, and crossed by receptors or ion channels of complex proteins. There 
are many contractile proteins crossing the cytoplasm including the cortical web which is 
a structure responsible for shape and elasticity. This affords some sensitivity to changes 
in intravascular tension and stiffness when there is an increase in intravascular pressure. 
Passage of solutes and macromolecules across the membrane are regulated by the 
junction-associated actin filament system known as the FAU system. Cyclic adenosine 
mono-phosphate (cAMP) and cyclic guanine mono-phosphate (cGMP) generated by a 
Ca2+ nitric oxide guanylate-cyclase dependent pathway are second messengers which 
stabilise the FAU system. Stress fibres made of actin and myosin filaments forming 
bundles cross the cytoplasm in all directions. When blood flow increases the fibres 
flatten and align in the direction of flow (reacting to shear stress) and vice versa with 
reduced blood flow they increase in volume and lose alignment. The cell membrane is 
covered with caveolae, flask shaped invaginations and through them, the endothelium 
regulates fluid and macromolecular passage between the vascular and cellular 
compartments (Esper et al. 2006). Adjacent endothelial cells are connected by low 
resistance Myoendothelial gap junctions (MEGJs) which allow electrical continuity as 
well as hyperpolarization important for spreading vasodilation. Fenestrae (openings) 
found in the internal elastic lamina aid MEGJs in providing the electric coupling 
between the endothelium cells and vascular smooth muscle cells and the movement of 
small molecules between the cell layers (Triggle et al. 2012). 
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2.3.2 Endothelial physiology 
Endothelial physiology is a huge field with many published papers and to carry out a 
full review of this area is out with the remit of this dissertation, however a brief 
overview will be detailed in this section. The endothelial cell senses physical or 
chemical stimuli inside the vessel (Figure 2.6) and can modify the shape of the vessel or 
release substances to counteract a stimulus and thus maintain homeostasis (Felton & 
Vanhoutte 1999). The endothelium has the capability of producing molecules as 
agonists or antagonists, creating a balance in both directions, these substances include 
vasodilators and constrictors, pro and anticoagulants, inflammatory and anti-
inflammatory agents, fibrinolytics and antifibrinolytics, oxidising and antioxidising 
agents and many others (Daugherty et al. 1995; Esper et al. 2006). 
 
Figure 2.6 Vascular smooth muscle and endothelial cell communication- close communication between the 
endothelial cells and vascular smooth muscle regulates vascular tone and blood flow. Factors such as shear 
stress lead to endothelial dysfunction and platelet aggregation. The dysfunction caused by shear stress and 
other factors reduces the levels of EDHF (endothelium derived hyperpolarising factor), nitric oxide and PGI2 
(prostacyclin). This combined with an increase in endothelium-derived constriction factors will lead to 
vascular smooth muscle cell depolarisation and results in constriction of the vessel. Contacts are made through 
the gap junctions which are closely associated with Na+/K+ ATPase (sodium-potassium adenosine 
triphosphatase, or sodium-potassium pump) on the vascular smooth muscle membrane (adapted from Rang & 
Dale’s Pharmacology 2007). 
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2.3.3 Endothelium-derived vasodilators 
2.3.3.1 Nitric oxide (NO) 
Initially in 1980, Furchgott and Zawadzki demonstrated an endothelial-derived 
relaxation factor which caused vasodilation in the underlying vascular smooth muscle, 
and this was later found to be nitric oxide (Ignarro et al. 1987a; Ignarro et al. 1987b; 
Daugherty et al. 1995; Mombouli & Vanhoutte 1999). NO is present in just about all 
tissues and with a low molecular weight and lipophilic features it can cross cell 
membranes very easily by diffusion. It reaches the arterial smooth muscle wall by 
crossing the endothelial intima causing relaxation of the muscle and vasodilation. It also 
passes into the lumen and has been found to reduce platelet aggregation, tissue 
oxidation, inflammation, activation of thrombogenic factors, cell growth, proliferation 
and migration (Esper et al. 2006). It has been established that NO is involved in 
vasomotor tone, vascular homeostasis and neural and immunological functions (Calles-
Escandon & Cipolla 2001), and a decreased production of NO is thought to play a role 
in vascular disease states such as atherosclerosis, hypertension and peripheral arterial 
disease (Daugherty et al. 1995).  
 
2.3.3.2 Production of NO 
Endogenous NO (Figure 2.7) is produced by the action of the enzyme NO-synthase 
(NOS) converting the amino acid L-arginine to L-citrulline and tetrahydrobiopterin 
(BH4) acts as an accelerator for the process (Moncada et al. 1991; Busse et al. 1993; 
Fleming & Busse 1993; Daugherty et al. 1995; Mombouli & Vanhoutte 1999; Calles-
Escandon & Cipolla 2001; Alp et al. 2003; Esper et al. 2006). NOS in endothelial cells 
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is localised in the caveolae and is negatively regulated by caveolin, a ‘scaffolding’ 
protein encoded by the CAV1 gene (Mombouli & Vanhoutte 1999).   
 
 
Figure 2.7 Production of nitric oxide – In the plasma membrane eNOS (endothelial nitric oxide synthase) is 
associated with caveolin-1. With an increase in free intracellular calcium and receptor mediated stimulation, 
eNOS dissociates from caveolae. The then free eNOS undergoes protein-kinase mediated phosphorylation and 
eventually the active eNOS catalyses the conversion of molecular oxygen to nitric oxide (NO) using L-arginine 
as the substrate and nitrogen donor. 
 
Three isoforms of NOS have been isolated (Table 2.2), two constitutive and low 
production, and one inducible. NOS-1 is from neurological tissue, isolated from the 
brain and NOS-111 from endothelial cells; both are seen to respond to agonists which 
increase intracellular Ca2+. The inducible NOS-111 is produced by macrophage and 
endothelial cells in response to pro-inflammatory cytokines. As a result it is said to 
participate in the defence of the host (Daugherty et al. 1995; Calles-Escandon & Cipolla 
2001; Esper et al. 2006). The constitutive isoforms produce NO for short periods when 
induced by vasodilators like ACh or bradykinin. The inducible NOS synthesises NO for 
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longer periods, constantly when stimulated by cytokines e.g. tumour necrosis factor –α 
(TNF-α) (Fleming & Busse; 2003; Esper et al. 2006). 
Table 2.2 Characteristics of the isoforms of NOS  
Characteristics Type I NOS 
(nNOS) 
Type II NOS 
(iNOS) 
Type III NOS 
(eNOS) 
Mol. Wt. of 
monomer 
160 kDa 130 kDa 133 kDa 
Subcellular 
localization 
Largely cytosolic 
(except skeletal 
muscle) 
Cytosolic Membrane bound 
Regulation of 
expression 
Constitutive 
Upregulated by sex 
hormones and after 
nerve injury 
Not normally present 
Expression induced 
by 
cytokines/endotoxins 
Constitutive 
Upregulated by sex 
hormones and shear 
stress 
Substrates Arginine  O₂, 
NADPH 
Arginine  O₂, 
NADPH 
Arginine,  O₂, 
NADPH 
Co-factors FAD, FMN, BH₄ FAD, FMN, BH₄ FAD, FMN, BH₄ 
Prosthetic groups Haem, calmodulin Haem, calmodulin Haem, calmodulin 
Ca2+-dependency of 
calmodulin binding 
Yes 
Activated by 
[Ca²⁺]i above 
normal resting 
concentration of 
cells 
No 
Tightly bound – 
activity independent 
of [Ca²⁺]i  
Yes 
Activated by [Ca²⁺]i  
above normal 
resting 
concentration of 
cells 
Levels of NO 
produced 
pmoles nmoles pmoles 
Major function Neuronal 
messenger 
Immunocytotoxicity Relaxation of 
vascular smooth 
muscle 
 
2.3.3.3 Stimulation for NO release 
An increase in blood velocity creates a shear stress and this shear stress is the most 
important stimulation for NO release. It leads to vasodilation which is proportional to 
the amount of NO released by the endothelium, and this is known as endothelium-
dependent vasodilation (Esper et al. 2006). 
Specialist ion channels e.g. Ca2+ activated K+ channels respond to shear stress and open 
up. This opening hyperpolarises the endothelial cell which generates NO by increasing 
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the force for Ca2+ entry, and activating NOS-111 (Busse et al. 1993; Calles-Escandon & 
Cipolla 2001). 
 
2.3.4 Other endothelium-derived vasoactive factors 
Like NO, prostacyclin (PG12) is a vasodilator which inhibits platelet aggregation 
through the activation of adenylyl cyclase rather than guanylyl cyclase (Daugherty et al. 
1995). It is primarily produced by endothelial cells in the vascular wall; however, its 
vasodilator activity is determined by the expression of specific receptors located in 
vascular smooth muscle so if the arterial beds do not have these receptors prostacyclin 
cannot function as a vasodilator. PG12 facilitates the release of NO and in turn its own 
action is potentiated by NO (Mombouli & Vanhoutte 1999). 
In studies investigating arteries such as the rat aorta in response to acetylcholine (Schini 
& Vanhoutte 1992), endothelium-dependent relaxations to acetylcholine or vasopressin 
were eliminated by inhibitors of L-arginine NO pathway, however, in vessels of smaller 
diameter this was not the finding (Vanhoutte 1993).  Furthermore, shear stress activates 
a factor distinct from NO in perfused arteries, with the most likely substance being an 
endothelium-derived hyperpolarizing factor (EDHF). EDHF mediated endothelium-
dependent vasodilation is insensitive to inhibition by a combination of NOS and 
cyclooxygenase (COX) inhibitors which results in hyperpolarisation of the vascular 
smooth muscle cells (Triggle et al. 2012). In vascular preparations acetylcholine and 
other endothelium-dependent agonists cause endothelium–dependent hyperpolarization 
which cannot be prevented by the inhibitors of NO formation. Nitric oxide synthase 
inhibitor NG-Monomethyl-L-Arginine (L-NMMA) is a known competitive inhibitor of 
NO synthase, and it also inhibits the release of NO from endothelial cells (Moncada et 
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al. 1991). In contrast to NO there is no basal release, but a stimulated release by 
substances like acetylcholine, bradykinin, adenine nucleotides, histamine, and thrombin.   
 
2.3.5 Endothelium-derived contracting factors  
2.3.5.1 Endothelin 
Vascular tone is regulated through the action of vasoconstrictors and vasodilators which 
are locally produced and vascular tone is a result of the balance between these opposing 
factors. Nitric oxide is the most important of the dilators and endothelin is the most 
potent of the vasoconstrictors (Mather et al., 2004).  Endothelial cells also synthesise 
the prohormone big-endothelin and express endothelin-converting enzyme to produce 
the vasoconstrictor endothelin. Endothelin stimulates NO production so creating a 
limiting effect on its own activity, and in turn NO inhibits endothelin production, which 
provides a mechanism of action of nitrovasodilators (Masaki 1995). 
 
2.3.5.2 Prostaglandins 
In endothelial cells, metabolism by COX of arachidonic acid leads to prostaglandin H 
secretion, which is the precursor of thromboxane A2. Both act on receptors in the 
smooth muscle and cause vasoconstriction to occur. However under normal 
circumstances the small amount of vasoconstrictor released by the endothelial cells is 
masked by the production of prostacyclin (Mombouli & Vanhoutte 1999). 
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2.3.5.3 Reactive oxygen species (ROS) 
Products of normal aerobic metabolism for example, superoxide anions, hydrogen 
peroxide, hydroxyl and lipid radicals, when they react with other molecules are referred 
to as ROS. Normally antioxidants neutralise their effects however, in pathological 
conditions ROS may reach excess known as ‘oxidative stress.’ De Vriese et al. (2000) 
defined oxidative stress as ‘an increase in the steady state levels of reactive oxygen 
species and may occur as a result of increased free radical generation and/or decreased 
anti-oxidant defence mechanisms.’ This may impact on cellular and tissue function and 
the excess ROS can oxidise NO forming peroxynitrite which can then lead to further 
oxidation (Mombouli & Vanhoutte 1999; Esper et al. 2006). 
 
2.3.5.4 Inflammation 
Endothelial cell activation can originate with inflammation, which in turn can lead to 
proliferation of the vascular smooth muscle cells and thus to vascular remodelling. This 
process is initiated by an increase in the vascular wall adhesion molecule (VCAM-1) 
and the intercellular adhesion molecule ICAM-1). The increase in the adhesion 
molecules on the endothelial cell membrane leads to a migration of, and accumulation 
of monocytes forming macrophages, and dendritic cells, as well as B and T 
lymphocytes which then cause an inflammatory response in the vascular wall to occur. 
The monocytes migrate to the intima (the inner layer of the arterial wall) and there they 
are transformed into macrophages. Foam cells are formed with the scavenger receptors 
binding oxidised low density lipoproteins (LDLs). The foam cells produce ROS and 
proinflammatory cytokines tumor necrosing factor and interleukin (TNF, IL-1β, IL-6) 
which then leads to the activation of more adhesion molecules thus cyclically producing 
more macrophages and B and T lymphocytes. This progressive accumulation of lipids 
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and foam cells then leads to fatty streak formation (Figure 2.8) (Esper et al. 2006; Khan 
et al. 2010; Savoia et al. 2011). 
 
 
Figure 2.8 Inflammation and endothelial dysfunction leading to the formation of foam cells and fatty streaks 
(adapted from Khan et al. 2010) 
 
2.3.6 Summary 
An understanding of the structure of the endothelium is important when investigating 
possible functional disorders. It can be noted in Section 2.3 that there are numerous 
elements involved in the function of this structure for regulation of blood flow and 
tissue haemostasis, with NO being of prime importance. With such a variety of 
substances involved in the function, it is inevitable that there would be several possible 
mechanisms which can lead to dysfunction of the endothelium. 
 
2.3.7 Endothelial dysfunction 
As endothelial dysfunction can be either a decrease or increase in secretion of a 
vasodilator, an increased in sensitivity to vascular smooth muscle, and similarly with 
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vasoconstrictors, no single definition would cover the possible alteration of normal 
function; however what it does is to create abnormalities in the lumen of vessels 
(Mombouli & Vanhoutte 1999; Calles-Escandon & Cipolla 2001), and the mechanism 
by which endothelial dysfunction actually occurs remains obscure (Khamaisi & Raz 
2006). Endothelial dysfunction has been given more emphasis in the pathogenesis of 
many disorders like atherosclerosis and hypertension and microvascular dysfunction 
with the complications of diabetes mellitus, PAD and kidney failure (Cracowski et al. 
2006). 
 
2.3.8 Endothelial dysfunction with diabetes mellitus 
With both Type 1 and Type 2 diabetes, the endothelium has been found to be more 
vulnerable to developing pathological changes, and there has been a large variety of 
mechanisms thought to contribute to this (Kampoli et al. 2009). In studies involving 
children and adolescents changes in endothelial function have been identified prior to 
the manifestation of clinical indications of dysfunction (Elhadd et al. 1998; Khan et al. 
2000). The pathogenesis of endothelial dysfunction in diabetes has been found to be 
multifactorial, and clinical studies have the added confounding element of the high 
prevalence of other cardiovascular risk factors also known to impact upon endothelial 
function (De Vriese et al. 2000; Khamaisi & Raz 2006). Hyperglycaemia is clearly 
implicated in the pathogenesis of complications associated with diabetes, and induces 
acute changes in intracellular metabolism such as activation of the polyol pathway, of 
protein kinase C and increasing oxidative stress as well as long term changes in 
macromolecular structure and function with the formation of AGEs (De Vriese et al. 
2000). 
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2.3.8.1 Oxidative stress 
There is an increasing amount of evidence implicating oxidative stress in the 
pathogenesis of diabetic endothelial dysfunction (De Vriese et al. 2000). The influence 
of puberty (a period noted for intense hormonal and metabolic changes) on endothelial 
dysfunction and oxidative stress was assessed in a group of 51 young patients with Type 
1 diabetes of which 12 were prepubertal children, 16 were adolescents and 23 young 
adults, all of which had no clinical indications of angiopathy or microalbuminuria. Skin 
blood flow responses to ACh were found to be significantly higher in the adolescent 
group in comparison to the young adult group and the markers of oxidative stress used, 
such as soluble intercellular cell adhesion molecule-1(ICAM-1) and E-selectin were 
also significantly higher in the adolescent group while von Willebrand factor (vWF) 
although not significant was found to be higher in the adolescent group, however there 
was no difference found between the groups for plasma thiol (PSH). They concluded 
that factors which contribute to the impact of puberty on endothelial function were 
possibly complex and quite likely to be associated to metabolic alterations in diabetes, 
an increase in lipid peroxidation and oxidative stress (Elhadd et al. 1998). Post 
occlusive reactive hyperaemia (PORH) utilising laser Doppler flowmetry was studied in 
a group of 58 children with Type 1 diabetes in comparison to 58 ages and sex matched 
healthy controls (Schlager et al. 2012). Their findings indicated peak perfusion post 
occlusion was significantly higher in the group with diabetes, but other parameters were 
not significantly different such as baseline perfusion, time to peak perfusion and 
recovery time. This high peak perfusion found at such an early stage in the disease 
process, was thought to be possibly linked to an impaired vasoconstrictive ability of the 
precapillary arterioles. Factors which have been linked to alterations in macro and 
microvascular reactivity found in diabetes are an increase in oxidative stress as well as 
elevated proinflammatory cytokines serum levels. They also concluded that as 
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autonomic neuropathy has been found to occur at an early stage, structural changes 
associated with this such as thickening of vascular basement membranes might also be 
involved with endothelial dysfunction. In agreement, Joannides et al. (2006) also noted 
that the peak flow found with PORH was mainly dependent upon structural and 
metabolic factors. Yamamoto–Suganuma & Aso (2009) also investigated PORH with 
104 subjects with Type 2 diabetes and 20 healthy controls, in agreement with Schlager 
et al. (2012) they found that an impaired PORH was associated with risk factors for 
micro and microvascular disease, however noted like Joannides et al. (2006) that 
maximum peak flow was dependent on structural and metabolic factors like adenosine 
and prostaglandins and thus not an index of endothelial function. This finding is 
somewhat puzzling as prostaglandins are known vasoconstrictor factors which can 
impact upon endothelial function.  
Alp et al. (2003) found increased production of ROS, in the form of endothelial cell 
superoxide production was raised in diabetes. This coupled with a loss of endothelial 
NO bioactivity was thought to be a key feature of vascular disease found with diabetes 
mellitus in animal studies. In agreement, Pacher et al. (2002) also noted oxidative stress 
played a critical role in the early onset of diabetic cardiomyopathy in animal studies.  
Kampoli et al. (2009) noted hyperglycaemia coupled with elevated free fatty acids and 
insulin resistance which characterise diabetes could act together to target endothelial 
cells. This combination was thought to lead to oxidative stress and in turn endothelial 
dysfunction.  Elevated blood glucose levels was found to drive the production of ROS 
via multiple pathways which in turn resulted in uncoupling of the mitochondrial 
oxidative phosphorylation and activation of protein kinase C (PKC) in vascular cells 
(Khamaisi & Raz 2006). 
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2.3.8.2 Advanced glycation end products (AGEs) 
AGE formation happens during the normal ageing process, but is accelerated during 
diabetes. They accumulate in the tissues with the formation of cross links and then 
generate oxygen-derived free radicals and cause a further increase in oxidative stress 
(De Vriese et al. 2000). Sampathkumar et al. (2005) evaluated a simple method of 
detecting serum levels of AGEs and correlated levels with diabetes and 
microangiopathy associated with retinopathy and nephropathy. The serum levels 
detected were higher with diabetes than in normal controls, and even higher with 
diabetes and known microvascular complications. They concluded that AGE could be a 
measure to predict microvascular complications in diabetes.  
 
2.3.8.3 The role of protein kinase C (PKC) 
 As PKC is involved in a variety of cellular functions, the consequences of activation 
can be multiple (De Vriese et al. 2000). It is a family of multifunctional isoenzymes that 
phosphorylate protein substrates. Of the 10 known mammalian isoforms 8 are activated 
by diacylglycerol (DAG), and activation of PKC is through ligand activation of G-
protein coupled receptors (Khamaisi & Raz 2006). Hyperglycaemia causes synthesis of 
DAG which then activates PKC and this pathway has been demonstrated in vascular 
tissues involved in diabetic complications like retinopathy and nephropathy, and there is 
increasing evidence that PKC activation in diabetes leads to endothelial dysfunction 
(Koya & King 1998; Khamaisi & Raz 2006).  
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2.3.8.4 Circulating biomarkers 
Brooks et al. (2008) investigated microvascular function on 20 subjects with diabetes 
with complications, 20 subjects with diabetes without complications and 20 healthy 
controls utilising laser Doppler flowmetry and iontophoresis of ACh and SNP. They 
also compared their blood flow results with biomarkers of endothelial dysfunction, 
including plasminogen activator inhibitor-1 (PAI-1), soluble intercellular adhesion 
molecule (sICAM), soluble vascular cell adhesion molecule (sVCAM) and high 
sensitivity C-reactive protein (hsCRP). They noted that traditionally the increase in 
blood flow in response to the endothelium-derived vasodilator ACh is taken as an 
indicator of endothelial function. However, they argued that this could only be the case 
when the response to SNP, which is not an endothelium-derived vasodilator (but 
dependent on NO) was normal, and both substances responded in association with 
diabetes in this study. Thus, they concluded that there must be another associated 
impairment in conjunction with endothelial dysfunction and postulated that an 
impairment of the vessels to react to vasodilator stimuli must also be present with 
diabetes. The abnormalities found in association with diabetes and complications were 
comparable with the hsCRP marker for inflammation. This link was found to be much 
stronger than displayed with the other markers assessed in this study. This finding was 
not in agreement with other studies but possibly attributed to the lower levels of 
albumin/creatinine ratio which in this study was in fact only twice the upper limit of 
normal. Caballero et al. (1999) when investigating groups who were at risk of 
developing diabetes, noted that cellular adhesion molecules were found in response to 
inflammation (being utilised to help the adhesion of circulating leukocytes to their 
surface which is an early stage in transendothelial migration and development of 
atherosclerosis). They have been reported as being higher in a number of cardiovascular 
conditions and diabetes in some studies. Release of vWF was reported as another 
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response of the activated endothelium and associated with the development of long term 
complications of diabetes. Freestone et al. (2008) investigated endothelial dysfunction 
in atrial fibrillation (AF) using flow-mediated dilatation (FMD) and investigated the 
relationship to plasma vWF. They reported higher levels in the group with AF in 
comparison to healthy controls and mentioned this as a measure of reduced endothelial 
NO production.  
 
2.3.8.5 Insulin 
There is controversy regarding the actual effect of insulin on NOS activity and the 
generation of NO. Kashyap et al. (2005) compared the response to insulin in a group of 
10 subjects with Type 2 diabetes with that of a group of 11 healthy controls. The base 
level of NOS found in the control group did not alter with the addition of insulin, 
whereas the NOS level of the diabetic subjects increased 2.5 fold with the addition of 
insulin. Their findings were that insulin stimulated muscle NOS activity was impaired 
in well controlled Type 2 diabetes and they concluded that impaired NOS activity could 
play a part in the insulin resistance in Type 2 diabetes.  The use of insulin therapy in 
Type 2 diabetes was found to actually improve endothelium-dependent and independent 
vasodilation, suggesting that it had a beneficial effect on vascular function (Vehkavaara 
et al. 2000). However, their implication that insulin therapy provided some 
improvement for endothelium-independent vasodilation would in fact imply that other 
aspects than improvement in NOS activity could be involved. 
Insulin has been found to exert cardiovascular actions by stimulating the release of NO 
and sympathetic neural outflow. The mechanism by which this occurs is not clear, and 
would appear to be either by stimulation of muscle blood flow and NO release by direct 
action on the vasculature, or by stimulation of neural mechanisms (Sartori et al. 1999). 
49 
 
Their findings, using sympathetically denervated limbs, would suggest that insulin had a 
direct vasodilator action in skeletal muscle in vivo. This action was directly mediated by 
stimulation of NO release and was masked by the sympathetic tone (vasoconstrictor) in 
innervated limbs. Sundell et al. (2002) looked at the effects of obesity on coronary flow 
response to insulin and found that young, obese, healthy men have reduced myocardial 
vasoreactivity. They noted that this could represent an early precursor of future arterial 
disease, however little evidence of this postulation could be drawn from their results. 
Laine et al. (1998) demonstrated that obesity was characterised by two defects in 
skeletal muscle: insulin resistance of cellular glucose extraction and an impaired 
endothelium-dependent vasodilation. They postulated that insulin resistance associated 
with obesity could not be overcome by normalizing muscle blood flow (a 75% increase 
in blood flow did not alter glucose uptake). In addition, Clark et al. (2003) when 
reviewing insulin action on blood flow and muscle metabolism noted that there was 
accumulating evidence to suggest that insulin resistance of muscle impaired glucose 
uptake could be partly due to impaired, insulin-mediated capillary recruitment.  
 
2.3.9 Summary 
As can been seen in Section 2.3.8, there are many areas of study and overlap of findings 
regarding the aetiological elements which contribute to glucose-induced damage to 
endothelial function. In several studies the intervention of strategies to correct one or 
more of the elements have provided a positive result, but this should not be taken as 
precluding other mechanisms from playing a role in endothelial dysfunction and in fact 
when for example, findings incorporate improvement in endothelium-independent 
vasodilation it must be presumed that other mechanisms are involved. 
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A wide variety of stimuli will invoke a response from an artery and these reactions can 
be utilised to evaluate endothelial function. Such stimuli include both physical and 
chemical elements, and measurements of biomarkers of endothelial activity, dysfunction 
or even damage have also been utilised to assess endothelial function. Both invasive and 
non-invasive methods of assessment have been developed for this purpose, however 
non-invasive methods have become the routine methods of choice (Steinmetz & Cole 
1993).   
 
2.3.10 Methods of assessing endothelial function 
A non-invasive method of measuring the endothelial function of the peripheral vessels 
is flow-mediated vasodilatation (FMD) which is often referred to as the ‘gold standard’ 
technique. It utilises high resolution ultrasonography to measure diameter changes in an 
artery. Shear stress is thought to initiate stimulation of the endothelium to produce a 
NO-dependent response and FMD, by measuring the changes in the artery provides a 
direct indicator of the NO bioavailability. The technique does require accurate image 
analysis and as such operator training is necessary for utilisation (Beveridge & Khan 
2012). Waveform analysis using Doppler ultrasound examines blood flow patterns. 
Laminar flow with the particles in the centre of the stream moving at maximum velocity 
and the peripheral particles stationary is the normal pattern of flow with undamaged, 
fully functioning vessels. With a stenosis, blood flow accelerates to form a jet and as the 
blood passes the actual area of stenosis, the flow pattern breaks down and produces 
areas of stagnation and often reverse flow. This disturbance is proportional to the degree 
of stenosis and also proportional to the range of recorded frequency shifts found within 
the pulsed Doppler sample volume. This alteration of flow velocities is known as 
spectral broadening (Steinmetz & Cole 1993).  
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Endothelium-derived biomarkers such as E-selectin, thrombomodulin and vWF can be 
utilised to identify possible cardiovascular risk. E-selectin plasma levels have been 
found to be indicative of endothelial cell activation as well as damage (Belch et al. 
1997). Thrombomodulin, a thrombin receptor found on vascular endothelial cells is 
released into the circulation when endothelial damage occurs, and vWF plasma levels 
have an inverse correlation with endothelial function and as such can be utilised as a 
predictor for cardiovascular disease (Beveridge & Khan 2012). 
Endothelial progenitor cells (EPCs) play a role in re-epithelialisation following injury to 
vessels and neovascularisation of ischaemic lesions. They are derived from bone 
marrow, and thought to have a role in the pathogenesis of atherosclerosis and 
cardiovascular disease (Werner et al. 2005). However, no precise definition of EPCs has 
been developed and no true standard of identification found and as such no protocol 
established for analysis of EPCs (Beveridge & Khan 2012). 
Currently, there are several commonly used non-invasive methods of assessing 
microvascular perfusion available such as laser Doppler flowmetry, laser speckle 
contrast imaging, photoplethysmography, thermography, transcutaneous oxygen 
tension, ankle brachial pressure index and nailfold capillaroscopy all of the methods 
offer advantages and disadvantages which can be found in Table 2.3. Of the methods 
available, laser Doppler flowmetry with iontophoresis and laser speckle contrast 
imaging were found to be the optimum methods for utilisation in this current study and 
as such are discussed in detail in the following sections. 
 
 
 
 
52 
 
Table 2.3 Selection of the current available techniques for assessing microvascular 
perfusion with their advantages and disadvantages 
Technique Function Advantages/Disadvantages 
Laser Doppler Flowmetry  Uses laser light 
Velocity of this back scattered 
light is detected providing 
Doppler frequency 
information 
Advantages 
-effective and reliable method for 
measurement of blood perfusion in the 
microvasculature 
-provides continuous, noninvasive and 
real-time measurement capabilities. 
-versatile and easy to use  
Disadvantages 
- motion artefact noise, lack of quantitative 
units for perfusion, lack of knowledge of  
depth of measurement  
Laser Speckle Contrast Imaging Interference when laser light 
has been reflected from 
different parts of an 
illuminated surface 
Advantages 
-rapid skin blood flow measurements over 
wide areas coupled with good resolution.  
-full-field imaging of skin perfusion in near 
real time 
Disadvantages 
-relationship between speckle contrast and 
velocity is highly non-linear, thus a lack of 
quantitative units 
Photoplethysmography Optical reflection mode 
system measuring scattering 
and absorption characteristics 
of tissue associated with 
changes in blood flow, with 
near infrared spectroscopy  
Advantages 
-non-invasive, Easy to use, cost effective 
and portable. 
Disadvantages 
-blood volume, movement of the vessel 
wall and orientation of erythrocytes may 
have an influence on the amount of light 
received.   
-cannot easily be calibrated. 
Thermography Thermal infrared imaging for 
the measurement of cutaneous 
circulation 
Advantages 
-can be used over large areas 
-allows for real time recording  
Disadvantages 
-If temperatures are very close in range, 
infrared imaging camera may misread the 
information and individual objects can 
become indistinguishable 
- current technology in thermography only 
allows for imaging to be applied to surface 
temperatures 
Transcutaneous Oxygen Tension Transcutaneous oxygen and 
carbon dioxide sensors 
directly measure tissue gas 
tensions with a short sensor 
response times 
Advantages 
-non-invasive and continuous 
Disadvantages 
Measurements do not equate directly to 
arterial blood flow due to skin perfusion 
Ankle Brachial Pressure Index Systolic pressure is measured 
at the ankle using either the 
posterior tibial artery or 
dorsalis pedis and the value in 
mmHg obtained here is 
divided by the brachial 
systolic pressure, utilising a 
pressure cuff and a hand held 
Doppler probe.A normal index 
value at rest is equal or higher 
than 1 
Advantages 
Easy to perform 
Non invasive 
Equipment is cheap and readily available 
Disadvantages 
Not useful for small vessel disease or with 
calcification of vessels  
Nailfold Capillaroscopy  Under 10x to 20x 
magnification has been used to 
assess digital microcirculation, 
and reproducibility  of 
capillary width and number of 
loops/millimeter have been 
measured.  
Advantages 
Simple to carry out and non-invasive, safe 
and cost effective 
Allows direct observation of nail fold 
capillaries. 
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2.3.11 Laser Doppler flowmetry (LDF) 
2.3.11.1 Background 
While many techniques such as photoplethsmography, thermography, transcutaneous 
oxygen tension, ankle brachial pressure index and nailfold capillaroscopy can provide 
an indirect indication of microvascular perfusion, laser Doppler flowmetry is one of the 
few that can assess the microcirculation directly. Changes in microvascular perfusion of 
the skin can be measured relatively easily utilising the non-invasive technique of laser 
Doppler flowmetry (Khan & Newton 2003; Rossi et al. 2006; Rossi et al. 2008; 
Fredriksson et al. 2010). The technique utilises the motion generated from a light source 
and captured by a detector, this is known as the Doppler effect. With LDF the moving 
erythrocytes, or in fact tissues, cause a scattering of the laser light, and the velocity of 
this back-scattered light is detected providing the Doppler frequency information 
(Wardell et al. 1993; Eun 1995; Khan & Newton 2003). The density and speed of the 
red blood cells when measured with a regular or constant haematocrit within the sample 
tissue, is known to be proportional to red blood cell flow, hence the utilisation of the 
term ‘flux’ as a unit of flow measurement. 
 
2.3.11.2 Instrument and measurement techniques 
Traditional LD flowmeters utilise a helium-neon laser light source of wavelengths 
varying between 630nm and 670nm with a fibre optic cable in contact with the skin 
surface (Figure 2.9). They provide an estimated perfusion depth of 1-1.5mm into the 
dermis and detect dermal blood flow without influence from the flow to the underlying 
skeletal muscle (Eun 1995; Fullerton et al. 2002; Khan & Newton 2003; Kvandal et al. 
2006; Turner et al. 2008).  An issue had been noted in that the optical fibres produce 
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low frequency noise artifacts; further developments have ensued to overcome this 
problem (Eun 1995).  
 
Figure 2.9 Laser Doppler flowmeter utilised in conjunction with an iontophoresis controller 
 
Semi-conductor laser diodes operating with near infrared light of 780nm to 820nm as a 
light source have been developed to replace the helium-neon lasers (Eun 1995; Khan & 
Newton 2003; Kvandal et al. 2006). The main advantages over traditional flowmeters 
being deeper penetration, and better reproducibility (Eun 1995; Khan & Newton 2003). 
In contrast to single point measurements, laser Doppler perfusion imaging affords non-
contact assessments (therefore desirable for wound assessments) with the laser beam 
position controlled by a system of mirrors. Currently, there are two main commercial 
laser Doppler imaging systems, produced by Lisca Development AB, Sweden and Moor 
Instruments Ltd UK. A digital image is produced, being developed as the combination 
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of many single-point recordings of a two dimensional matrix of the blood flow over an 
extended skin surface, and over a larger area, thus producing a detailed perfusion map.  
Both LDF and LDPI have been found to be user-independent by utilising established 
protocols and maintaining external factors which can influence the readings, such as 
controlling environmental temperature, reducing movement as well as reflection 
artifacts where possible, removal of topical agents, as well as refraining from smoking 
and caffeine ingestion for a period of at least 2 hours prior to assessments (Fullerton et 
al. 2002; Khan & Newton 2003, Turner et al. 2008)  
 
2.3.11.3 Utilisation of laser Doppler flowmetry 
LDF has been utilised for many applications including dermatology, wound healing, 
diabetology and peripheral vascular aspects (Eun 1995; Fullerton et al. 2002). LDI and 
capillary microscopy have been used to assess subpapillary and nutritive 
microcirculation in 17 patients with arterial occlusive disease and chronic venous 
insufficiency ulcers in 4 regions, a non-granulating tissue area, a granulating tissue area, 
an area of skin adjacent to the ulcers (within a distance of 1-8mm), and a more distant 
area of 9-25mm (Ambrozy et al. 2009). Laser Doppler flux was significantly higher in 
granulating areas than in areas without granulation tissue and intact skin. In scar tissue 
flux was found to be higher than in both intact skin and in ulcers without granulation 
tissue being present. Thus, ulcers without granulation tissue had poor perfusion and did 
not display healing, whereas when granulation tissue was present, high perfusion was 
found. They also noted that the blood supply in the intact skin adjacent to the ulcers was 
affected by an altered microcirculation found in the ulcers. Furthermore, it was noted 
that LDI flux measurement could provide information to aid the optimum evaluation of 
microcirculation in ulcers of mixed aetiology. Krupa (2003) investigated the 
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relationship between plantar pressure and skin perfusion on the foot in subjects with 
Type 2 diabetes, peripheral neuropathy and a history of plantar ulceration.  Although the 
heel area was found to display high pressures, in comparison to the forefoot areas in the 
study it displayed a higher skin perfusion, thus findings indicated that understanding of 
the skin vasculature response to plantar pressures could add valuable insight into re-
ulceration issues.  
Pressure ulcers were investigated as a complication of tissue ischaemia resulting from 
diabetes. When comparison was made between subjects with diabetes and controls, skin 
blood flow decreased markedly in subjects presenting with diabetes without neuropathy, 
as measured with single point LDF in response to initial locally applied increasing 
pressure. This inability of the microcirculation to respond to local pressure was noted as 
a possible factor in ulcer development in this group (Fromy et al. 2002). The utility of 
LDI versus transcutaneous gases (TcPCO2 and TcPO2) for the assessment of limb 
perfusion in cases with severe ischaemia was assessed by Figoni et al. (2006), in order 
to determine the degree and progression of the pathological process leading to possible 
amputation. They compared 31 patients who required amputation with 29 age–matched 
non ischaemic controls and found that LDI could detect a proximal to distal gradient of 
perfusion of the lower limb which was not discernible with TcPO2. LDI was also found 
to discriminate between ischaemic and non ischaemic skin which was not possible with 
TcPO2 thus overall LDI proved to perform better than TcPO2. Skin perfusion in the 
hallux utilising LDI with 14 patients with peripheral arterial occlusive disease was 
compared with 11 healthy volunteers (Fischer et al. 1995). Significantly lower digital 
artery pressure and skin perfusion pressure was found in the patient group. They noted 
that LDI provided an easy and non-invasive method of simultaneously assessing digital 
artery and skin perfusion, enabling the severity of peripheral arterial occlusion to be 
assessed thus predicting possible healing of foot ulcerations. 
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One major limitation of laser Doppler flowmetry is that despite attempts, it is not 
possible to measure in absolute perfusion values and as such arbitrary units (PU or AU) 
are universally used. The arbitrary units are also referred to as blood flux rather than 
flow, and flux is the product of average speed and concentration of the moving 
erythrocytes in the tissue volume sample (Cracowski et al. 2006). 
 
2.3.12 Laser Doppler flowmetry and iontophoresis 
Iontophoresis is a useful technique where small doses of vasoactive substances are 
required to stimulate skin microvessels locally without systemic effects to gain a better 
understanding of mechanisms of vascular dysfunction. Utilising iontophoresis with LDF 
provides a non-invasive method using a small electric charge to aid migration of 
charged substances across the skin surface (Figure 2.9) (Newton et al. 2001; Ferrell et 
al. 2002; Khan & Newton 2003; Newton et al. 2005; Turner et al. 2008).  The polarity 
of the active electrode used has to be the same charge as the substance itself (Pitei et al. 
1997; Turner et al. 2008). During the process of iontophoresis, the electric dose, which 
is calculated from duration and current strength, is thought to correlate with the amount 
of substance delivered across the skin (Henricson et al. 2009). The most commonly 
utilised substances for this purpose are those for investigating endothelial function, 
namely ACh an endothelium-dependent agonist, and SNP an endothelium–independent 
vasodilator, although other substances have also been used such as bradykinin and 
substance P (Newton et al. 2001; Ferrell et al. 2002; Khan & Newton 2003; Kiotka et 
al. 2004b; Turner et al. 2008; Henricson et al. 2009). However, when using 
iontophoresis, several methodological issues need to be considered, which have been 
reviewed elsewhere (Turner et al. 2008).  
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2.3.12.1 Utilisation of iontophoresis 
Iontophoresis in conjunction with LDF and LDI has been utilised to investigate many 
pathological conditions, in particular diabetes mellitus and peripheral arterial disease. 
Sensory neuropathy is recognised as a contributory factor to development of wounds. 
Kelly et al. (2001) studied endothelial responses in the diabetic foot with sensory 
neuropathy. Analysis of the ACh and SNP response revealed no significant differences 
between groups of subjects with diabetes and neuropathy, without neuropathy and 
controls without diabetes. However this study utilised a protocol with a higher current 
for a shorter duration of iontophoresis than found in most other protocols and with a 
small number of subjects, six in each of the groups with diabetes with and without 
neuropathy, as well as the healthy controls studied. 
 Children, adolescents and young adults with Type 1 diabetes were studied by Khan et 
al. (2000). They measured skin microvascular function using LDF with iontophoresis of 
ACh and SNP in the dorsum of the feet. Findings indicated that early reductions in the 
microvascular function in the form of endothelium-dependent and independent vascular 
responses, as well as a reduction in maximal vasodilator capacity, was present prior to 
any manifestation of clinical presentation.  
Impaired pressure induced vasodilation (PIV) in young adults with Type 1 diabetes was 
investigated by Koitka et al. (2004a) who noted that vascular and neurological 
mechanisms were both likely to be involved in foot ulceration. They found an impaired 
vasodilation to ACh but not to SNP between the group with diabetes and the control 
group with twelve subjects in each. Although Sigaudo-Roussel et al. (2004) carried out 
their study on streptozotocin-induced diabetic mice and healthy control animals; they 
also found that endothelial impairment was enough to severely alter PIV. PIV 
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suppression was noted as possibly leading to complications such as foot ulceration in 
their study utilising ten subjects in both groups under investigation. 
A pilot study to investigate the effects of local pressure on microvascular function in the 
diabetic foot, with 16 patients and 8 healthy controls was carried out (Newton et al. 
2005). The subjects with diabetes displayed higher plantar pressures than the control 
group, but no significant difference was found in basal skin perfusion or in ACh 
response. Within the patient group, however, baseline flow was increased significantly 
(p=0.041) but the acetylcholine response reduced significantly (p=0.03) at the high-
pressure compared with the low-pressure site; this was most apparent in those who were 
particularly at risk of ulceration due to high plantar pressures. The authors concluded 
that further work is required to determine whether, and under what conditions, this 
additional hyperaemia is protective or maladaptive. 
 
2.3.13 Laser Doppler flowmetry and reactive hyperaemia 
An additional tool for assessing the integrity of the microvasculature is to measure the 
reactive hyperaemic response, which is defined as a temporary increase in skin and 
muscle blood flow following an arterial occlusion (Humeau et al. 2002; Yamamoto-
Suganuma & Aso 2009).  Post occlusive reactive hyperaemia (PORH) has been 
specified as a useful, non-invasive and sensitive indicator for microvascular 
dysfunction, and has been associated with myogenic, neural and metabolic factors as 
well as endothelial function, with some debate around which of these elements are 
responsible for the peak as well as the recovery phase (Humeau et al. 2002; Cracowski 
et al. 2006; Rossi et al. 2006; Yamamato Suganuma & Aso 2009; Schlager et al. 2012).   
60 
 
The ability to continuously monitor perfusion has made LDF an important mode for 
study for post-occlusive reactive hyperaemia (PORH) (Humeau et al. 2002; Morales et 
al. 2005; Roustit et al. 2010). Useful parameters for reactive hyperaemia include time to 
peak flow and the value of peak flow. These parameters have been found to provide 
early detection of vascular alterations such as prior to the development of clinical 
symptoms in diabetes mellitus, and also to show the effects of smoking and peripheral 
vascular disease (Humeau et al. 2002; Morales et al. 2005; Rossi et al. 2005). PORH 
was compared in subjects with Fontaine classification of stage 11 PAOD displaying 
intermittent claudication, but with no pain on resting, with healthy controls (Rossi et al. 
2005). In PAOD patient’s skin perfusion was not impaired during baseline i.e. prior to 
occlusion, which was thought to be a result of compensatory mechanisms related to 
endothelial, myogenic and sympathetic activities. During hyperaemia however, patients 
displayed reduced vasoreactivity suggesting perhaps an exhaustion of compensatory 
mechanisms.  
Although LDF is useful for monitoring the PORH response, until recently this has only 
really been possible with single point instruments (which have their inherent limitations 
as mentioned in a previous section) since these instruments are able to continuously 
monitor perfusion and capture the rapid changes in perfusion post occlusion. A recent 
development, however, has been the introduction of laser speckle contrast imaging 
which has the capacity to perfusion from larger areas of tissue in near real time. 
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2.3.14 Laser speckle contrast imaging (LSCI) 
2.3.14.1 Background 
In the1960s a ‘grainy’ pattern was discovered when laser light was viewed on a matt 
surface such as glass, paper or dull metal, and this speckle pattern lead to the term being 
adopted (Briers 2001). It has been described as an interference when light has been 
reflected from different parts of an illuminated surface (Briers 2001; Royl et al. 2006). 
With movement of an object, changes are noted in the speckle pattern. When a solid 
object undergoes small movements the speckles appear to move with the object, 
however with large movements the pattern undergoes complete change and frequency 
of the fluctuations is dependent on the velocity of the motion. This phenomenon is 
known as ‘time-varying’ speckle; Stern in 1975 was the first to note the potential for 
speckle changes when assessing blood flow. Royl et al. (2006) noted that ‘during 
increased blood flow the intensity variations of the speckle pattern are more rapid’. The 
group found that in the exposure time the contrast of the pattern was reduced and 
quantification of the blurring effect was in fact possible with analysis of adjacent areas 
within the illuminated area. The speckle contrast K was then calculable thus; the mean 
velocity of moving elements could be calculated using this speckle contrast. It was 
noted that this offered a faster way of signal processing which allowed full-field 
imaging of skin perfusion in near real time (Briers 2001; Roustit et al. 2010; Tew et al. 
2011). 
 
2.3.14.2 Utilisation of LSCI in blood flow measurement 
LSCI was reviewed as a method of assessing skin microvascular function and 
dysfunction and it was concluded to be a promising new method of assessment both 
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with and without pharmacological intervention in iontophoresis, with the main 
advantage being the reproducibility of the equipment (Figure 2.10) (Mahe et al. 2012). 
The reproducibility of laser speckle contrast imaging (LSCI) was compared with LDF 
as a method of assessing skin microvascular reactivity when utilising PORH (Roustit et 
al. 2010). It was found to offer both rapid skin blood flow measurements over wide 
areas coupled with good resolution. LSCI also displayed very good inter-day 
reproducibility when assessing forearm PORH and local thermal hyperaemia. Although 
the findings were positive, the study had some limitations such as low number of 
subjects and the authors concluded that more data would be required to clearly evaluate 
any linearity between LSCI and skin blood flow. 
A comparison of inter-day reproducibility utilising PORH with single point LDF 
integrated probe LDF with LSCI was carried out (Tew et al. 2011).  In agreement with 
Roustit et al. (2010) they found LSCI fared better than LDF due probably to the larger 
skin area under measurement, however they found that LDF was more sensitive to 
changes in skin blood flow at lower levels found on the finger pad area. It was also 
noted that the LSCI signal was more sensitive to changes in red blood cell velocity than 
concentration, and in agreement with Nakagami et al. (2010) they found that the speckle 
contrast was not linear to either velocity or perfusion. In fact, the relationship between 
speckle contrast and velocity was highly non-linear. It was concluded that this did not 
preclude the use of LSCI for quantitative analysis of perfusion, but that careful 
calibration and or interpretation would be required. However, the known percentage 
change in velocity did produce the same change in speckle contrast, thus LSCI was 
found to be more useful in measuring changes in perfusion rather than absolute 
measurements (Tew et al. 2011). The advantages over LDF are that it offers high spacial 
and temporal resolution and is relatively user friendly and cheap to use (Choi et al. 
2004).  
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An investigation into the use of LSCI for the assessment of circulation in pressure 
ulcers was undertaken (Nakagami et al. 2010). Although this work was utilising animal 
studies and small numbers were used, nevertheless it was concluded that LSCI could 
have great potential for assessing the severity of tissue damage in deep tissue injury, 
although much more work would be required in the area. 
 
 
Figure 2.10 LSCI-FLPI® system (Moor Instruments Ltd.) 
 
2.3.15 Summary 
LDF being non-invasive, has proven to be an easy to use method of assessing the 
microvasculature directly. It utilises a helium-neon light source of wavelength 630-
670nm. Some issues with reproducibility have arisen, but generally by careful 
utilisation of protocols the artefacts which could arise have been controlled. LSI 
displays better reproducibility, but is limiting in that pressure cannot be directly applied 
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to the area when LSI is being utilised. It is not possible to utilise absolute units of 
measurement with laser Doppler equipment, and arbitrary units (AU) have been 
universally adopted, with blood flux being utilised which is the average speed and 
concentration of moving erythrocytes in the tissue volume under study. Iontophoresis is 
a non-invasive, local method of migrating substances across the skin surface using a 
small electric current which is safe and has little systemic impact. It is particularly 
useful when investigating blood flux in the locality of subjects with systemic disorders 
like diabetes, when little disruption to systemic blood flow is important. Reactive 
hyperaemia is a temporary increase in skin and muscle blood flow following a 
temporary arterial occlusion. It can be utilised as a non-invasive indicator for 
microvascular dysfunction as the peak flow and time to reach peak flow on release of 
the occlusion are related to NO activity and as such the method is a good indicator for 
endothelial function. LSCI was developed from an interference when light has been 
reflected from different parts of an illuminated surface. Movement of objects lead to 
changes in the speckle pattern. This method of assessment for blood flow offers rapid 
and real time capabilities as well as good inter-day reproducibility, however, little work 
to date has been carried out with this equipment on the lower limb and in particular to 
explore the relationship between pressure and perfusion. 
 
2.4 THE RELATIONSHIP BETWEEN PRESSURE AND BLOOD FLOW 
2.4.1 Background  
Much work has been carried out in the past concentrating on the area of decubitus 
ulceration, as this form of tissue breakdown has long been associated with externally 
applied pressure leading to occlusion of local microvascular vessels with the outcome of 
ischaemic injury to the soft tissues (Schubert & Fagrell 1989; Xakellis et al. 1993; Abu-
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Own et al. 1993 and 1995; Schubert & Heraud 1994; Colin & Saumet 1996; Mayrovitz 
et al. 1997; Mayrovitz & Smith 1998). Xakellis et al. (1993) showed that pressure 
induced tissue damage followed a time-pressure curve, i.e. the lower the applied 
pressure, the longer time required to cause tissue damage. They also stated that due to 
the exploratory nature of their study of two different age groups, definite conclusions 
could not be drawn, but their preliminary findings suggest that healthy adults, regardless 
of age, display an increase in dermal blood flow with time when low levels of 
compressive pressure are applied. This suggests a more complex association exists 
between blood flow and externally applied compressive pressure. Meinders et al. (1996) 
noted that when loads are high enough and the skin subjected to the loads for a 
prolonged period of time, ischaemia and necrosis can result. Their findings were that 
heel microcirculation is vulnerable to compression. However, they went on to note that 
the relatively high pressures exerted on the plantar aspect of the foot during normal 
standing and walking never resulted in necrosis. They reported that the capillary 
basement membrane is known to be at its thickest in the foot and is thought to be 
involved in resisting externally applied pressures which when coupled with the 
hyperaemic response following reduction of pressure could offer protection from tissue 
damage.  The post occlusive hyperaemic response following heel loading was found to 
offer protection following rapid and significant reduction in heel perfusion when 
investigating the skin microvascular response of the plantar aspect of the foot to 
changes in externally applied pressure (Mayrovitz & Smith 1998). 
A comparison of skin blood cell flux (SBF) on different sites, namely the sacrum and 
gluteus region was carried out by Schubert and Fagrell (1989). They found that the 
cause of greater numbers of pressure sores being sited at the sacrum could be related to 
the comparatively poorer regulation of microvascular flow recorded in this area. In a 
subsequent study it was noted that shear force could also play a role, but was much 
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more difficult to measure than compressional pressure, as well as vasomotion, i.e. 
spontaneous rhythmic changes in small vessel diameter produced by contraction and 
relaxation of their walls was noted as decreasing in frequency with age in animal studies 
(Schubert & Heraud 1994). 
The effects of external pressure on transcutaneous oxygen tension (tcPO2) and skin 
blood flow (SKBF) were investigated over the sacral region in healthy subjects with a 
significant decrease in tcPO2  occurring when the external pressure was 40mmHg 
(5.3kPa) which continued to decrease up to 100mmHg (13.4kPa) when it stabilised. A 
significant decrease in SKBF was also found when the external pressure was at 
20mmHg (2.7kPa) (Colin & Saumet 1996). 
Sacks et al. (1985) used cylindrical indenters to assess skin blood flow and tissue 
deformations noted that the decrease in skin blood flow found in association with 
external loading was a result of 3 variables, the ratios of bone depth and diameter to 
indenter diameter, and the percent of tissue compression overlying the bone.  In a 
subsequent study (Sacks et al., 1988) the group observed problems with the sensitivity 
found with the laser Doppler signals when measuring skin blood flow under externally 
applied pressure. The problems were thought to be due to the sensitivity of the laser 
Doppler to red cell motion of any kind, including random motion associated with 
changes in vessel occlusion. This effect became particularly important when blood flow 
was compromised when the random aspect of the signal became significant in 
comparison to the diminished blood flow, so that signals were observed when the 
researchers would have reasonably expected the flow to have reached zero. This study 
questioned the accuracy of the use of laser Doppler flowmetry for assessing the 
microcirculation in conditions when the point is reached when the random red cell 
motion becomes significant.  
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2.4.2 Biological zero 
The ‘biological zero’ or a critical closing pressure and whether it should be subtracted 
from laser Doppler values are controversial issues (Ashton 1975; Khan & Newton 
2003). It implies an actual closure of the muscular blood vessels as the endothelial 
transmural pressure where the circular tension in the wall overcomes the pressure across 
it causing an abrupt shut down. At least two mechanisms have been cited as involved in 
this process, active closure of small arterioles when transmural pressure is lowered 
either by falls in intravascular pressure, or a rise in tissue pressure above intracapillary 
pressure (Ashton 1975).  The impact of pressure on the microcirculation of the heel was 
investigated by Abu-Own et al. (1995) and they found that at an interface pressure of 
50mmHg (6.67kPa) the LDF signal was reduced to a minimal value. They noted that the 
level of compression had reached the point likely to have caused occlusion as increased 
pressure caused no further alteration in the laser Doppler signal, which they felt could 
have indicated the ‘biological zero’. Meinders et al. (1996) using healthy volunteers 
applied static loads to the heel aspect of the foot with the subject in a supine position. 
Contact pressure and skin blood flow using laser Doppler were simultaneously 
measured. They found that pressure above 40 kPa stopped skin microvascular blood 
flow. Nielsen (1983) noted that blood flow could be stopped when the diastolic aspect 
of pressure was reduced to zero.  External pressure required to stop blood cell flux was 
assessed and it was concluded that flow cessation pressure (FPC) at the ankle level was 
on average 28 mmHg (3.73 kPa) lower than the systolic ankle pressure.  However, it 
was also noted that in those individuals with pronounced arterial occlusive disease FCP 
it could be equal or even higher than the ankle pressure (Svensson et al. 1990). Thus, 
there is some debate regarding the pressure at which biological zero occurs, and Khan & 
Newton (2003) noted that the value of biological zero was in fact insignificant in 
comparison to the blood flow measurements found in other studies.   
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2.4.3 External pressure and pressure induced vasodilation (PIV) 
In a study of subjects with diabetes and severe diabetic neuropathy, nutritional blood 
flow to the plantar region of the foot was not found to be decreased, in comparison to 
control subjects (Proano et al. 1992). They found that the critical plantar foot pressure 
which caused nutritional blood flow to the skin to be arrested was 3 N/cm2 (30 kPa) in 
both diabetic and control subjects, and below this value blood flow was independent of 
pressure. This finding indicated that large areas of the sole of the foot were generally 
subjected to circulatory arrest when in a standing position. This study was limited in 
that only 10 subjects and 8 controls were included, and fluorescein flowmetry does not 
measure rapidity of circulatory return as the laser Doppler would. However, it should be 
noted that although a limited study in terms of numbers of subjects, the neuropathic 
group did display severe neuropathy coupled with a known history of previous 
ulceration. The effects of applying an external uniform compression to the lower limb 
have also been investigated for any unwanted effects on the arterial flow to the lower 
limb. Fromy et al. (1997) reported that both arterial inflow to the lower limb and 
forefoot microcirculation were reduced even in healthy young subjects with a uniform 
pressure of 10 mmHg (1.33 kPa). Sabri et al. (1971) noted that compression produced 
by bandaging in horizontal supine subjects may be harmful unless carefully controlled 
in that external pressure of 15 mmHg (2.00 kPa) significantly reduced femoral arterial 
flow.  
Fromy et al. (2002) used Doppler flowmetry over the internal anklebone in response to 
local pressure applied at 5.0 mmHg (0.67 kPa) per minute in three groups of subjects.  
One group displaying clinical and subclinical neuropathy, another without neuropathy, 
and the third was healthy matched control subjects all assessed at usual room 
temperature.  Their findings were in contrast to Proano et al. (1992) in that even in 
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those subjects with diabetes but without neuropathy, blood flow response to locally 
applied pressure was impeded, and in agreement with the findings of Newrick et al. 
(1988) who also found peak flow to be reduced in neuropathic patients as well as noting 
a prolonged period for blood flow to return to baseline with neuropaths. In fact Fromy 
et al. (2002) noted that skin blood flow decreased significantly from baseline at much 
lower pressure in diabetic subjects, i.e. at 7.5 mmHg (1.00 kPa) in diabetic subjects and 
48.8 mmHg (6.51 kPa) in controls which they noted could explain the high risk in 
diabetes of developing plantar and decubitus ulceration, although this extrapolation 
needs to be viewed with caution in light of the positioning of the study site not being on 
the plantar aspect of the foot. Fizanne et al. (2004) utilising rodents discovered that a 
transient increase in blood flow could be elicited in response to an innocuous local 
pressure application, and defined this as pressure-induced vasodilation (PIV). This 
response was dependent upon capsaicin-sensitive nerve fibres and calcitonin gene-
related peptide (CGRP). A further study investigated the impact of diabetes on PIV 
utilising streptozotocin-induced diabetic mice, suggested that endothelial impairment in 
the mice was enough to severely alter the PIV response which appeared to be highly 
sensitive to endothelial NO levels (Sigaudo-Roussel et al. 2004). This was advanced to 
an investigation utilising human subjects by Koitka et al. (2004a) who found that PIV, 
which relied on unmyelinated afferent excitability, might be impaired in diabetic 
patients.  They measured cutaneous blood flow using LDF on the head of the first 
metatarsus in response to applied pressure at 5.0 mmHg (0.67kPa) in warm conditions. 
Responses to iontophoresis of ACh (endothelium-dependent) and SNP (endothelium-
independent) were measured in the forearm. Their findings suggested that PIV was 
impaired in the feet of diabetic subjects. The non-endothelial mediated response to SNP 
was preserved in diabetic subjects while the endothelium-mediated response to ACh 
was impaired. The study was limited in that Type 2 diabetic subjects were excluded 
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from the study and the subject numbers were 12 in each of the patient and control 
subject groups, and were derived from a young adult population. In a subsequent study 
PIV was found to be impaired by low skin temperatures (Koitka et al. 2004a). Local 
skin temperature variations have been noted to have an effect on postural skin blood 
flow (Hassan et al. 1986; Hassan and Tooke, 1988; Oberle et al., 1988; Flynn et al. 
1989). PIV reaction was also found to be age related, and was found to lacking in an 
older age group (Fromy et al. 2010), this finding was in agreement with Petrofsky et al. 
(2009), who also found PIV to diminish in an older group of subjects with diabetes 
when compared with a group of young subjects with diabetes and healthy controls. 
 
2.4.4 Summary 
Initial work regarding the impact of pressure on blood flow has been in the area of 
decubitus ulcers which are essentially soft tissue breakdown associated with externally 
applied pressure. The biological zero is a critical measurement which leads to closure of 
the vessels under pressure. It is a controversial subject and several different values have 
been proposed as the level of closure, however the values mooted are insignificant when 
compared with the actual blood flow measurement and as such the impact on 
measurements makes little impression. PIV has been found to be a transient increase in 
blood flow which can be elicited in response to an innocuous local application of 
pressure. It has been found to be age related, impaired at low temperatures and more 
importantly impaired with diabetes. 
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2.5 METHODS OF ASSESSING PRESSURE DELIVERY AND BLOOD FLOW 
Abu-Own et al. (1995) set out to develop equipment to investigate the impact of 
compression of the lateral aspect of the heel on blood flow to the area. They utilised a 
weighbridge device with a cantilever mechanism around a central pivot which was 
loaded with weights at one end. The other end was placed in contact with the heel 
utilising an acrylic indenter attached to a pressure sensor. The pressure sensor was 
attached to the laser Doppler which then logged the data recorded on a computer. The 
weights used to apply forces were 50, 100, 200, 400, 600, 800, 1000, 1250 and 1500g. 
The interface pressure and LDF was measured using the pressure transducer. The study 
was carried out in a temperature controlled environment of 22o C and 30% relative 
humidity following a period of 20 minutes acclimatisation. They noted some of the 
known limitations of LDF in that its reproducibility is good in a given population, but 
not in individual subjects, however no limitations were discussed around their pressure 
delivery system or any details given about calibration or repeatability with the system. 
An experimental set up to allow the application of several levels of load on the plantar 
aspect of the foot with the subject in a relaxed supine position was constructed by 
Meinders et al. (1996) (Figure 2.11). The area under study was the central aspect of the 
heel area and in order to apply the load, the foot was placed in a shoe construction. The 
shoe was then attached to a rigid board placed at the end of the bed. The heel area of the 
shoe was cut out so that a piston with a 2.0cm2 flat contact area could be used to 
penetrate and apply the load. A spindle mechanism was placed behind the piston so that 
load could be released. The applied load was measured by a load cell situated 
underneath the piston and blood flow measured by LDF, with the LDF probe acting as 
the piston for the application of the load. The testing was carried out with constant 
temperatures and subjects were acclimatised to the environment for a period of 15 
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minutes and had refrained from alcohol for 24 hours as well as caffeine for 12 hours 
prior to commencement of the study. Experimental limitations were discussed, for 
example the small contact area of the piston could have induced pain when applied for 5 
minutes. Pain is a stimulus for the sympathetic nervous system which also controls 
arterio-venous anastomoses (AVA) blood flow, so could have been responsible for 
some of the alterations in blood flux found. They also noted that as the study was 
carried out with the subjects in a supine position and not with the limbs in the dependent 
position, the rise in capillary pressure could have been limited by precapillary 
vasoconstriction. However when subjects are asked to stand the small inevitable 
movements which occur to maintain position could cause a disturbance of the LDF 
signal, thus the researchers made the decision carry out the study with the subjects in a 
supine position.  
 
Figure 2.11 The experimental set-up: 1, spindle mechanism; 2, load cell; 3, board at the end of the bed; 4, shoe; 
 5, LDF probe with the laser source; and two photodiodes detecting the reflected light; 6, foot                                        
(adapted from Meinders et al. 1996). 
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A progressive calibrated pressure device to measure cutaneous blood flow changes to 
external pressure strain was developed by Fromy et al. (2000) as illustrated in Figure 
2.12. This device consisted of a similar system to that of Abu-Own et al. (1995), with a 
mechanical aluminium bar (400mm long with a diameter of 8mm) used as the axis of 
the weighbridge. The homemade balance was designed to receive a cutaneous laser 
Doppler probe and a small circular plastic container to increase the pressure on the site 
of measurement at one end of the aluminium bar and an adjustable balance weight (15g) 
which could move along the bar to balance and maintain the bar in a horizontal position. 
A laser Doppler probe was connected to a laser Doppler flowmeter. The container was 
filled with water and the instrument was calibrated before each study with an electronic 
weighing system to find the linear relationship between the volume of water and the 
mass reading on the weighing system. This device was subsequently used for a series of 
studies measuring skin blood flow and locally applied pressure in the fingers of diabetic 
subjects (Fromy et al. 2002; Koitka et al.2004b; Fromy et al. 2010). No issues were 
recorded around the pressure device, although again the limitations of the LDF were 
detailed. 
 
 
 
Figure 2.12 The mechanical device developed by Fromy et al. (2000).The device was used to apply a 
progressive calibrated pressure to a local area of skin and simultaneously measure cutaneous blood flow with a 
laser Doppler probe at the same site. PC: plastic container; AB: aluminium bar; ABW: adjustable balance 
weight (adapted from Fromy et al.(2000). 
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Cobb and Claremont (2001 and 2002) have investigated a method of measuring blood 
flux in plantar skin tissue under the first metatarsal head in standing and walking. They 
developed a custom made shoe for each test subject, using an orthopaedic insole made 
of plastazote foam, with a recess cut out at the first metatarsal head and a channel cut 
from the recess of the heel to house the sensor and electronic connection (Figure 2.13). 
A prototype sensor length 30mm and depth 12.5 mm made from double-sided copper 
clad board and acrylic sheet was developed. The device repeatability and device to 
device repeatability were recorded as better than 12.5%. The instrumentation recorder 
had an internal rechargeable battery to allow continuous recording for 50 mins. onto 
digital audiotape and was carried by the subject at waist level with a shoulder strap. 
Recorded data was then downloaded to a computer. As well as the limitations in 
possible subject numbers this posed, other problems like movement artefacts limited 
analysis to the swing phase of gait rather than capturing true foot to insole or foot to 
ground data. It should also be noted that having connections attached to the subject can 
lead to an alteration in normal gait pattern. 
 
 
Figure 2.13 Measurement shoe and waist mounted instrumentation unit, with the sensor situated under first 
metatarsal head (adapted from Cobb & Claremont 2001). 
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Simultaneous measurement of plantar pressure and blood flow was taken a stage further 
with the development of a system which could measure both in a semi-weightbearing 
position. Santos et al. (2003) found a significant difference between the blood flow 
measurements under pressure in a supine position to that in a semi-weightbearing 
position (Figure 2.14). A significant difference was found between baseline laser 
Doppler flowmetry (LDF) in the supine and semi-weight bearing positions. Differences 
between both positions in the maximum hyperaemic response measured on release of 
the pressure and the time taken to actually reach the maximum hyperaemic response. 
This was a pilot study and only 4 subjects were included and as such it is difficult to see 
how meaningful statistical analysis could be achieved. 
Figure 2.14 The device in a semi-weightbearing position (adapted from Santos et al. 2003) 
Hahn et al. (2007) developed a lumped-parameter model to assess the impact of plantar 
pressure on the diameter of blood vessels in the big toe. The system utilised an energy 
system approach to develop the lumped-parameter differential equations which was 
based upon results of published data. It was hoped that this could then be expanded to 
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model the foot as a whole rather than just the hallux. Limitations included the fact that 
this was a lumped-model which resulted in averaging of blood flow for the region rather 
than providing actual values. However, further limitations could be the validity of the 
studies utilised to develop the model itself. 
 
2.6 SUMMARY 
Increased plantar pressures and impairment of the local microvasculature have both 
been cited as risk factors in the development of foot disorders, in particular ulceration 
found in association with conditions such as diabetes. The mechanisms for increased 
plantar pressures in association with diabetes are multifactorial, and contradictory 
evidence regarding the alterations in skin structure indicates that further work is 
required in that area. Although much development work has improved available 
measurement systems, there is still no perfect system available and there are pros and 
cons for both platform and in–shoe systems with further work required in the area of 
shear stress.  
The endothelium is a complex structure with its function being regulated by the 
production of many dilatory and constricting substances. Recent work would indicate 
that impairment in nitric oxide production is associated with diabetes. When LDF is 
utilised with a strict protocol, artefacts can be limited to ensure reproducibility, and in 
association with iontophoresis it provides a sound method of investigating endothelial 
function. Nitric oxide activity can be measured non-invasively with reactive 
hyperaemia. 
From the literature it would appear that further work is required to investigate 
endothelial function when under local pressure. Current commercial systems have not 
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been designed to measure both pressure and blood flow simultaneously, and methods 
developed to measure blood flow in conjunction with pressure to date have been at best 
experimental, with none of the systems utilised to investigate actual endothelial function 
in conjunction with pressure.   This study aimed to develop equipment to measure both 
pressure and endothelial function simultaneously and to utilise reactive hyperaemia as a 
measure of endothelial function as well as to compare endothelial function under 
pressure in a group with diabetes when compared to healthy control subjects. 
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Chapter Three 
Design and Development methods 
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3 DESIGN AND DEVELOPMENT METHODS 
 
3.1 THE PRESSURE DELIVERY SYSTEM  
3.1.1 Introduction 
Studies of plantar foot pressure and blood flow to the lower limb are areas which have 
generated great interest, particularly when investigating pathologies such as diabetes 
mellitus. Much research has been carried out into the aetiological factors leading to 
issues with tissue viability, and amongst the factors, prominence has been given to both 
plantar pressure abnormalities and vascular disorders.  Many advanced computerised 
systems have been developed and are currently available to measure plantar pressure 
both in healthy feet and in disease as noted in Section 2.2. Similarly, numerous systems 
are available to measure blood flow resulting in the capability of utilising non-invasive 
methods to assess both macro and microcirculation. The ability to measure plantar 
pressure and blood flow simultaneously still remains elusive due to a lack of 
commercially available equipment capable of measuring both. Thus, in order to 
investigate the impact of plantar pressure on blood flow to the plantar aspect of the foot, 
a pressure delivery system that could deliver known pressure had to be developed, 
capable of functioning in situ while the blood flow measurement was being carried out 
simultaneously. 
 
3.1.2 Development of a plantar pressure delivery system 
In order to enable pressure to be directly applied whilst simultaneous blood flux 
measurements were being undertaken, the decision to utilise the laser Doppler 
flowmeter DRT4® (Moor Instruments UK Ltd.) rather than e.g. laser Doppler perfusion 
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imaging was made as it was possible to have the probe measuring blood flux with LDF 
in skin contact.  Around 10 months of exploratory work was undertaken to investigate 
and develop equipment which would provide the optimum method of accurately 
applying pressure to the plantar aspect of the foot while investigating endothelial 
function with iontophoresis.  
Initial work considered having the subject in a weightbearing position, thus providing 
natural pressure delivery to the area. This proved to be difficult to achieve due to several 
factors, the bulk of equipment required to be in situ to undertake iontophoresis and 
blood flux measurements, the requirement to ensure that the probe and iontophoresis 
solution remained in contact with the skin, but the overriding factor was movement 
artefacts created by the natural body movement when an individual is maintaining a 
standing position prevented accurate blood flux measurements. Thus, the decision was 
made to place the subjects in the supine position where movement artefacts could be 
more easily controlled and the equipment would be visible and easily monitored. As 
ideally pressure delivery and blood flux measurements were to be carried out in the 
same position on the foot, investigations were then carried out regarding the possibility 
of a LDF probe acting as the final point of delivery for the pressure as well as 
measuring blood flux. During preliminary testing, the Doppler probe (DP2), which is a 
standard probe utilised with the DRT4® system suitable for use with an iontophoresis 
chamber, was found to have a strong, rigid plastic cylinder casing with a length of 30 
mm and diameter of 6 mm. This outer durable shell was designed to house and protect 
the optic fibres. However the optic fibres themselves required to be free of pressure or 
angulation which could have resulted in damage as well as impacting upon the results. 
Thus a metal housing or ‘cuff’ was developed which could firmly hold the DP2 cylinder 
allowing it to act as the end point of the pressure delivery system, and to allow freedom 
for the optic fibres to function as normal which can be seen in Figures 3.1, 3.2 and 3.3.  
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The method of pressure delivery had to be accurate, light and easy to manoeuvre as well 
as delivering a pre-measured, sustainable pressure, without altering the function of the 
DRT4® equipment. After much thought and discussion, it was decided that the pressure 
could be delivered via a spring. The spring used consisted of a roll of high yield Type 
301 stainless steel finished with zinc plate. The spring had 11.5 coils with an outside 
diameter of 4.775 mm, free length of 22.224 mm with a load at solid length of 47.282 
Newtons/mm2 (47282 kPa)  (Lee Springs). The spring was housed within a metal tube 
for protection and to allow unimpeded movement. A measuring gauge was attached to 
the spring indicating the pressure delivered, and the pressure could be set and adjusted 
via a control dial as illustrated in Figure 3.4. 
The delivery system also had to remain in situ and the limb held securely to prevent 
movement, but to allow for comfort of the individual as the data collection was a 
relatively lengthy process. A post-surgical boot which had a rigid plastic leg/foot back 
plate and a fleece lining was thought to be the optimum choice as it was firm enough to 
hold the limb securely as well as providing comfort for the subject. A metal plate was 
then devised and attached to the base of the boot. This was adjustable in two directions, 
in height so that the position of the pressure delivery system and the LDF probe could 
be altered according to the foot size of the subject, and in depth to ensure that the probe 
was held in the correct position against the skin surface. Once in place the boot ensured 
that the equipment and the lower limb of the subject would not move, so ensuring the 
correct and stable positioning for the data gathering process. The customised boot can 
be seen in Figure 3.5 and the equipment in situ in Figure 3.8. 
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Figure 3.1 The pressure delivery system displaying the housing ‘cuff’ and the LDF probe 
        
 
Figure 3.2 DP2 probe held within the base of the pressure delivery system  
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Figure 3.3 The pressure delivery system with DP2 probe attached allowing freedom for the optic fibres to 
function unimpeded 
 
 
Figure 3.4 The pressure delivery system displaying the measuring gauge and control dial 
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Figure 3.5 The customised boot with adjustable baseplate 
 
3.1.3 In vitro repeatability (test-retest reliability) of the pressure delivery system 
The pressure delivery system was tested for repeatability over 14 individual sessions 
during a period of 3 weeks, utilising a universal testing machine as illustrated in Figure 
3.6. The testing equipment manufactured by Zwick Roell measures tensile stress as well 
as compressive strength of materials, thus a known force can be exerted on the material 
under test. The universal testing machine consists of a load frame which is the two 
supports for the equipment, a force transducer affording measurement of the load 
required, a cross head which is controlled to move up or down with the force as well as 
a means of measuring extension of deformation. The pressure delivery system was 
placed in the machine between the grips and the required force was exerted upon it. 
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Throughout the testing sessions a series of accurate and known forces were applied to 
the pressure delivery device and measurements taken as noted in Table 3.1 below. The 
interclass Correlation Coefficent (ICC) with absolute agreement and average measure 
was utilised to assess repeatability for the data. The ICC was 0.999, 95% C.I. (0.997-
1.000), F = 13381.911, p < 0.0001. The results indicated good repeatability of the 
device and Figure 3.7 graphically displays the linear relationship between the values 
obtained and reflects the repeatability of the equipment.  
Table 3.1 Mean forces applied with standard deviations to achieve the pressure 
device dial readings displayed during the testing of the delivery system 
   Pressure device 
     dial readings 
Force means          Std. Dev. 
0.5 2.32 0.097 
1.0 4.21 0.192 
1.5 6.36 0.122 
              2.0 8.46 0.122 
2.5 10.57 0.131 
3.0 12.62 0.164 
3.5 14.86 0.210 
4.0 16.99 0.267 
ICC 0.999      (0.997 - 1.000) 
ANOVA F = 13381.911 p < 0.0001 
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Figure 3.6 Universal testing machine (Zwick Roell) with the pressure delivery device in situ 
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              Figure 3.7 Linear relationship of the pressure device scale and applied forces 
 
3.1.3.1 Conversion of force to pressure for utilisation of the pressure delivery device 
The DRT4® DP2 probe (Figures 3.1, 3.2 and 3.3) which was the surface contact for 
pressure delivery had a radius of 3mm, thus an area of 29.16mm2. As pressure is 
force/area then e.g. 17.4 Newtons /29.16mm2 delivers a pressure of 0.59 N/mm2 or 590 
kiloPascals (kPa). Table 3.2 provides a conversion of the readings obtained from the 
pressure device, and thus the pressures delivered via the system to the plantar aspect of 
the foot. 
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Table 3.2 Conversion from force to pressure readings for the pressure delivery 
system 
  Pressure device 
     dial readings 
Force means           N/mm2             kPa 
0.5 2.32 0.0799 79.9 
1.0 4.21 0.1444 144.4 
1.5 6.36 0.2181 218.1 
2.0 8.46 0.2901 290.1 
2.5 10.57 0.3625 362.5 
3.0 12.62 0.4331 433.1 
3.5 14.86 0.5096 509.6 
4.0 16.99 0.5826 582.6 
 
3.1.4 In vivo repeatability of the pressure delivery system 
Utilising a single subject, and setting the pressure delivered to 1.5 and 3 on the scale of 
the device (an equivalent of 218.1 and 433.1 kPa, respectively), a series of 8 testing 
sessions was carried out on separate occasions assessing the inter-day repeatability of 
the equipment (Figure 3.8). During each measurement session, the subject was in a 
supine position on a plinth under the same temperature conditions and pre-test 
abstinence from food and caffeine for 2 hours as the main study. The tests were carried 
out in a quiet, temperature controlled room of 22° ± 1° C following a 20 minute 
acclimatisation period. On each occasion baseline blood flow was recorded under the 3rd 
metatarsophalangeal joint of the right foot, followed by 1.5 and then 3 scale pressures 
delivered in conjunction with the laser Doppler flowmetry as illustrated in Figure 3.7. 
ICC was carried out and a value of 0.976 obtained with 95% C.I. (0.809 - 1.000), F = 
42.187, p < 0.0001, which indicates good repeatability as illustrated in Table 3.3. Thus 
the system delivered repeatable in vivo measurements when utilised over a period of 8 
separate sessions carried out over a period of 3 weeks under consistent external 
conditions. 
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Figure 3.8 Equipment in situ measuring blood flow under the 3rd metatarsophalangeal joint of the right foot, 
using laser Doppler flowmetry in conjunction with the pressures delivery system simultaneously delivering 
pressure to the area. 
 
 
Table 3.3 Inter-day repeatability of the pressure delivery system 
 
Baseline 
Perfusion (AU) 
Perfusion with 
1.5 scale  pressure 
added (AU) 
Perfusion with 
3 scale pressure 
added (AU) 
83  11.2 
144.3 40.4 9.4 
216.5 42.2 9.9 
51.8 20.2 8.2 
125.4  11.5 
159.6 57.3 11.7 
168 28.1 8.2 
101.9 42.2 14.2 
ICC 0.976 
F = 42.187 
C.I. (0.809 – 1.000) 
p < 0.0001 
 
On each occasion baseline perfusion was measured under the 3rd metatarsophalangeal joint, and perfusion 
again measured at the same site with the addition of pressure to a value of 1.5 on the scale (218.1 kPa) followed 
by pressure to a value of 3 on the scale (433.1 kPa). ICC = 0.976 (0.809 - 1.000) F = 42.187 with p < 0.0001 
indicated good repeatability. 
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3.2 UTILISATION OF LASER DOPPLER FLOWMETRY (LDF) 
3.2.1 Introduction 
While there are many techniques available for indicating tissue perfusion, LDF is one of 
the few systems which can directly assess the microcirculation non-invasively, and can 
achieve this function relatively easily (Khan & Newton 2003; Rossi et al. 2006, 2008; 
Fredriksson et al. 2010). The laser Doppler flowmetry system has been extensively 
validated as an assessment tool for superficial skin blood flow, being found to be user-
independent by utilising established protocols which help by controlling environmental 
temperature, reducing movement and reflection artefacts and refraining from ingesting 
cigarette smoke, caffeine and food for at least a period of 2 hours prior to assessment 
(Fullerton et al. 2002; Khan & Newton 2003). The DRT4® utilises a helium-neon laser 
light source operating at around 780 nm (Moor Instruments Ltd.). This provides an 
estimated perfusion depth of 1-1.5 mm into the dermis, detecting dermal perfusion 
without deeper influence from the circulation to the underlying skeletal muscle (Eun 
1995; Morris & Shore 1996; Fullerton 2002; Khan & Newton 2003; Kvandal et al. 
2006; Turner et al. 2008). While laser Doppler perfusion imaging (LDI) has advantages 
over the traditional LDF system, having the capability of providing a two dimensional 
matrix of the blood flux of a larger skin surface area producing a detailed perfusion 
map, it would be difficult to add pressure directly to the area with this type of system, 
thus the decision was made to utilise LDF as the DP2 probe could simultaneously 
measure flux as well as being durable enough to act as a component of the pressure 
delivery system as described  in Section 3.1.2. 
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3.2.2 Calibration of the DRT4® LDF system with DP2 probe 
Prior to utilisation and on a regular basis i.e. every 6 months or following movement of 
the equipment the DP2 probe was calibrated. Manufacturer recommendations are that 
recalibration is carried out on an annual basis, although the calibration solution has a 
shelf life of 6 months (Moor Instruments Ltd.).  The probe was calibrated for the 
channel of the system chosen for use. The calibration solution uses a thermal 
(Brownian) motion of polystyrene microspheres in water which produces the reference 
signals required and is thus temperature dependent. The calibration process was carried 
out in a temperature-controlled environment of between 20 and 22 degrees centigrade. 
The probe head was positioned in the calibration solution near the centre of the fluid 
without contact with the container, and the fibre optic lead was unsupported during the 
calibration process. Successful calibration is registered as ‘Calibration OK’ on the 
system.  
 
3.2.3 Choice of chamber for iontophoresis 
The chambers utilised for iontophoresis are constructed of Perspex with an internal 
platinum wire electrode. As this work was to be carried out on the plantar aspect of the 
foot with the ion chamber in a vertical position, trials were carried out using different 
chamber sizes to find the optimal size of the ion chamber to use. The ion chamber had 
to be small enough to be located on the metatarsophalangeal joint plantar aspect of the 
forefoot, ensuring total contact to prevent surface burning due to uneven current 
distribution, as well as being strong enough to endure pressure from the delivery system 
and to house the DP2 probe. Several iontophoresis chambers were investigated, offering 
more area for solution retention versus affording contact and an element of control and 
accurate positioning for the DP2 probe. Smaller chambers have been associated with an 
92 
 
increase in skin perfusion when applying either positive or negative charges referred to 
as a ‘galvanic response’ (Ferrell et al. 2002; Turner et al. 2008), however overall the 
decision was made to utilise a smaller chamber with a central aperture of 6.1 mm 
diameter and the MIC1-Ion1 chamber was chosen as illustrated in Figure 3.9.  
 
 
 
Figure 3.9 The chosen MIC1-Ion1 chamber. Dimensions of the elements of the chamber are a central aperture 
of 6.1mm and three connecting apertures each 4mm in diameter connected by a 2mm drill which allows flow 
of solution and top up when required. 
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3.2.4 Iontophoresis solutions 
Acetylcholine (ACh) was the chosen endothelium-dependent agonist and sodium 
nitroprusside (SNP) as an endothelium-independent vasodilator for comparison (Khan 
& Newton 2003). Several vehicles have been utilised to dissolve the substances used 
during iontophoresis, commonly deionised water, tap water, and sodium chloride have 
been used (Ferrell et al. 2002). In fact Morris & Shore (1996) actually found that 
vehicle alone could lead to an increase in skin perfusion i.e. the ‘galvanic response’. 
Deionised water was the original vehicle of choice; however the dimensions of the 
chamber then lead to the issue of retaining enough solution in contact with the skin for 
iontophoresis with the equipment being held in a vertical position and with the addition 
of the pressure delivery system preventing the utilisation of a cover to prevent spillage. 
During piloting, difficulties were experienced ensuring the chosen vasodilator solutions 
containing ACh and SNP remained in sufficient quantities in the iontophoresis chamber. 
It was decided that some form of inert thickening agent would help prevent leakage and 
spillage from the chamber. Noon et al. (1998) had successfully utilised 2% 
methylcellulose, and found it to prevent a current induced vasodilator response. The 
manufacturers also recommend the use of methylcellulose to help with contoured sites 
(Moor Instruments Ltd.). Methylcellulose is a water soluble derivative of pine pulp 
which dissolves quickly and is generally used as a thickener, binder or for water 
retention in pharmaceutical applications. It is stable at room temperatures, colourless, 
odourless and non-ionic (Dow Wolff 2012). 
 
3.2.5 Ionotophoresis protocol development 
Most studies utilising iontophoresis have been carried out on the upper limbs, or the 
dorsum of the foot (Pitei et al. 1997; Caballero et al. 1999; Khan et al. 2000; Kelly et 
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al. 2001; Pfutzner et al. 2001; Koitka et al. 2004a; Rossi et al. 2005). The area under 
investigation in this study was the plantar skin of the foot which in comparison to skin 
elsewhere on the body is relatively thick, with a lack of sebaceous glands but many 
sweat glands, and the proposed position of the foot was such that the equipment was to 
be held vertically on the plantar aspect. Thus, a suitable protocol had to be developed 
and the possibility of utilising methylcellulose as a thickening agent investigated.  
Initially 2% and 4% solutions of methylcellulose in deionised water were constituted 
and mixed with 2% solutions of ACh and SNP. The 4% mixture was found to be fairly 
viscous and proved too thick to top up the iontophoresis chamber easily via the 2 mm 
channels connecting the central aperture which housed the DP2 probe. This allowed 
some air pockets to develop and if bubbling at the probe end had occurred it could have 
significantly reduced the effect of the drug. Thus, the decision was made to carry out 
further testing of protocols utilising 2% solution of methylcellulose. It has been noted 
that the choice of vehicle does not have an impact on the voltage being applied (Khan et 
al. 2004), however as the vehicle was also thickening the fluid, analysis of the impact of 
different solutions on protocols was carried out. It was decided that a gradual increase in 
current over time would be utilised, this method is thought to prevent possible non-
specific, current induced galvanic response and in light of the small size of chamber 
coupled with the thickened solution it was felt this would offer the optimum opportunity 
to monitor the response at low currents (Turner et al. 2008).  
 5 gradual increasing protocols comparing a 2% solution of ACh and SNP with a 
thickened solution with added 2% methylcellulose were investigated, with the aim of 
finding the optimum protocol as detailed in Table 3.4. Each protocol was tested with 
both ACh and SNP in 2% solutions and again with the 2% solution combined with 2% 
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methylcellulose on 3 occasions. The testing took place utilising the same subject for 
each protocol. 
Table 3.4 The 5 protocols tested using both 2% solution of ACh and SNP with 
added 2% methylcellulose and a graduated increase in currents from 0 to 100µA 
over time in seconds. 
 
Protocol 1 Protocol 2 Protocol 3 Protocol 4 Protocol 5 
0µA     120secs 0µA     60secs 0µA     120secs 0µA     120secs 0µA     60secs 
10µA   120secs 20µA   120secs 20µA   120secs 10µA   240secs 20µA   120secs 
15 µA  120secs 40 µA  240secs 40 µA  240secs 20 µA  240secs 40 µA  120secs 
20 µA  120secs 50 µA  240secs 50 µA  240secs 50 µA  240secs 50 µA  240secs 
40 µA  120secs 75 µA  120secs 75 µA  240secs 75 µA  240secs 75 µA  240secs 
50 µA  120secs 100 µA  300secs 100 µA  240secs 100 µA  240secs 100 µA  120secs 
75 µA  120secs  0µA      300secs  0µA      300secs  0µA      240secs  0µA      240secs 
100 µA  120secs     
0 µA      300secs     
 
Testing was carried out over a period of 2 months, in a temperature controlled 
environment of 22° + 1°C under the same conditions which would be followed for the 
main study; i.e. avoiding food ingestion and caffeine based drinks for at least 2 hours 
beforehand and with a 20 minute period of acclimatisation. Mean perfusion values were 
obtained for each substance with and without thickening agent, and ICC analysis was 
carried out on the data. There was a high degree of repeatability for the protocols, and 
Table 3.5 displays the findings. 
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Table 3.5 Results obtained from testing the 5 protocols with and without 
methylcellulose thickening agent as a vehicle for SNP and ACh used in the 
iontophoresis process 
Protocol ICC values 95% C.I. ANOVA  
F value 
P values 
Protocol 1-SNP 0.978 (0.867-0.996) 38.434 < 0.0001 
Protocol 1-ACh 0.885 (0.008-0.978) 19.657 < 0.0001 
Protocol 2-SNP 0.735 (-0.271-0.960) 5.117 0.049 
Protocol 2-ACh 0.957 (0.512-0.993) 44.116 < 0.0001 
Protocol 3 -SNP 0.784 (-0.228-0.977) 15.759 0.010 
Protocol 3-ACh 0.747 (-0.267-0.957) 8.713 0.009 
Protocol 4-SNP 0.982 (0.857-0.998) 49.761 0.001 
Protocol 4-ACh 0.955 (0.216-0.994) 56.109 < 0.0001 
Protocol 5-SNP 0.988 (0.928-0.998) 86.638 < 0.0001 
Protocol 5-ACh 0.982 (0.749-0.998) 106.338 < 0.0001 
 
The results indicated that all protocols could be utilised with methylcellulose as a 
vehicle without having a significant impact on the perfusion values obtained. Protocols 
4 and 5 displayed the highest repeatability and as protocol 5 displayed the highest 
repeatability and also was shorter in duration, it was chosen as the preferred protocol for 
the main study. Figure 3.10 displays the mean flux obtained in the testing of protocol 5 
for SNP and Figure 3.11 displays the mean flux obtained for ACh, both with and 
without methylcellulose as a thickening agent. 
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Figure 3.10 Graph of the mean flux values obtained for SNP with and without the addition of 
the thickening agent methylcellulose 
 
Figure 3.11 Graph of the mean flux values obtained for ACh with and without the addition of                          
the thickening agent methylcellulose 
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3.2.6 In vivo inter-day repeatability testing of the laser Doppler flowmeter 
Iontophoresis utilising 2% acetylcholine and 2% methylcellulose was carried out on the 
plantar aspect of the third metatarsophalangeal joint with 8 healthy volunteers on two 
separate occasions and at least two days apart. Each test was held in a temperature 
controlled environment of 22° ± 1° C following a 20 minute acclimatisation period, at 
the same time of day for both runs of the test and on each occasion the individual 
subject had followed the same protocol re abstaining from food and caffeine ingestion 
prior to testing. ICC analysis was carried out with a value of 0.933, 95% C.I. (0.674-
0.987) F = 13.732, p = 0.001 indicative of good repeatability.  
 
3.3 LASER SPECKLE CONTRAST IMAGING (LSCI) 
Laser speckle contrast imaging is a relatively new method of measuring blood flow; 
however the reproducibility of the equipment when compared with other methods such 
as laser Doppler has been found to be very good, including inter-day reproducibility 
when assessing forearm post occlusive reactive hyperaemia (Roustit et al. 2010; Tew et 
al. 2011). As this equipment had not been used to measure the dynamics of perfusion in 
the form of a perfusion map on the plantar aspect of the foot before, a pilot study was 
conducted on 22 healthy subjects to assess feasibility for use to assess reactive 
hyperaemia on the plantar aspect of the foot.  
 
3.3.1 Inter-day repeatability of LSCI-full field perfusion imager FLPI®  
(Moor Inst. Ltd)  
Prior to carrying out a pilot study utilising the LSCI-FLPI®  with a single subject under 
the experimental  protocol conditions, repeated measurements were taken on the plantar 
aspect of the forefoot with the area of interest being the 3rd metatarsophalangeal joint 
area. The testing was carried out on 5 consecutive days, at the same time of day with the 
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pre-test conditions of no ingestion of food or caffeine for a period of 2 hours.  ICC 
analysis was carried out and a value of 0.982, 95% C.I. (0.906-1.000) F = 55.187,          
p < 0.0001 obtained indicative of good repeatability.  
 
3.3.2 Pilot study with LSCI-FLPI® equipment, methodology and recruitment 
Initially ethical approval was sought and granted for this pilot study from Queen 
Margaret University research ethics committee. Recruitment was via an electronic 
poster distributed through the internal mail system (Appendix 1).  Participants were 
healthy adult volunteers between the ages of 20 and 48 years of age (mean 30.3 years) 
and consisted of 32% (7) males and 68% (15) females. The exclusion criteria consisted 
of any underlying lower limb vascular or neurological conditions; or any underlying 
pathology of the spine/lower limbs which results in an inability to walk unaided. All 
subjects were provided with a written information sheet (Appendix 2) and indicated 
their consent by signing a consent form (Appendix 3). 
 
3.3.3 Pilot study protocol 
The volunteers were initially acclimatised in a temperature controlled room of 22° ±1°C 
for a period of 20 minutes in a supine position. During the initial 5-10 minutes details of 
the procedure were explained to the volunteer and information sheets provided, and if 
the volunteer was happy to proceed then consent forms were signed off. It was clearly 
outlined to all volunteers that they could stop the procedure at any stage. Using the 
LSCI-FLPI® system (Moor Instruments Ltd.) the perfusion for the plantar aspect of the 
foot was recorded for 4 minutes providing baseline resting blood flow data as seen in 
Figure 3.12. The FLPI® system does not require being in direct contact with the skin but 
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sits approximately 10 cms away from the skin surface. Five areas were chosen at the 
peripheral aspect of the plantar aspect of the foot for analysis. They consisted of three 
toes, and the metatarsophalangeal joint area of the foot directly behind the toes, thus 
covering the peripheral plantar aspect of the foot. Following this initial resting blood 
flow period of measurement, a pressure cuff was placed around the calf area and 
inflated to 200 mmHg for a period of 4 minutes providing an occlusive stage during 
which measurements of flux continued across the same areas of the foot. Following the 
occlusive stage, recordings were taken again for a period of up to 15 minutes to record 
the reactive hyperaemia which consisted of a peak of maximum blood flow followed by 
a slower return to baseline resting perfusion. 
 
  
Figure 3.12 LSCI-FLPI® system with the pressure cuff utilised for the pilot study 
 
 
101 
 
3.3.3.1 Resting perfusion for the group 
Resting perfusion for the group was measured at the first, third and fifth toes as well as 
the first and lesser (2nd, 3rd and 4th) MPJs on the plantar aspect of the foot. Generally 
each area displayed similar readings, with the exception of the third toe which displayed 
a much smaller range of values than the other forefoot areas under study which can be 
noted in Table 3.6 and displayed in Figure 3.13. 
Table 3.6 Descriptive statistics for resting flux obtained at the areas under study 
 1st toe 3rd toe 5th toe Mid MPJs 1ST MPJ 
Mean 13.86 14.09 13.23 18.00 18.68 
Median 14.00 12.00 13.00 16.50 17.00 
St. Dev 5.72 8.06 9.32 9.50 8.05 
 
 
Figure 3.13 Box plots of resting perfusion for first, third, and fifth toes as well as the 2nd, 3rd and 4th 
metatarsophalangeal joints and the 1st metatarsophalangeal joint on the plantar aspect of the foot 
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3.3.3.2 Occlusive perfusion for the group 
Occlusive perfusion or flux for the group was measured for the same areas of interest as 
the resting perfusion. As expected on occlusion, the perfusion registered over each area 
under study was very much reduced in comparison to the resting perfusion. The values 
obtained for each area of interest can be seen in Table 3.7 and displayed in Figure 3.14. 
Table 3.7 Descriptive statistics for occlusion at the areas under study 
 1st toe 3rd toe 5th toe Mid MPJs 1ST MPJ 
Mean 13.86 14.09 13.23 18.00 18.68 
Median 14.00 12.00 13.00 16.50 17.00 
St. Dev 5.72 8.06 9.32 9.50 8.05 
 
 
 
 
 
 
Figure 3.14 Box plots of occlusive perfusion for first, third, and fifth toes as well as the 2nd, 3rd and 4th 
metatarsophalangeal joints and the 1st metatarsophalangeal joint on the plantar aspect of the foot 
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3.3.3.3 Post occlusion peak perfusion values 
Peak perfusion values registered a large increase in volume on release of the occlusion, 
with up to ten times the value of the resting flux being registered. Peak perfusion 
statistics can be seen in Table 3.8 and are displayed in Figure 3.15. 
 
Table 3.8 Descriptive statistics for peak flux immediately following occlusion for 
the areas under study 
 
 1st toe 3rd toe 5th toe Mid MPJs 1ST MPJ 
Mean 810.05 776.41 811.91 1024.23 1029.36 
Median 804.00 759.50 848.50 1031.50 1002.50 
St. Dev 282.35 230.37 311.79 348.84 414.42 
 
 
 
 
 
 
 
Figure 3.15 Box plots of peak perfusion following occlusion for first, third, and fifth toes as well as the 2nd, 3rd 
and 4th metatarsophalangeal joints and the 1st metatarsophalangeal joint on the plantar aspect of the foot 
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3.3.3.4 Time taken to return to resting perfusion 
The time taken to return to baseline resting flux displayed a mean value of 2.17 minutes 
with standard deviation of 0.82 and median value 2.10 minutes. The range was from 
1.25 to 4.92 minutes. 
 
3.4 SUMMARY 
The plantar pressure delivery system was specifically developed for this study and was 
found to produce repeatable values, and thus could be utilised for the main study to add 
pressure when investigating blood flow in conjunction with laser Doppler flowmetry. 
The process of iontophoresis was fully investigated for utilisation, with assessment of 
the specific chamber dimensions, investigation of the optimum thickness for the 
solutions and the protocol for use on the plantar surface of the foot. Repeatability 
studies were carried out on the laser Doppler flowmeter to ensure both equipment and 
protocols were suitable for use in the main study. 
The LSCI-FLPI® equipment performed well under testing and during a pilot study when 
utilised on the lower limb, with no adverse results or issues raised during or after 
testing, thus it was also found to be a suitable method of assessing the post occlusive 
hyperaemic response for the main study. 
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4 APPLICATION OF THE DEVELOPED PROTOCOL 
 
4.1 INTRODUCTION 
Investigating the function of the microvasculature supplying the plantar surface of the 
foot when under the normal pressures exerted during ambulation, could be key to 
understanding why the tissues are compromised in conditions such as diabetes mellitus, 
leading to breakdown and the development of ulceration. Assessment of endothelial 
function during ambulation has proven to be extremely difficult to achieve due to the 
requirements to house blood flux analysis equipment for the plantar aspect of the foot 
within a pressure analysis base or insole, and to date no commercial equipment is 
available to carry out this analysis. The rationale for the methods employed in this study 
was to develop an in-vivo, reliable, and repeatable, as well as user friendly, method for 
simultaneous assessment of endothelial function of the microvasculature while 
simulating the normal pressures exerted on the forefoot area during ambulation.   
 
4.2 CHOICE OF ENVIRONMENT FOR THE STUDY 
The equipment developed and chosen for this study was portable; however 
standardisation of the external conditions was important to minimise fluctuations in skin 
perfusion. Consequently, all procedures were conducted in a temperature controlled 
laboratory in the Vascular Unit at Ninewells Hospital, Dundee.  
 
4.3 ETHICAL APPROVAL 
Prior to any development work and the actual procedure being carried out, ethical 
approval was sought and granted from Tayside Committee on Medical Research Ethics 
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B. The laser speckle imaging equipment is a relatively new piece of equipment which 
was not available at the start of this study. Following exploratory work utilising this 
equipment it was thought to be particularly useful for the assessment of the post 
occlusive hyperaemia (PORH) component of this study, and a substantial amendment 
application was submitted and further approval for this amendment to the original 
protocol sought, which was approved by the committee. 
 
4.4 PROCEDURE 
4.4.1 Background  
The study group consisted of 60 volunteers based in and around the city of Dundee. 
This group was further divided into 30 subjects with Type 2 diabetes mellitus (19 males 
and 11 females), with an age range from 36 to 81 years (mean of 68 years). The 
duration of diabetes ranged from 5 years to 23 years (mean duration 11.3 years).  
The control group was also made up of 30 volunteers, of which 18 were male and 12 
female. The range of ages was from 37 to 80 years, with the mean age being 60.1 years. 
The control subjects were questioned about their medical history, with a particular 
emphasis on diabetes mellitus and vascular problems. However, testing of blood 
glucose levels was not carried out, thus it should be noted that it is possible that some of 
the controls may have been undiagnosed with asymptomatic diabetes. 
 
4.4.2 Volunteers with diabetes 
Ninewells hospital in Dundee has an established reputation for the care of diabetes and 
thus attracts patients from many areas in and around Dundee. Therefore it was chosen 
for the source of volunteers with Type 2 diabetes and permission to approach patients to 
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become volunteers was given by Honorary Professor Graham Leese, Consultant 
Physician in Diabetes. 
  
4.4.2.1 Invitation to participate 
Subjects with diabetes who could be suitable for inclusion in the study were identified 
from adult patients on the diabetes centre database Scottish Care Information-Diabetes 
Collaboration (SCI-DC) (Diabetes in Scotland 2010). SCI-DC provides a centralised 
source of detailed information for all people in Scotland who have diabetes. It was set 
up originally for clinical use and designed to improve the quality of care for those with 
diabetes by allowing shared information across the health care team. A random 
selection of 46 possible subjects was made from the database, living in and around 
Dundee. Letters of invitation to take part in the study, along with subject information 
sheets (Appendix 4) were initially sent out with return slips included.  Individuals who 
had returned favourable return slips were then contacted via telephone and further 
details and explanations provided with an invitation to attend for the study issued. Of an 
initial list of 46 possible volunteers contacted, 32 agreed to participate with 2 proving to 
be not suitable for the study. One having open wounds on the plantar aspect of the foot 
and with the possibility of cross infection and alteration of the normal gait pattern was 
declined. The second had a pacemaker fitted and following discussion, the individual 
did not feel comfortable in taking part in the study. The exclusion criteria for the group 
were underlying pathology of the spine/lower limbs which results in an inability to walk 
unaided. Thus, of the original 46 possible volunteers approached 65% agreed to 
participate who were suitable for the study. 
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4.4.3 Control volunteers 
The control group consisted of 30 healthy adults with no known symptomatic vascular 
complications who were recruited from posters placed on Ninewells Hospital and 
University of Dundee electronic notice boards (Appendix 5). Word of mouth also 
gained some of the more mature volunteers such as retired staff members and relatives 
of current staff who had noted the electronic recruitment request. 
The exclusion criteria in the control group were any underlying lower limb vascular or 
neurological conditions, or any underlying pathology of the spine/lower limbs which 
could have resulted in an inability to walk unaided. The individuals were questioned 
about their general health and a lower limb assessment was carried out checking skin 
appearance for colour, temperature, and lower limb pulses. Ankle reflexes and lower 
limb muscle power was assessed as well as sensation in the form of touch/pressure, 
temperature and proprioception. Of the volunteers who came forward only 1 withdrew 
from the study due to lower back pain which prevented the individual lying in a supine 
position for any length of time. 
 
4.5 ASSESSMENT PROTOCOL 
Prior to the procedure being carried out, following a discussion and full explanation of 
the study, written informed consent was obtained (Appendix 6). This was followed by a 
short interview with each volunteer and details such as age, sex, general health, 
medication and, where appropriate, duration of diabetes and mode of management for 
diabetes, were obtained. Initial assessment of the lower limbs was then carried out for 
the control group to ensure suitability of the volunteer for the study as detailed in 
Section 4.4.3. 
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4.5.1 Procedure 
4.5.1.1 Initial plantar pressure analysis 
Initial barefoot peak plantar pressure analysis of the individual’s right foot was carried 
out using the Emed-x/E system. This was to provide the peak pressure exerted under the 
forefoot of each subject when walking as displayed in Figure 4.1. It is a computerised, 
dynamic, portable pressure analysis system which consists of a footplate containing 
6,080 sensors with a sensor area of 0.25cm2 set into a portable walkway (Novel 
Instruments) as illustrated in Figure 4.2. The portable walkway consisted of a 
lightweight, rigid material, with a cut out section which allowed the plate to sit flush 
within the walkway itself. Each individual was asked to walk across the walkway and 
plate at their own walking pace, looking ahead to prevent targeting of the plate which 
could alter their natural gait and as such might impact on the pressure measurement. 
Two full steps were taken prior to stepping onto the plate, which is an accepted protocol 
to achieve a natural strike of the foot on the pressure plate (Myers-Rice et al. 1994). 
Three strikes were recorded for each subject and the mean peak pressure was used for 
the 6 areas of the forefoot included in this study i.e. 1st, 3rd and 5th toes and 1st, 3rd and 
5th MPJs of the right foot. 
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Figure 4.1 Emed-x/E pressure analysis system with peak plantar pressures displayed in kPa during walking 
 
 
Figure 4.2 Emed-x/E pressure analysis system set into the portable walkway 
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4.5.1.2 Recording of reactive hyperaemia 
Subjects were then taken to the temperature controlled laboratory in the vascular unit 
and asked to remove their shoes and socks/tights, and then to rest on the plinth in a 
supine position. Any overlying callous found in the locality under study was reduced by 
debridement using a sterile scalpel blade to allow effective penetration of the 
iontophoresis solutions for the experiments described in Section 4.5.1.3.  
Following acclimatisation in the temperature controlled laboratory of 22° ± 1°C for 20 
minutes, 6 areas of interest on the forefoot were marked out using the laser speckle 
imaging system. The areas of interest were the 5th toe, 3rd toe, 1st toe and the 5th, 3rd and 
1st metatarsophalangeal joint areas on the plantar aspect of the foot. As foot sizes varied 
across the subjects, a set size of area of interest was not possible but the area was chosen 
to ensure flux measurements only over the areas under study. Baseline data were 
recorded for 2 minutes and following this, a pressure cuff placed around the calf area 
was then inflated to 200 mmHg for a period of 5 minutes providing an occlusive stage 
as illustrated in Figure 3.12. Following release of the occlusive cuff, the reactive 
hyperaemia was recorded continuously for 5 minutes and readings taken at 2 and 5 
minutes post occlusion to enable analysis of the recovery period as illustrated in Figures 
4.3 and 4.4.   
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Figure 4.3 Superimposed trace of the 6 areas under study displayed together with initial baseline resting flux, 
followed by occlusion and the release of the cuff 
 
 
 
Figure 4.4 Individual traces from each of the 6 forefoot areas under study during the assessment of reactive 
hyperaemia displaying the 3 stages of baseline flux, occlusion and release of the cuff with resultant hyperaemia 
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4.5.1.3 Measurement of blood flux with the application of vasodilator solutions and 
simultaneous addition of pressure 
 
The right foot was then placed in the customised boot designed to support the lower part 
of the limb and foot comfortably for the time required for gathering data, as well as 
holding it in a stable position for delivery of pressure as illustrated in Figure 4.5. The 
skin over the area of interest, the third metatarsophalangeal joint area on the plantar 
aspect of the foot (chosen as an area which sustains high pressure during ambulation 
across the forefoot), was cleansed with an alcohol swab. The iontophoresis chamber was 
attached to the skin using double sided adhesive pads specifically designed for use with 
the system, and the 2% solution of ACh with 2% methylcellulose added to the chamber. 
The DRT4® DP2 probe and pressure delivery system were then placed in position with 
the chamber and secured. Local blood flow to the third metatarsophalangeal joint area 
of the plantar aspect of the right forefoot was measured using a laser Doppler flowmeter 
while iontophoresis was being carried out as displayed in Figure 4.6. Iontophoresis was 
carried out using the protocol detailed in Section 3.2.5, with 2% acetylcholine in a 
vehicle of 2% methylcellulose, with the process being repeated using 2% sodium 
nitroprusside also in a vehicle of 2% methylcellulose. During the process, application of 
differing pressures were delivered to the area starting with no pressure, followed by 
50% and then 100% of the subject’s individual peak pressure while measuring blood 
flow. The pressures were calculated for each subject utilising the mean peak walking 
pressure found under the third metatarsophalangeal joint area of the plantar aspect 
utilising the Emed-x/E pressure analysis system and delivered during iontophoresis 
using the pressure delivery system as illustrated in Figure 4.5. A second probe was 
positioned on the 5th metatarsophalangeal joint area of the same foot as a control 
measure of blood flux. 
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Figure 4.5 The pressure delivery system held in position via the adapted boot with the iontophoresis chamber 
housing the laser Doppler probe and the solutions with the vasodilators 
 
 
Figure 4.6 Laser Doppler flowmeter trace during the process of iontophoresis with ACh with the active 
iontophoresis statistics displayed. F1 is the active probe flux and F2 is the control probe trace 
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4.6 STATISTICAL METHODS 
The data collected from this study was analysed using the Statistical Package for the 
Social Sciences (SPSS) version 19. The significance level adopted for all analysis 
carried out was p < 0.05. Assessment of the repeatability of equipment during the 
development stage of the project was carried out utilising the Interclass Correlation 
Coefficient (ICC) with 95% confidence interval. Spearman’s correlation coefficient has 
been utilised to display associations between the different areas of the forefoot under 
study with the LSCI, and between the data obtained from laser Doppler flowmetry and 
laser speckle imaging, as well as the association between the actual forefoot pressures 
and baseline blood flux. Repeated measures ANOVA with Bonferonni correction was 
used to investigate the impact of pressure on endothelial function when utilising ACh 
and SNP with iontophoresis on the subjects with diabetes and the healthy control group, 
and for the laser speckle data when comparing the group with diabetes and the control 
group. This was followed with Mann-Whitney U test to further analyse the data in the 
assessment of pressure on endothelial function when utilising ACh and SNP with 
iontophoresis on the subjects with diabetes and the healthy control group. 
 
4.7 RESULTS OF THE APPLICATION OF THE PROTOCOL 
4.7.1 Results of post occlusive reactive hyperaemia (PORH) assessment using LSCI 
4.7.1.1 Introduction  
PORH was measured in the two groups of subjects to assess for any differences in the 
response across the groups, as well as to compare the response across the plantar 
pressure areas in the 30 volunteers who had Type 2 diabetes and 30 age and sex 
matched healthy control subjects. Laser speckle contrast imaging (LSCI) data was 
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available for 94.24% of the overall group with a breakdown of 95.38% of the subjects 
with Type 2 diabetes and 93.11% of the control subjects when measuring the resting 
flux, occlusion values, peak and time to peak as well as 2 minutes and 5 minutes post 
peak parameters. 100% data was not achieved due to slight movement of the limbs in a 
small number of individuals during the data gathering process. Initial testing of the data 
showed that it did not follow a normal distribution pattern, which was revealed by 
calculating the z value for the data utilising the skewness and kurtosis values with a 
skewness value of 1.96 or greater indicative of significance at p < 0.05. As can be seen 
in Table 4.1 the majority of z values obtained were in excess of 1.96, thus non-
parametric statistical analysis was utilised with the exception of repeated measures 
ANOVA where the F value is thought to be robust, and as such can be utilised without a 
normal distribution (Field 2013).  
 
4.7.1.2 Post occlusive reactive hyperaemia findings between the two groups 
Six stages of reactive hyperaemia, over six areas of interest on the plantar aspect of the 
forefoot were investigated in both groups. The six elements were:- 
• an initial baseline resting blood flux measurement 
• an occlusive stage with reduction in blood flux  
• the peak blood flux on removal of the occlusion  
• the time to reach peak flux  
• 2 minutes following removal of the occlusion blood flux as an indicator of 
recovery of blood flow   
• 5 minutes following removal of the occlusion blood flux as an indicator of 
recovery of blood flow  
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Comparisons between the stages of the hyperaemic response were made between the 2 
groups using repeated measures ANOVA with post hoc Bonferroni analysis. Mauchly’s 
test indicated that the assumption of sphericity had been violated therefore the degrees 
of freedom were corrected with Huynh-Feldt. As the data did not follow a normal 
distribution pattern as indicated in Section 4.7.1.1, and noted in Table 4.1 a non-
parametric statistical analysis was chosen for the follow up investigation of the 
individual areas of study, thus Mann-Whitney U test was used.  
Table 4.1 Descriptive statistics indicating skewness of LSCI data for n=60 
 
Resting Flux measured in arbitrary units (AU) 
 
Area Mean St.Dev. Skewness 
Statistic  
St.error Z 
value 
Kurtosis 
Statistic 
St.error Z 
value 
5th toe 167.00 125.99 1.273 0.319 3.99 1.334 0.628 2.12 
3rd toe 149.60 115.51 2.051 0.314 6.53 5.770 0.618 9.34 
1st toe 149.56 126.00 1.914 0.314 6.10 4.093 0.618 6.62 
5th MPJ 157.02 139.13 2.308 0.327 7.06 7.108 0.644 11.04 
3RD MPJ 159.42 151.07 2.417 0.314 7.70 7.114 0.618 11.51 
1ST MPJ 146.72 113.07 1.489 0.314 3.18 2.273 0.618 3.68 
 
 
 
Flux during occlusion measured in arbitrary units (AU) 
 
Area Mean St.Dev. Skewness 
Statistic  
St.error Z 
value 
Kurtosis 
Statistic 
St.error Z 
value 
5th toe 26.90 18.09 3.086 0.319 9.67 15.223 0.628 24.24 
3rd toe 28.80 16.48 1.811 0.314 5.77 3.690 0.618 5.97 
1st toe 25.15 16.40 1.925 0.314 6.13 3.824 0.618 6.19 
5th MPJ 27.18 16.39 2.045 0.327 6.25 5.080 0.644 7.89 
3RD MPJ 28.89 17.27 2.329 0.314 7.42 6.290 0.618 10.18 
1ST MPJ 25.18 13.34 1.642 0.314 5.23 4.413 0.618 7.14 
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Table 4.1 Descriptive statistics indicating skewness of LSCI data for n=60 
continued 
 
Peak flow measured in arbitrary units (AU) 
 
Area 
 
Mean St. 
Dev. 
Skewness 
Statistic  
St.error Z value Kurtosis 
Statistic 
St.error Z value 
5th toe 440.19 242.05 0.968 0.322 3.01 1.061 0.634 1.67 
3rd toe 423.84 221.70 1.121 0.314 3.57 1.334 0.618 2.16 
1st toe 417.04 238.27 0.881 0.316 2.79 0.050 0.623 0.08 
5th MPJ 471.10 224.67 0.463 0.327 1.42 -0.029 0.644 0.05 
3RD MPJ 485.74 231.60 0.470 0.314 1.50 -0.070 0.618 0.11 
1ST MPJ 457.27 239.06 0.875 0.314 2.79 0.617 0.618 1.00 
 
 
Time to peak flow measured in seconds 
 
Area 
 
Mean St.Dev. Skewness 
Statistic  
St.error Z 
value 
Kurtosis 
Statistic 
St.error Z 
value 
5th toe 14.22 9.09 2.189 0.322 6.80 7.976 0.634 12.58 
3rd toe 15.19 9.93 1.711 0.314 5.45 4.076 0.618 6.60 
1st toe 14.04 9.29 2.240 0.314 7.13 7.312 0.618 11.83 
5th MPJ 15.15 12.26 2.615 0.325 8.05 8.576 0.639 13.42 
3RD MPJ 14.39 9.69 2.069 0.314 6.59 5.822 0.618 9.42 
1ST MPJ 15.17 11.97 2.451 0.314 7.81 7.572 0.618 12.25 
 
 
2 minutes post peak flow (AU) 
 
Area 
 
Mean St.Dev. Skewness 
Statistic  
St.error Z 
value 
Kurtosis 
Statistic 
St.error Z 
value 
5th toe 172.55 115.90 1.379 0.319 4.38 2.587 0.628 4.12 
3rd toe 168.17 110.08 0.916 0.311 3.22 0.078 0.613 0.13 
1st toe 148.61 114.31 1.317 0.322 4.09 1.570 0.634 2.48 
5th MPJ 152.27 110.79 1.215 0.319 3.81 1.318 0.628 2.10 
3rd MPJ 171.36 121.89 1.125 0.314 3.58 .854 0.618 1.38 
1st MPJ 141.82 101.13 1.365 0.316 4.32 1.586 0.623 2.55 
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Table 4.1 Descriptive statistics indicating skewness of LSCI data for n=60 
continued 
 
5 minutes post peak flow (AU) 
 
Area 
 
Mean St.Dev. Skewness 
Statistic  
St.error Z 
value 
Kurtosis 
Statistic 
St.error Z 
value 
5th toe 139.81 104.32 0.900 0.322 2.80 -0.226 0.634 0.36 
3rd toe 142.33 106.87 1.281 0.311 4.12 1.395 0.613 2.28 
1st toe 134.38 108.13 1.031 0.325 3.17 0.380 0.639 0.60 
5th MPJ 133.54 104.68 1.376 0.319 4.31 1.764 0.628 2.81 
3rd MPJ 144.25 109.96 1.087 0.314 3.46 0.593 0.618 0.96 
1st MPJ 124.95 103.07 1.324 0.322 4.11 1.125 0.634 1.77 
 
The majority of z values are over 1.96 indicative of a skewed distribution thus requirement generally for non-
parametric analysis. 
 
4.7.1.3 Analysis of the resting flux measurements between the group with Type 2 
diabetes and the control group 
 
 The resting blood flux values obtained for the group with Type 2 diabetes and the 
control group were comparable, although the group with Type 2 diabetes displayed 
slightly higher values as can be seen in Table 4.2 and illustrated in Figure 4.7. There 
was no significant difference found within the subjects between the sites under study for 
resting flux (F = 1.354, p = 0.264) with no significant difference across the groups       
(F = 0.211, p = 0.651) and no significant interaction effect for resting flux and the 
groups (F = 0.536, p = 0.584). With follow up analysis utilising Mann Whitney U test, 
no significant difference was found between the groups across any of the six individual 
sites under study as illustrated in Table 4.2.  
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Table 4.2 Comparison of the resting flux across the two groups 
Area T2DM 
Mean flux 
T2DM 
St. Dev. 
Controls 
Mean flux 
Controls 
St. Dev. 
Significance 
p value 
5th toe 178.79 123.92 154.34 129.31 0.254 
3rd toe 154.06 105.17 145.14 126.73 0.489 
1st toe 164.98 128.57 134.14 123.68 0.142 
5th MPJ 161.94 110.54 151.90 165.84 0.206 
3rd MPJ 152.64 103.10 166.19 189.04 0.194 
1st MPJ 149.23 97.24 144.22 128.67 0.363 
T2DM is the group with Type 2 diabetes and Controls are the control subjects, Mann-Whitney U test was used 
for the follow up analysis and p values obtained. There was no significant difference found within subjects 
between the sites under study for resting flux (p = 0.264, ANOVA), or the groups (p = 0.651, ANOVA) or for 
the interaction effect between resting flux and the group (p = 0.584 ANOVA). 
 
 
 
                          Figure 4.7 Comparison of the resting flux (AU) for the two groups 
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4.7.1.4 Comparison of the occlusive stage blood flux values for the two groups 
During the occlusive stage of the PORH assessment the blood flow in both groups was 
reduced substantially from resting flux. No significant difference was found with 
occlusion across the sites under study (F = 1.654, p = 0.165) or across the groups         
(F = 0.930, p = 0.345) and no significant interaction was found between occlusion and 
the groups (F = 0.683, p = 0.567). With follow up analysis, there was no significantly 
different between the flux values obtained for the groups during the occlusive stage at 
any of the individual areas under study as can be seen in Table 4.3 and illustrated in 
Figure 4.8. 
 
 
Table 4.3 Comparison of the occlusion flux values across the two groups 
Area T2DM 
Mean flux 
T2DM 
St. Dev. 
Controls 
Mean flux 
Controls 
St. Dev. 
Significance 
p value 
5th toe 26.57 12.86 27.25 22.67 0.676 
3rd toe 28.89 15.56 28.71 17.63 0.859 
1st toe 23.83 13.10 26.46 19.30 0.675 
5th MPJ 27.95 14.88 26.38 18.09 0.499 
3rd MPJ 28.96 14.88 28.82 19.65 0.592 
1st MPJ 24.83 10.29 25.52 16.00 0.913 
T2DM is the group with Type 2 diabetes and Controls are the control subjects, Mann-Whitney U test was used 
for the follow up analysis and p values obtained. There was no significant difference found within subjects for 
occlusion (p = 0.165, ANOVA), or the groups (p = 0.345, ANOVA) or for the interaction effect between 
occlusion and the group (p = 0.567, ANOVA). Follow up analysis indicated no significant difference between 
the groups in any of the areas under study. 
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                Figure 4.8 Blood flux during occlusion (AU), a comparison between the two groups 
4.7.1.5 Comparison of the peak flux achieved post occlusion between the two groups 
A significant difference was found for peak flux achieved on release of the occlusion   
(F = 4.560, p = 0.004), and for the group (F = 6.337, p = 0.020) as well as a significant 
interaction found between the peak flux and the groups (F = 0.235, p = 0.032).  As can 
be noted in Table 4.4 and illustrated in Figure 4.9, the trend was for the group of 
subjects with Type 2 diabetes to have a higher peak flux value than the control group. 
With follow up analysis the peak flux following occlusion found on the plantar aspect 
of the 5th toe was significantly higher in the group with Type 2 diabetes than in the 
control group (p = 0.049). The value for the peak flux following occlusion found on the 
plantar aspect of the 3rd toe was significantly higher in the group with Type 2 diabetes 
than found in the control group (p = 0.013). There was no significant difference found 
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between the groups on the plantar aspect of the hallux, however the trend indicated in 
Figure 4.9 clearly displayed that the actual mean values obtained across the group at the 
hallux were higher than found in the control group, although statistical significance was 
not achieved (p = 0.175. N.S.). There was a significant difference found on the plantar 
aspect of the 5th MPJ between the groups, again with the subjects with diabetes 
displaying a higher peak flux on release of occlusion in comparison with the control 
group (p = 0.004). On the plantar aspect of the 3rd MPJ a significant difference was 
noted with higher values achieved in peak flux in the group with type 2 diabetes           
(p = 0.014) and a significant difference was found on the plantar aspect of the 1st MPJ 
with the diabetic subjects displaying a higher peak flux on release of occlusion than the 
control group (p = 0.019). 
 
Table 4.4 Comparison of peak flux values (AU) following release of occlusion 
between the two groups 
Area T2DM 
Mean flux 
T2DM 
St. Dev. 
Controls  
Mean flux 
Controls 
St. Dev. 
Significance 
p value 
5th toe 486.58 225.02 388.45 254.09 0.049 
3rd toe 482.51 210.06 365.17 220.90 0.013 
1st toe 452.99 236.97 382.33 238.45 0.175 N.S. 
5th MPJ 561.62 215.21 377.10 196.93 0.004 
3rd MPJ 569.77 225.51 401.71 209.09 0.014 
1st MPJ 532.47 250.39 382.06 204.76 0.019 
 
T2DM is the group with Type 2 diabetes and Controls are the control subjects, Mann-Whitney U test was used 
for the follow up analysis and p values obtained. There was a significant difference found within subjects for 
peak flux (p = 0.004, ANOVA), for the groups (p = 0.020, ANOVA) and for the interaction effect between peak 
flux and the group (p = 0.032, ANOVA). On follow up analysis, there was a significant difference found 
between the groups in the areas under study with the exception of the 1st toe (p = 0.175, M.W.U). 
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Figure 4.9 Comparison of peak flux values (AU) following release of occlusion in the two groups 
 
4.7.1.6 Comparison of the time to reach peak flux following occlusion between the 
group with Type 2 diabetes and the control group 
 
The time taken for each of the groups (measured in seconds) to reach the peak flux 
following release of the occlusion to the area was very similar, and no significant 
difference was found with the time taken to reach peak flux (F = 0.973, p = 0.417) or for 
the effect of group (F = 0.130, p = 0.722) and no significant interaction between time to 
reach peak flux and the group (F = 0.235, p = 0.868). With the follow up analysis using 
Mann-Whitney U test, there was no significant difference found between the time taken 
to reach peak flux on the plantar aspect of the 5th toe (p = 0.561), and as measured on 
the plantar aspect of the 3rd toe (p = 0.858) or as measured on the plantar aspect of the 
hallux (p = 0.714). Again no significant difference was found in the time taken to reach 
peak flux when measured on the plantar aspect of the 5th MPJ (p = 0.938), or the 3rd 
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MPJ (p = 0.889) nor on the plantar aspect of the 1st MPJ (p = 0.895) as can be seen in 
Table 4.5 and illustrated in Figure 4.10. 
Table 4.5 Comparison of the time to reach peak flux values across the two groups 
Area T2DM 
Mean flux 
T2DM 
St. Dev. 
Controls  
Mean flux 
Controls  
St. Dev. 
Significance 
p value 
5th toe 14.49 8.54 13.92 9.82 0.561 
3rd toe 14.58 8.47 15.79 11.32 0.858 
1st toe 14.05 8.08 14.03 10.51 0.714 
5th MPJ 15.40 13.12 14.88 11.53 0.938 
3rd MPJ 14.34 8.64 14.45 10.79 0.889 
1st MPJ 15.24 12.59 15.10 11.54 0.895 
T2DM is the group with Type 2 diabetes and Controls are the control subjects, Mann-Whitney U test was used 
for the follow up analysis and p values obtained. There was no significant difference found within subjects for 
time to peak flux (p = 0.417, ANOVA), or the groups (p = 0.722, ANOVA) or for the interaction effect between 
time to peak flux and the group (p = 0.868, ANOVA). No significant difference was found between the groups 
in any of the areas under study in the follow up analysis. 
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Figure 4.10 Comparison of the time to peak flux (seconds) following removal of occlusion 
 between the two groups 
 
 
4.7.1.7 Comparison of the blood flux values registered 2 minutes post peak values 
between the two groups   
Although the group with Type 2 diabetes registered slightly higher values across the 
areas of study than the control group, there was no significant difference found within 
subjects for blood flux values obtained two minutes after the peak flux following 
occlusion (F = 1.324, p = 0.261) or for the group (F = 0.362, p = 0.555) or for the 
interaction between 2 minutes post peak flux values and the group (F = 0.685, p = 
0.487).  As can be noted in Table 4.6 and illustrated in Figure 4.11, there was no 
significant difference found on follow up analysis between the blood flux on the plantar 
aspect of the 5th, 3rd and 1st toes or 5th, 3rd or 1st MPJ areas between the groups at a 
period of 2 minutes post maximum or peak flux.  
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Table 4.6 Comparison of 2 minutes post peak flux values (AU) following release of 
occlusion between the two groups 
Area T2DM 
Mean flux 
T2DM 
St. Dev. 
Controls  
Mean flux 
Controls 
St. Dev. 
Significance 
p value 
5th toe 170.60 95.67 174.80 137.57 0.681 
3rd toe 170.87 117.01 165.38 104.42 0.940 
1st toe 163.50 118.92 135.27 110.38 0.345 
5th MPJ 175.24 127.09 127.59 85.73 0.222 
3rd MPJ 186.74 128.15 155.97 115.45 0.273 
1st MPJ 146.07 93.61 137.09 110.50 0.598 
 
T2DM is the group with Type 2 diabetes and Controls are the control subjects, Mann-Whitney U test was used 
for the follow up analysis. There was no significant difference found within subjects for 2 mins. post peak flux 
(p = 0.261, ANOVA), or the groups (p = 0.555, ANOVA) or for the interaction effect between 2 mins. post peak 
flux and the group (p = 0.487, ANOVA) and no significant difference between the groups in any of the sites on 
follow up analysis. 
 
Figure 4.11 Comparison of the blood flux values at 2 minutes post peak flux (AU) between the two groups 
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4.7.1.8 Five minutes post peak flux values, comparison between the two groups 
At five minutes post peak flux values the flux values obtained are slightly higher in the 
group with Type 2 diabetes when compared with the control group. There was no 
significant difference found for 5 minutes post peak flux (F = 1.197, p = 0.320) or for 
the group (F = 1.206, p = 0.288) and no significant interaction was found between the 5 
minutes post peak flux values and the groups (F = 0.740, p = 0.573). However, on 
follow up analysis there was a significant difference found between two of the areas 
under study i.e. in the areas of the first toe and the 5th MPJ, it should be noted that the 
significance levels obtained were marginal. The results can be seen in Table 4.7, and are 
illustrated in Figure 4.12. There was no significant difference noted between the groups 
on the plantar aspect of the 5th toe (p = 0.749), or on the plantar aspect of the 3rd toe (p = 
0.317). However, on the plantar surface of the hallux a significant difference in blood 
flux measured 5 minutes post peak flux was found between the groups, although 
marginal in value (p = 0.047), and on the plantar aspect of the 5th MPJ area of study, 5 
minutes post peak pressure a significant difference was found between the groups        
(p = 0.045) however as in the hallux the value of the level of significance was marginal. 
There was no significant difference found between the groups on the plantar aspect of 
the 3rd MPJ area of the foot at 5 minutes post peak flux (p = 0.062) or at the plantar 
aspect of the 1st MPJ area (p = 0.207). 
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Table 4.7 Comparison of 5 minutes post peak flux values (AU) following release of 
occlusion between the two groups 
Area T2DM 
Mean flux 
T2DM 
St. Dev. 
Controls 
Mean flux 
Controls 
St. Dev. 
Significance 
p value 
5th toe 145.63 110.62 133.30 98.58 0.749 N.S. 
3rd toe 157.88 122.38 126.25 87.297 0.317 N.S. 
1st toe 165.07 123.93 105.89 83.57 0.047 
5th MPJ 162.79 120.67 102.13 74.30 0.045 
3rd MPJ 171.53 120.26 116.97 92.79 0.062 N.S. 
1st MPJ 138.25 98.34 111.16 107.86 0.207 N.S. 
T2DM is the group with Type 2 diabetes and Controls are the control subjects, Mann-Whitney U test was used 
for the follow up analysis. There was no significant difference found within subjects for 5 mins. post peak flux 
(p = 0.320, ANOVA), or the groups (p = 0.288, ANOVA) or for the interaction effect between 5 mins. post peak 
flux and the group (p = 0.573, ANOVA). On follow up analysis, there was no significant difference found 
between the groups in the areas under study with the exception of the 1st toe (p = 0.047, M.W.U) and 5th MPJ 
areas (p = 0.045, M.W.U). 
 
Figure 4.12 Comparison of the blood flux values (AU) 5 minutes post peak following  
release of occlusion between the groups 
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4.7.2 Investigation of the association between values obtained for the different 
areas under study with reactive hyperaemia and the LSCI –FLPI® system 
 
There was a strong association found between the 6 areas of the plantar aspect under 
study when assessed across the group as a whole, and also across both the group with 
Type 2 diabetes and the control group (with the exception of 3 associations during 
occlusion) when assessed as individual groups, however the correlations were stronger 
in the group with Type 2 diabetes than found in the control group. A normal distribution 
was not found across the data obtained from the reactive hyperaemia assessment using 
LSCI as noted in Section 4.7.1 and Table 4.1 so a non-parametric method of analysis 
was used to analyse the data i.e. Spearman’s correlation coefficient. The association 
found across the group as a whole can be found in Tables 4.8 and 4.9 and demonstrated 
in the scatterplots Figures 4.13 to 4.18. The association found between the areas in the 
group with diabetes can be found in Tables 4.10 and 4.11 and seen in scatterplots 4.19 
to 4.24, with data for the control subjects in Tables 4.12 and 4.13 and Figures 4.25 to 
4.30. 
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Table 4.8 Mean values and standard deviations for the areas for n=60 under study for association 
Area Resting flux (AU) 
Mean ± S.D. 
Occlusion (AU) 
Mean ± S.D. 
Peak flux (AU) 
Mean ± S.D. 
Time to peak flux (secs.) 
Mean ± S.D. 
2 mins post peak flux (AU) 
Mean ±  S.D. 
5 mins. post peak flux (AU) 
Mean ± S.D. 
 
5th toe 167.00±125.99 26.90±18.09 440.19±242.05 14.22±9.09 172.55±115.90 139.81±104.32 
3rd toe 149.60±115.51 28.80±16.48 423.84±221.70 15.19±9.93 168.17±110.08 142.33±106.87 
1st toe 149.56±126.00 25.15±16.40 417.04±238.27 14.04±9.29 148.61±114.31 134.38±108.13 
5th MPJ 157.02±139.13 27.18±16.39 471.10±224.67 15.15±12.26 152.27±110.79 133.54±104.68 
3rd MPJ 159.42±151.07 28.89±17.27 485.74±231.60 14.39±9.69 171.36±121.89 144.25±109.96 
1st MPJ 146.72±113.07 25.18±13.34 457.27±239.06 15.17±11.97 141.82±101.13 124.95±103.07 
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Table 4.9 Correlation found between the areas of the plantar aspect of the forefoot 
in the group where n=60, including both subjects with Type 2 diabetes and the 
control subjects 
Areas Resting Flux Occlusion Peak Flux Time to  
Peak Flux 
2 mins. post 
Peak Flux 
5 mins. post 
Peak Flux 
 
 r p r p r p r p r p r p 
5tv3t 0.929 <0.0001 0.627 <0.0001 0.891 <0.0001 0.797 <0.0001 0.833 <0.0001 0.884 <0.0001 
5tv1t 0.853 <0.0001 0.421 0.0001 0.600 <0.0001 0.812 <0.0001 0.802 <0.0001 0.801 <0.0001 
5tv5m 0.864 <0.0001 0.465 0.0001 0.791 <0.0001 0.768 <0.0001 0.836 <0.0001 0.812 <0.0001 
5tv3m 0.845 <0.0001 0.557 <0.0001 0.889 <0.0001 0.771 <0.0001 0.855 <0.0001 0.782 <0.0001 
5tv1m 0.879 <0.0001 0.495 <0.0001 0.589 <0.0001 0.787 <0.0001 0.767 <0.0001 0.745 <0.0001 
3tv1t 0.877 <0.0001 0.569 <0.0001 0.666 <0.0001 0.859 <0.0001 0.793 <0.0001 0.842 <0.0001 
3tv5m 0.845 <0.0001 0.605 <0.0001 0.770 <0.0001 0.787 <0.0001 0.770 <0.0001 0.783 <0.0001 
3tv3m 0.844 <0.0001 0.599 <0.0001 0.826 <0.0001 0.832 <0.0001 0.792 <0.0001 0.824 <0.0001 
3tv1m 0.871 <0.0001 0.567 <0.0001 0.594 <0.0001 0.794 <0.0001 0.814 <0.0001 0.824 <0.0001 
1tv5m 0.837 <0.0001 0.533 <0.0001 0.449 <0.0001 0.866 <0.0001 0.791 <0.0001 0.831 <0.0001 
1tv3m 0.850 <0.0001 0.600 <0.0001 0.573 <0.0001 0.851 <0.0001 0.820 <0.0001 0.815 <0.0001 
1tv1m 0.877 <0.0001 0.637 <0.0001 0.590 <0.0001 0.869 <0.0001 0.808 <0.0001 0.872 <0.0001 
5mv3m 0.944 <0.0001 0.784 <0.0001 0.848 <0.0001 0.880 <0.0001 0.894 <0.0001 0.912 <0.0001 
5mv1m 0.910 <0.0001 0.773 <0.0001 0.665 <0.0001 0.849 <0.0001 0.833 <0.0001 0.842 <0.0001 
3mv1m 0.939 <0.0001 0.907 <0.0001 0.725 <0.0001 0.900 <0.0001 0.864 <0.0001 0.895 <0.0001 
 
 
In Table 4.9 t = toe, m =MPJ, r = Spearman’s correlation coefficient, p=significance 
There was a significant association found between all areas under study in the group with both subjects with 
Type 2 diabetes and control subjects where n=60, with 5th toe n=56, 3rd toe n=58, 1st toe n=58, 5th MPJ n=53, 
3rd MPJ n=58 and 1st MPJ n=58. 
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Figure 4.13 Scatterplot displaying the association between resting flux (AU) found at the 5th and 3rd toes 
 
 
 
 
Figure 4.14 Scatterplot displaying the association between occlusion flux (AU) found at the 5th and 3rd toes 
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Figure 4.15 Scatterplot of the association of peak flux (AU) following occlusion for the 5th and 3rd toes 
 
Figure 4.16 Scatterplot of the association of time to peak flux (seconds) following occlusion for the  
5th and 3rd toes 
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Figure 4.17 Scatterplot of the association for 2 minutes post peak flux (AU) between 5th and 3rd toes 
 
Figure 4.18 Scatterplot of the association for 5 minutes post peak flux (AU) between 5th and 3rd toes 
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Table 4.10 Mean values with standard deviations for the group with Type 2 diabetes found in the areas under study for association  
Area Resting flux 
(AU) 
Mean ± S.D. 
Occlusion (AU) 
 
Mean ± S.D. 
Peak flux (AU) 
 
Mean ± S.D. 
Time to peak 
flux (secs.) 
Mean ± S.D. 
2 mins post peak 
flux (AU) 
Mean ± S.D. 
5 mins. post 
peak flux (AU) 
Mean ± S.D. 
 
5th toe 178.79±123.92 26.57±12.86 486.58±225.02 14.49±8.54 170.60±95.67 145.63±110.62 
3rd toe 154.05±105.17 28.89±15.56 482.51±210.06 14.58±8.47 170.87±117.01 157.88±122.38 
1st toe 164.98±128.57 23.83±13.10 452.99±236.97 14.05±8.08 163.50±118.92 165.07±123.93 
5th MPJ 161.94±110.54 27.95±14.88 561.62±215.21 15.40±13.12 175.24±127.09 162.79±120.67 
3rd MPJ 152.65±103.10 28.96±14.88 569.77±225.51 14.34±8.64 186.74±128.15 171.53±120.26 
1st MPJ 149.23±97.24 24.83±10.29 532.47±250.39 15.24±12.59 146.07±93.61 138.25±98.34 
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Table 4.11 Correlation found between the areas of the plantar aspect of the 
forefoot in the group with Type 2 diabetes (n=30) 
Areas Resting Flux Occlusion Peak Flux Time to  
Peak Flux 
2 mins. post 
Peak Flux 
5 mins. post 
Peak Flux 
 
 r p r p r p r p r p r p 
5tv3t 0.912 <0.0001 0.677 <0.0001 0.862 <0.0001 0.867 <0.0001 0.774 <0.0001 0.862 <0.0001 
5tv1t 0.835 <0.0001 0.442 0.016 0.596 0.001 0.824 <0.0001 0.830 <0.0001 0.804 <0.0001 
5tv5m 0.936 <0.0001 0.686 <0.0001 0.738 <0.0001 0.895 <0.0001 0.817 <0.0001 0.814 <0.0001 
5tv3m 0.863 <0.0001 0.741 <0.0001 0.845 <0.0001 0.891 <0.0001 0.815 <0.0001 0.767 <0.0001 
5tv1m 0.870 <0.0001 0.720 <0.0001 0.595 0.001 0.867 <0.0001 0.701 <0.0001 0.717 <0.0001 
3tv1t 0.878 <0.0001 0.578 <0.0001 0.694 <0.0001 0.961 <0.0001 0.877 <0.0001 0.941 <0.0001 
3tv5m 0902 <0.0001 0.725 <0.0001 0.737 <0.0001 0.948 <0.0001 0.805 <0.0001 0.805 <0.0001 
3tv3m 0.890 <0.0001 0.781 <0.0001 0.792 <0.0001 0.930 <0.0001 0.789 <0.0001 0.869 <0.0001 
3tv1m 0.888 <0.0001 0.724 <0.0001 0.644 <0.0001 0.927 <0.0001 0.831 <0.0001 0.881 <0.0001 
1tv5m 0.851 <0.0001 0.499 0.008 0.492 0.011 0.972 <0.0001 0.866 <0.0001 0.885 <0.0001 
1tv3m 0.867 <0.0001 0.693 <0.0001 0.459 0.014 0.945 <0.0001 0.885 <0.0001 0.913 <0.0001 
1tv1m 0.854 <0.0001 0.736 <0.0001 0.572 0.001 0.950 <0.0001 0.835 <0.0001 0.932 <0.0001 
5mv3m 0.937 <0.0001 0.889 <0.0001 0.712 <0.0001 0.922 <0.0001 0.855 <0.0001 0.898 <0.0001 
5mv1m 0.940 <0.0001 0.848 <0.0001 0.585 0.001 0.986 <0.0001 0.803 <0.0001 0.803 <0.0001 
3mv1m 0.922 <0.0001 0.953 <0.0001 0.727 <0.0001 0.982 <0.0001 0.861 <0.0001 0.916 <0.0001 
 
In Table 4.11 t = toe, m =MPJ, r = Spearman’s correlation coefficient, p=significance 
There was a significant association found between all areas under study in the group with Type 2 diabetes and 
n=30 for the group, for 5th toe, 3rd toe and 1st toe n=29, 5th MPJ n=27 and for 3rd and 1st MPJs n=29. 
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Figure 4.19 Scatterplot of the association between the resting flux (AU) at 5th and 3rd toes in the  
group with Type 2 diabetes 
 
 
Figure 4.20 Scatterplot of the association between the 5th and 3rd toes (AU) with occlusion in the  
group with Type 2 diabetes 
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Figure 4.21 Scatterplot of the association between the peak flux at the 5th and 3rd toes (AU) in the  
group with Type 2 diabetes 
 
 
Figure 4.22 Scatterplot of the association between time to peak flux at the 5th and 3rd toes (seconds)) in the 
group with Type 2 diabetes 
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Figure 4.23 Scatterplot of the association found between 2 minutes post peak flux on the 5th and 3rd toes (AU) 
in the group with Type 2 diabetes 
Figure 4.24 Scatterplot of the association between the post peak flux after 5 minutes for the 5th and 3rd toes in 
the group with Type 2 diabetes 
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Table 4.12 Mean values and standard deviations for the group of healthy control subjects n = 30 found in the areas under study for association  
 
Area Resting flux (AU) 
Mean ± S.D. 
Occlusion (AU) 
Mean ± S.D. 
Peak flux 
(AU) 
Mean ± S.D. 
Time to peak flux (secs.) 
Mean ± S.D. 
2 mins post peak flux (AU) 
Mean ± S.D. 
5 mins. post peak flux (AU) 
Mean ± S.D. 
 
5th toe 154.34±129.31 154.34±129.31 388.45±254.09 13.92±9.82 174.80±137.57 133.30±98.58 
3rd toe 145.14±126.73 145.14±126.73 365.17±220.90 15.79±11.32 165.38±104.42 126.25±87.30 
1st toe 134.14±123.68 134.14±123.68 382.33±238.45 14.03±10.51 135.27±110.38 105.88±83.57 
5th MPJ 151.90±165.84 151.90±165.84 377.10±196.93 14.88±11.53 127.59±85.73 102.13±74.30 
3rd MPJ 166.19±189.04 166.19±189.04 401.71±209.09 14.45±10.79 155.97±115.45 116.97±92.79 
1st MPJ 144.22±128.67 144.22±128.67 382.06±204.76 15.10±11.54 137.09±110.50 111.16±107.86 
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4.13 Correlation found between the areas of the plantar aspect of the forefoot  
(n = 30) in the group of control subjects 
 
Areas Resting Flux Occlusion Peak Flux Time to  
Peak Flux 
2 mins. post 
Peak Flux 
5 mins. post 
Peak Flux  
 
 r p r p r p r p r p r p 
5tv3t 0.951 <0.0001 0.577 0.002 0.889 <0.0001 0.708 <0.0001 0.912 <0.0001 0.911 <0.0001 
5tv1t 0.812 <0.0001 0.370 0.058N.S. 0.575 0.002 0.795 <0.0001 0.772 <0.0001 0.824 <0.0001 
5tv5m 0.838 <0.0001 0.196 0.359N.S. 0.806 <0.0001 0.510 0.013 0.867 <0.0001 0.841 <0.0001 
5tv3m 0.834 <0.0001 0.413 0.032 0.891 <0.0001 0.581 0.002 0.867 <0.0001 0.822 <0.0001 
5tv1m 0.858 <0.0001 0.291 0.141N.S. 0.495 0.010 0.684 <0.0001 0.849 <0.0001 0.786 <0.0001 
3tv1t 0.887 <0.0001 0.534 0.003 0.628 <0.0001 0.723 <0.0001 0.733 <0.0001 0.739 <0.0001 
3tv5m 0.814 <0.0001 0.468 0.016 0.772 <0.0001 0.503 0.009 0.801 <0.0001 0.768 <0.0001 
3tv3m 0.847 <0.0001 0.452 0.014 0.806 <0.0001 0.705 <0.0001 0.795 <0.0001 0.799 <0.0001 
3tv1m 0.876 <0.0001 0.446 0.015 0.504 0.005 0.636 <0.0001 0.828 <0.0001 0.765 <0.0001 
1tv5m 0.767 <0.0001 0.571 0.002 0.426 0.03 0.679 <0.0001 0.673 <0.0001 0.768 <0.0001 
1tv3m 0.817 <0.0001 0.527 0.003 0.685 <0.0001 0.698 <0.0001 0.750 <0.0001 0.692 <0.0001 
1tv1m 0.864 <0.0001 0.553 0.002 0.611 <0.0001 0.754 <0.0001 0.751 <0.0001 0.785 <0.0001 
5mv3m 0.939 <0.0001 0.691 <0.0001 0.850 <0.0001 0.708 <0.0001 0.902 <0.0001 0.930 <0.0001 
5mv1m 0.892 <0.0001 0.729 <0.0001 0.646 <0.0001 0.674 <0.0001 0.897 <0.0001 0.890 <0.0001 
3mv1m 0.936 <0.0001 0.876 <0.0001 0.676 <0.0001 0.815 <0.0001 0.911 <0.0001 0.893 <0.0001 
In Table 4.13 t = toe, m =MPJ, r = Spearman’s correlation coefficient, p=significance  
There was a significant association found between all areas under study with the exception of associations 
between 5th toe and 1st toe, 5th toe and 5th MPJ and 5th toe and 1st MPJ which during occlusion only did not 
display a significant association in the control group with n=30 for the group, for 5th toe n=27, 3rd toe and 1st 
toe n=29, 5th MPJ n=26 and for 3rd and 1st MPJs n=29. 
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Figure 4.25 Scatterplot of the association between the resting flux (AU) found at the 5th and 3rd toes in the 
control subjects 
Figure 4.26 Scatterplot of the association between 5th and 3rd toe (AU) during occlusion in the control subjects 
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Figure 4.27 Scatterplot displaying the association between the peak flux (AU) found at the 3rd and 5th toes in 
the group of control subjects 
 
Figure 4.28 Scatterplot displaying the association between the time to peak flux found at the 5th and 3rd toes 
(seconds) in the group of control subjects 
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Figure 4.29 Scatterplot displaying the association found at 2 mins. post peak flux at the 5th and 3rd toes (AU) in 
the group of control subjects 
Figure 4.30 Scatterplot displaying the association found between the 5th and 3rd toes (AU) 5 mins. post peak 
flux in the group of control subjects 
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4.7.3 Comparison of LDF and LSCI when utilised to measure blood flux on the 
foot in this study 
  
Both LSCI and LDF were used to assess the baseline resting flux on the plantar aspect 
of the 3rd MPJ and a strong correlation was found between the two systems.  As the data 
did not display a normal distribution the non-parametric Spearman’s correlation 
coefficient was used. With inclusion of all subjects with Type 2 diabetes and the control 
subjects, the correlation coefficient was 0.601 and p < 0.0001, thus a strong association 
was found between the resting flux at the 3rd MPJ. When the results obtained for the 
group with diabetes between the two methods were compared for resting blood flux 
prior to intervention with occlusion, or current with ACh there was a strong correlation 
(r = 0.638 p < 0.0001). For the group of control subjects there was also a strong 
association between the methods of assessment (r = 0.549, p = 0.003). The comparison 
was also carried out between the LSCI resting flux data found at 3rd MPJ, and the LDF 
data obtained with SNP prior to initiating the current for iontophoresis.  For the group 
as a whole r = 0.458, p = 0.001 indicated a strong association, for the group with Type 2 
diabetes the association again was strong (r = 0.61, p = 0.001) and for the control group 
data there was also a strong association found (r = 0.742, p < 0.0001). Thus in this 
particular study, a strong association was found between the resting flux as measured on 
the plantar aspect at the 3rd MPJ when using LSCI and LDF methods of assessing blood 
flux as can been noted in Table 4.14 and displayed in Figures 4.31 to 4.36. 
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Table 4.14 Results of the comparison between utilisation of LSCI and LDF when measuring baseline resting flux on the plantar aspect 
 of  3rd MPJ 
Group under study Comparison Corr. co.  
     r 
Significance  
    p value 
Whole group-n=60 
subjects with Type 2 diabetes plus controls LSCI vs LDF-ACh 0.601 < 0.0001 
Subjects with type 2 diabetes-n=30 LSCI vs LDF-ACh 0.638 < 0.0001 
Control subjects n=30 LSCI vs LDF-ACh 0.549     0.003 
Whole group-n=60 
subjects with Type 2 diabetes plus controls LSCI vs LDF-SNP 0.458     0.001 
Subjects with Type 2 diabetes n=30 LSCI vs LDF-SNP 0.611     0.001 
Control subjects n=30 LSCI vs LDF-SNP 0.742 < 0.0001 
 
There was a significant association found between laser speckle contrast imaging and laser Doppler flowmetry when measuring resting blood flux on the plantar aspect of the 3rd MPJ in both 
the group as a whole, and the subjects with Type 2 diabetes and control subjects. 
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Figure 4.31 Scatterplot of the association between LSCI and LDF with ACh at the 3rd MPJ across the group 
with Type 2 diabetes plus the control subjects n=60 
Figure 4.32 Scatterplot of the association between LSCI and LDF with ACh in the group with Type 2 diabetes 
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Figure 4.33 Scatterplot of the association between LSCI and LDF with ACh at the 3rd MPJ in  
the control group 
Figure 4.34 Association between the resting flux at 3rd MPJ with LSCI and LDF with SNP and no current 
across the group with Type 2 diabetes and the control group n = 60 
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Figure 4.35 Association between the resting flux at 3rd MPJ between the LSCI and LDF with SNP and no 
current in the group with Type 2 diabetes 
Figure 4.36 Association between the measurement of resting flux at 3rd MPJ between the LSCI and LDF with 
SNP and no current in the group of control subjects 
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4.7.4 Results of the impact of pressure on endothelial function as measured with 
laser Doppler flowmetry (LDF) 
  
4.7.4.1 Introduction 
In this component of the study, adding a known pressure and investigating the impact of 
the pressure on endothelial function was measured. Of the 60 subjects who took part in 
this aspect of the study, laser Doppler flowmetry data was available for 91.5%, for the 
group with Type 2 diabetes, 90.65% of the data was available and for the control group 
92.35%. A small number of participants requested to stop the study prior to completion, 
in the case of two individuals a tingling sensation was felt at the site of the 
iontophoresis, and with the other subjects time was given as the reason to stop. As 
found with the assessment of reactive hyperaemia, examination of the data revealed that 
it did not follow a normal distribution pattern, when the z value was calculated for the 
data using a skewness value of 1.96 or greater to indicate significance at p < 0.05.The 
majority of z values obtained were in excess of 1.96, as noted in Table 4.15 thus non-
parametric statistical analysis was utilised for this data again with the exception of 
repeated measures ANOVA where the F value was thought to be robust (Field 2013).  
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Table 4.15 Descriptive statistics for the LDF data with ACh (n=60) 
ACh 
Current + pressure 
Mean Flux 
(AU) Standard Dev. 
Skewness 
Statistic 
 
St. error 
 
Z value 
Kurtosis 
Statistic 
 
St. error 
 
Z value 
0µa +0p 68.50 75.80 1.998 0.316 6.32 4.084 0.623 6.56 
20µa +0p 82.14 83.24 1.686 0.316 5.34 2.733 0.623 4.39 
40µa +0p 101.42 94.50 1.29 0.316 4.08 0.852 0.623 1.37 
50µa +0p 129.39 119.22 1.103 0.316 3.49 -0.057 0.623 0.09 
75µa +0p 154.36 124.25 1.205 0.316 3.81 0.873 0.623 1.40 
100µa +0p 177.38 124.13 0.844 0.316 2.67 -0.141 0.623 0.23 
0µa +50%p 58.99 68.53 3.306 0.311 10.63 14.738 0.613 24.04 
20µa +50%p 63.84 71.70 2.884 0.311 9.27 10.851 0.613 17.7 
40µa +50%p 75.03 79.19 2.216 0.311 7.13 6.308 0.613 10.29 
50µa +50%p 87.93 93.98 2.110 0.311 6.78 4.857 0.613 7.92 
75µa +50%p 112.48 112.45 1.787 0.311 5.75 3.011 0.613 4.91 
100µa +50%p 126.09 114.91 1.283 0.311 4.13 0.727 0.613 1.19 
0µa +100%p 53.30 54.09 2.616 0.319 8.20 8.039 0.628 12.80 
20µa +100%p 66.09 65.54 2.061 0.319 6.46 4.431 0.628 7.06 
40µa +100%p 75.19 75.27 1.803 0.319 5.65 2.991 0.628 4.76 
50µa +100%p 85.48 78.26 1.332 0.319 4.18 1.036 0.628 1.65 
75µa +100%p 103.52 96.73 1.379 0.319 4.32 1.094 0.628 1.74 
100µa +100%p 129.60 106.46 1.095 0.319 3.43 0.712 0.628 1.13 
 
With the majority of z values for skewness in excess of 1.96 utilisation of non-parametric analysis of the data is indicated. 
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Table 4.16 Descriptive statistics for the LDF data with SNP (n=60) 
SNP 
Current + pressure 
Mean Flux (AU) Standard Dev. Skewness Statistic 
 
St. error 
 
Zvalue 
Kurtosis 
Statistic 
 
St. error 
 
Zvalue 
0µa +0p 72.29 89.29 2.503 0.325 7.70 7.280 0.639 11.39 
20µa +0p 77.52 92.98 2.287 0.325 7.04 5.460 0.639 8.54 
40µa +0p 77.42 94.56 2.218 0.325 6.82 4.903 0.639 7.67 
50µa +0p 89.93 98.39 2.045 0.325 6.29 4.318 0.639 6.76 
75µa +0p 107.04 97.31 1.486 0.325 4.57 2.139 0.639 3.35 
100µa +0p 123.40 103.78 1.216 0.325 3.74 1.004 0.639 1.57 
0µa +50%p 58.76 61.45 1.878 0.325 5.78 3.121 0.639 4.88 
20µa +50%p 63.64 65.51 1.767 0.325 5.44 2.469 0.639 3.86 
40µa +50%p 63.41 66.25 1.93 0.325 5.94 3.274 0.639 5.12 
50µa +50%p 65.08 65.71 2.009 0.325 6.18 4.123 0.639 6.45 
75µa +50%p 67.37 61.22 1.583 0.325 4.87 2.640 0.639 4.13 
100µa +50%p 66.07 58.40 1.757 0.327 5.37 4.197 0.644 6.52 
0µa +100%p 39.66 37.08 1.893 0.340 5.57 3.206 0.668 4.80 
20µa +100%p 40.71 40.27 2.079 0.340 6.11 3.730 0.668 5.58 
40µa +100%p 41.84 43.20 2.333 0.340 6.86 5.396 0.668 8.08 
50µa +100%p 44.94 46.71 2.026 0.340 5.96 4.350 0.668 6.51 
75µa +100%p 49.02 47.05 1.246 0.340 3.66 0.634 0.668 0.95 
100µa +100%p 53.52 51.61 1.433 0.340 4.21 1.388 0.668 2.08 
The majority of z values for skewness are in excess of 1.96 thus would indicate the utilisation of non-parametric analysis of the data. 
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4.7.4.2 Actual pressure values as measured with Emed-x/E pressure analysis system 
across the two groups 
The actual pressure exerted on the forefoot during normal walking was measured for 
each subject utilising the Emed-x/E pressure analysis system. There was no significant 
difference found between the group with Type 2 diabetes and the control group for the 
mean pressures exerted on the 1st toes, 3rd toes, and 5th toes, 1st MPJs, 3rd MPJs and 5th 
MPJs. The descriptive statistics and significance values utilising Mann Whitney U 
analysis are presented in Table 4.17. The pressure values obtained under the 3rd MPJ 
areas were those used to obtain 50% and 100% of the individual walking pressures 
added to the laser Doppler probe. 
The plantar pressures recorded across the 6 areas of the forefoot under study were 
compared for both groups, there was a significant association found in the group with 
Type 2 diabetes between the 5th and 3rd toes, 5th and 1st toes and 3rd and 1st toes as well 
as the 5th MPJ with 1st, 3rd and 5th toes. In the group of control subjects there was a 
significant correlation between the 5th toe and 1st MPJ, the 3rd toe and 5th MPJ and the 
1st toe and 1st MPJ with no other significant associations found as presented in Table 
4.18. and illustrated in Figures 4.37 to 4.45. 
The plantar pressures found across the 6 areas of the forefoot were also compared with 
the baseline flux measured with LDF found in each of the areas, and no significant 
association was found as can be noted in Table 4.19. 
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Table 4.17 Descriptive statistics for normal walking pressures of the group with Type 2 diabetes and the control group,                                  
units for pressure measurements are kilopascals (kPa) 
                                Group with Type 2 diabetes                                      Control Group                     p value 
Area of 
the foot 
Range  
 
Minimum  Maximum  Mean St. Dev. Range Minimum Maximum Mean St. Dev. p value 
 
1st toe 460.00 95.00 555.00 285.25 131.66 885.00 100.00 985.00 372.80 183.50 0.65 
3rd toe 218.30 21.70 240.00 124.93 65.43 310.00 20.00 330.00 141.09 83.21 0.643 
5th toe 166.70 0.00 166.70 59.40 48.24 251.70 0.00 251.70 76.42 50.29 0.159 
1st MPJ 326.70 190.00 516.70 302.36 94.12 365.80 152.50 518.30 280.55 102.72 0.300 
3rd MPJ 645.00 230.00 875.00 434.46 125.73 390.00 290.00 680.00 474.37 121.67 0.341 
5th MPJ 313.40 58.30 371.70 143.70 64.01 439.20 67.50 506.70 165.67 102.85 0.755 
 
 
Utilising Mann-Whitney U test, there was no significant difference found between the group of subjects with Type 2 diabetes and the control group at any of the areas  
of the forefoot under study.
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Table 4.18 Correlation of pressure found between the areas of the plantar aspect of 
the forefoot in the group with Type 2 diabetes (n=28) and control subjects (n=27) 
Areas Group with Type 2 diabetes Control group 
 
 r p r p 
5thtoe v 3rd toe 0.375 0.049 (s) 0.354 0.070 
5th toe v 1st toe 0.516 0.005 (s) 0.286 0.148 
5th toe v 5th MPJ -0.596 0.001 (s) -0.142 0.480 
5th toe v 3rd MPJ 0.028 0.889 0.238 0.233 
5th toe v 1st MPJ -0.085 0.669 0.533 0.004 (s) 
3rd toe v 1st toe 0.395 0.037 (s) 0.151 0.452 
3rd toe v 5th MPJ -0.457 0.015 (s) 0.550 0.003 (s) 
3rd toe v 3rd MPJ -0.042 0.830 0.018 0.930 
3rd toe v 1st MPJ -0.068 0.730 0.321 0.103 
1st toe v 5th MPJ 0.516 0.005 (s) -0.005 0.981 
1st toe v 3rd MPJ 0.272 0.161 0.305 0.122 
1st toe v 1st MPJ -0.060 0.761 0.613 0.001 (s) 
5th MPJ v 3rd MPJ 0.033 0.869 -0.293 0.138 
5th MPJ v1st MPJ 0.154 0.434 0.014 0.943 
3rd MPJ v1st MPJ -0.094 0.636 0.116 0.565 
In Table 4.18 toe = toe, MPJ= metatarsophalangeal joint, r = Spearman’s correlation coefficient, 
p=significance and (s) = significant correlation 
There was a significant association found in the group with Type 2 diabetes between the 5th and 3rd toes, 5th 
and 1st toes and 3rd and 1st toes as well as the 5th MPJ with 1st, 3rd and 5th toes. 
In the group of control subjects there was a significant correlation between the 5th toe and 1st MPJ, the 3rd toe 
and 5th MPJ and the 1st toe and 1st MPJ with no other significant correlations found. 
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Table 4.19 Correlation found between the pressure exerted on the forefoot areas of the plantar aspect v baseline flux measured in  
the areas n=60 
 
 Baseline flux  at 5th 
toe 
Baseline flux at 3rd 
toe 
Baseline flux at 1st 
toe  
Baseline flux at 5th 
MPJ 
Baseline flux at 3rd 
MPJ 
Baseline flux at 1st 
MPJ 
Pressure exerted on  5th toe r  -0.116 
p=0.413 
r  -0.111 
 p= 0.427 
r  -0.181 
p=0.195 
r -0.106 
p=0.473 
r -0.086 
p=0.539 
r  -0.109 
p=0.438 
Pressure exerted on  3rd toe r  -0.206 
p=0.143 
r  -0.132 
p=0.347 
r  -0.126 
p=0.370 
r  -0.007 
p=0.963 
r  -0.054 
p=0.704 
r  -0.094 
p=0.503 
Pressure exerted on  1st toe r  -0.182 
p=0.200 
r  -0.192 
p=0.168 
r  -0.113 
p=0.420 
r  -0.115 
p=0.437 
r  -0.096 
p=0.494 
r-0.158 
p=0.259 
Pressure exerted on 5th MPJ r -0.041 
p=0.775 
r -0.053 
p=0.704 
r 0.083 
p=0.555 
r 0.141 
p=0.339 
r 0.029 
p=0.838 
r 0.044 
p=0.756 
Pressure exerted on 3rd MPJ r -0.111 
p=0.432 
r -0.179 
p=0.200 
r -0.138 
p=0.324 
r -0.217 
p=0.139 
r -0.101 
p=0.472 
r -0.095 
p=0.500 
Pressure exerted on 1st MPJ r -0.076 
p=0.594 
r 0.050 
p=0.723 
r 0.048 
p=0.735 
r 0.006 
p=0.966 
r -0.028 
p=0.844 
r 0.005 
p=0.974 
In Table 4.19 r is the Correlation Coefficient and the p value indicates significance. There was no significant association found between any of the areas under study and baseline flux as 
measured in the locality of the pressure delivered across the whole group n=60.
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Figure 4.37 Scatterplot of the association between the pressures (kPa) exerted on 5th and 3rd toes for the group 
with Type 2 diabetes 
 
Figure 4.38 Scatterplot of the association between the pressures (kPa) exerted on the 5th and 1st toes for the 
group with Type 2 diabetes 
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Figure 4.39 Scatterplot of the association between the pressures (kPa) exerted on the 3rd and 1st toes for the 
group with Type 2 diabetes 
Figure 4.40 Scatterplot of the association between the pressures (kPa) exerted on the 3rd toe and 5th MPJ for 
the group with Type 2 diabetes 
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Figure 4.41 Scatterplot of the association between the pressures (kPa) exerted on the 1st toe and 5th MPJ for 
the group with Type 2 diabetes 
 
Figure 4.42 Scatterplot of the association between the pressures (kPa) exerted on the 5th toe and 5th MPJ for 
the group with Type 2 diabetes 
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Figure 4.43 Scatterplot of the association between the pressures (kPa) exerted on the 5th toe and 1st MPJ for 
the control group 
Figure 4.44 Scatterplot of the association between the pressures (kPa) exerted on the 3rd toe and 5th MPJ for 
the control group 
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Figure 4.45 Scatterplot of the association between the pressures (kPa) exerted on the 1st toe and 1st MPJ for the 
control group 
 
4.7.4.3 Results of the impact of pressure on endothelial function when using ACh and 
iontophoresis for the whole group n=60 
At baseline flux with all subjects (both groups) prior to addition of any current across 
the skin surface, the addition of both 50% and 100% pressure added to the area 
impacted upon the flux values obtained. The mean baseline flux without pressure was 
68.50 ± 75.80 (AU), with 50% simulated walking pressure added was 58.99 ± 
68.53(AU) and with the application of 100% pressure, flux at baseline was 53.30 ± 
54.09 (AU). The application of ACh with iontophoresis without pressure produced a 
steady incline in blood flux as the vasodilator effect was apparent, rising to a maximum 
flux of 177.38 ± 124.13 (AU). With the addition of 50% and 100% pressure blood flux 
responses were similar with little difference found in the maximum flux values obtained 
(maximum flux with 50% pressure was 126.09 ± 114.91(AU) and for 100% pressure 
addition maximum flux achieved was 129.60 ± 106.46 (AU) as can be seen in Figure 
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4.46. Thus, the major reduction in flux caused by the addition of pressure with ACh and 
iontophoresis on the plantar aspect of the foot with the whole group occurred at 50% 
application of the normal walking pressure of the subjects in the study, and the further 
addition of pressure to 100% had little further impact on flux. Repeated measures 
ANOVA with post hoc Bonferroni analysis was used to assess the impact of pressure 
and increase in dose of ACh on flux. Mauchly’s test indicated that the assumption of 
sphericity had been violated therefore degrees of freedom were corrected with Huynh-
Feldt and there was a significant difference within subjects from pressure (F = 8.017 
and p = 0.001). There was also a significant effect within subjects of the dose of ACh 
administered on the pressure (F = 51.719 and p < 0.0001) and there was a significant 
interaction effect between the pressure applied and dose of ACh (F = 2.732 and p = 
0.033).  Follow up analysis of the individual pressure effect was performed with Mann-
Whitney U test and a significant difference was found at maximum flux between no 
pressure and 50% pressure (p = 0.006) and between no pressure and 100% pressure     
(p = 0.002). However as illustrated in Figure 4.46 there was no significant difference 
found between maximum flux with 50% and 100% pressure delivery (p = 0.738), these 
findings are clearly illustrated in Figure 4.47 with the percentage change from baseline 
flux displayed against the increase in ACh dose with current strength. 
Table 4.20 Descriptive statistics for pressure and increased dose of ACh with 
iontophoresis 
Pressure 
applied 
Resting flux(AU) 
Mean ± S.D. 
Max. flux(AU) 
Mean ± S.D. 
Sig. 
p value 
Sig. 
p value 
Sig. 
p value 
0 pressure 68.50 ± 75.80 177.38 ± 124.13 0.006 0.002  
50% pressure 58.99 ± 68.53 126.09 ± 114.91 0.006  0.738 
100% pressure 53.30 ± 54.09 129.60 ± 106.46  0.002 0.738 
There was a significant difference found within subjects with pressure (p = 0.001, ANOVA) and for increase in 
dose (p < 0.0001, ANOVA) also for the interaction effect of pressure with increase in ACh dose (p = 0.033, 
ANOVA). There was a significant difference between 0 pressure and 50% pressure application (p = 0.006, 
M.W.U) and 0 pressure and 100% pressure (p = 0.002, M.W.U) but no significant difference between 50% and 
100% pressure (p = 0.738, M.W.U). 
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Figure 4.46 Plot of the three levels of pressure against the increase in current strength on application of 
iontophoresis with ACh for the subjects with Type 2 diabetes and the control group n=60 
 
 
Figure 4.47 Plot of the percentage change from baseline flux against the increase in ACh dose with current for 
the group with Type 2 diabetes plus the control group n = 60 
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4.7.4.4 Results of the impact of pressure on endothelial function when using ACh and 
iontophoresis for the group with Type 2 diabetes 
 The group with Type 2 diabetes also displayed differences in the baseline flux with the 
addition of the different pressures prior to starting the iontophoresis current. When no 
pressure was added a mean and standard deviation for flux of 79.72 ± 81.87(AU) was 
noted, and with the addition of 50% pressure 63.01 ± 58.49 (AU) and with 100% 
pressure, flux values were 56.90 ± 48.67(AU). At the higher levels of current it was 
noticeable that with 50% pressure the peak flux achieved with this group tailed off, 
whereas the 100% pressure plot actually followed a similar increase to the plot for no 
pressure additions, although at a lower flux value. The peak flux achieved without 
pressure for the group with Type 2 diabetes was 190.66 ± 124.72 (AU), with 50% 
pressure this reduced to 134.28 ± 113.27 (AU), and with the application of 100% 
pressure 138.18 ± 112.91(AU), so as in the combined groups of those with Type 2 
diabetes and the control subjects, 50% addition of pressure had a marked effect on flux 
values, however increasing this pressure to 100% of the simulated normal walking 
pressure for the group had little further impact. Repeated measures ANOVA with 
Huynh-Feldt correction and post hoc Bonferroni test indicated a significant difference 
for pressure (F = 5.209, p = 0.009) and for dose of ACh administered with pressure      
(F = 24.274, p < 0.0001). In the group with Type 2 diabetes there was no significant 
interaction effect found between the pressure applied and dose of ACh (F = 1.084,         
p = 0.369). Follow up analysis of the individual effects of pressure was carried out and 
there was no significant difference found between the maximum flux achieved with no 
pressure and with 50% pressure added, although this result was marginal (p = 0.058 
M.W.U). There was a significant difference found between the maximum flux achieved 
with no pressure and with the application of 100% pressure (p  =0.037 M.W.U) and as 
illustrated in Figure 4.48 there was no significant difference found between the addition 
of 50% and 100% pressure application to maximum flux achieved (p = 0.614 M.W.U). 
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The findings are clearly illustrated in Figure 4.49 with the percentage change from 
baseline flux against increase in dose of ACh. 
 
Table 4.21 Descriptive statistics for pressure and increased dose of ACh with 
iontophoresis for the group with Type 2 diabetes 
Pressure 
applied 
Resting flux(AU)  
Mean ± S.D. 
Max. flux(AU) 
Mean ± S.D. 
Sig. 
p value 
Sig. 
p value 
Sig. 
p value 
0 pressure 79.72 ± 81.87 190.66 ± 124.72 0.058 0.037  
50% pressure 63.01 ± 58.49 134.28 ± 113.27 0.058  0.614 
100% pressure 56.90 ± 48.67 138.18 ± 112.91  0.037 0.614 
 
There was a significant difference found within subjects with pressure (p=0.009, ANOVA) and for increase in 
dose (p < 0.0001, ANOVA) but no significance was found for the interaction effect of pressure with increase in 
ACh dose (p = 0.369, ANOVA). Although marginal, there was no significant difference between 0 pressure and 
50% pressure application (p = 0.058, M.W.U) there was a significant difference found between 0 pressure and 
100% pressure delivery (p = 0.037, M.W.U) and no significant difference between 50 and 100% pressure (p = 
0.614, M.W.U). 
 
Figure 4.48 Plot of the three levels of pressure against the increase in current on application of iontophoresis 
with ACh for the group with Type 2 diabetes 
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Figure 4.49 Percentage change in blood flux from baseline against increase in ACh dose with current for the 
group with Type 2 diabetes 
 
4.7.4.5 Results of the impact of pressure on endothelial function when using ACh and 
iontophoresis for the group of healthy control subjects 
For the group of control subjects, the baseline flux with ACh prior to the initiation of 
current for 50% pressure was very similar to the baseline flux without any pressure 
(baseline flux with no pressure 56.88 ± 68.48 AU and with 50% pressure 55.11 ± 77.83 
AU) thus adding 50% pressure had no impact on the baseline flux, whereas application 
of 100% pressure reduced the baseline flux to 49.94 ± 59.36 (AU). Once again the 
maximum flux achieved without pressure was higher (163.64 ± 124.25 AU) than 
achieved with 50% pressure at 118.17 ± 117.86 (AU), however as with the combined 
group with both subjects with Type 2 diabetes and control subjects n = 60, and the 
group with Type 2 diabetes n = 30, increasing the pressure to 100% of natural walking 
pressure did not have a great impact on the maximum flux achieved over that for 50% 
pressure, achieving a mean value with standard deviation of 121.60 ± 101.42 (AU). For 
the control group there was no significant difference found for the effect of pressure     
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(F = 2.778, p = 0.091 within subject repeated measures ANOVA with Huynh-Feldt 
correction and post hoc Bonferroni). For dose administered there was a significant 
difference (F = 31.910, p < 0.0001) and no significant interaction effect found between 
the pressure applied and the dose of ACh administered (F = 1.872, p = 0.132).  
Follow up analysis for the individual elements of pressure noted significant differences 
between 0 pressure and 50% pressure (p = 0.034 M.W.U) and 0 pressure and 100% 
pressure (p = 0.013 M.W.U), however no significant difference was found between the 
maximum flux values for 50% and 100% added pressure (p = 0.991 M.W.U) as 
illustrated in Figure 4.50. These results are also illustrated in Figure 4.51 which displays 
the percentage change from baseline flux against increase in dose of ACh. 
 
Table 4.22 Descriptive statistics for pressure and increased dose of ACh with 
iontophoresis for the group of healthy control subjects 
Pressure 
applied 
Resting flux(AU)  
Mean ± S.D. 
Max. flux(AU) 
Mean ± S.D. 
Sig. 
p values 
Sig. 
p values 
Sig. 
p values 
0 pressure 56.88 ± 68.48 163.64 ± 124.25 0.034 0.013  
50% pressure 55.11 ± 77.83 118.17 ± 117.86 0.034  0.991 
100% pressure 49.94 ± 59.36 121.60 ± 101.42  0.013 0.991 
There was no significant difference found within subjects with pressure (p = 0.091, ANOVA) for the control 
group. A significant difference was found for increase in dose (p < 0.0001, ANOVA) but no significance was 
found for the interaction effect of pressure with increase in ACh dose (p = 0.132, ANOVA). There was a 
significant difference found between 0 pressure and 50% pressure application (p = 0.034, M.W.U) and 
between 0 pressure and 100% pressure delivery (p = 0.013, M.W.U) however, no significant difference between 
50 and 100% pressure was found (p = 0.991, M.W.U). 
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Figure 4.50 Plot of the three levels of pressure against the increase in current on application of iontophoresis 
with ACh for the healthy control group 
 
 
Figure 4.51 Percentage change from baseline flux against increase in ACh dose with current strength for the  
control group 
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4.7.4.6 Differences found between the group with Type 2 diabetes and the healthy 
control group in blood flux response to pressure addition under iontophoresis with 
ACh 
When iontophoresis with ACh was carried out without any added pressure, both groups 
displayed a similar curve for increase in flux with dose of ACh as can be seen in Figure 
4.52. The most noticeable difference was that the group with Type 2 diabetes display 
higher flux values throughout, with baseline flux prior to current application mean and 
standard deviation for subjects with diabetes being 79.73 ± 81.87 (AU) and for the 
control subjects was 56.88 ± 68.48 (AU) rising to a maximum flux for the group with 
Type 2 diabetes of 190.66 ± 124.72 (AU) and for the control group maximum flux was 
163.63 ± 124.25 (AU). Utilising repeated measures ANOVA with Huynh-Feldt 
correction and post hoc Bonferroni test within subjects there was no significant 
difference found for the group measured with increase in dose (F = 2.328, p = 0.139). 
There was a significant difference for dose administered (F = 33.042, p < 0.0001) with 
no significant interaction between the group and dose of ACh (F = 0.437, p = 0.634). 
Follow up analysis of the maximum flux achieved in both groups was not significant    
(p = 0.527 M.W.U). The findings are displayed in Figure 4.52, and with the percentage 
change from baseline flux in Figure 4.53. 
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Figure 4.52 Plots of the groups with Type 2 diabetes and controls with increase in flux and no added pressure 
 
Figure 4.53 Percentage change from baseline flux for the groups with Type 2 diabetes and controls with 
increase in flux and no added pressure 
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4.7.4.7 Differences across the groups with the addition of 50% pressure 
With the addition of 50% pressure both groups follow a similar flux increase curve as 
ACh levels were increased across the skin surface, with the group with Type 2 diabetes 
levelling out at the maximum flux achieved as illustrated in Figures 4.54 and 4.55. As 
with no pressure application, again the group with Type 2 diabetes both started and 
ended with higher flux values than the control group displayed. The baseline flux mean 
and standard deviation values for the group with Type 2 diabetes were 63.01 ± 58.49 
(AU) and for the control group were 55.11 ± 77.83 (AU) and the maximum flux values 
achieved with the group with Type 2 diabetes were 134.28 ± 113.27 (AU) and for the 
control group were 118.17 ± 117.86 (AU). There was no significant difference found for 
the main effect of group with increase in ACh dose (F = 3.072, p = 0.91). There was a 
significant difference for the dose administered (F = 22.093, p < 0.0001) with no 
significant interaction found between the group and dose (F = 1.002, p = 0.362). Mann-
Whitney U test applied to the maximum flux achieved across the groups was not 
significant (p = 0.358). 
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Figure 4.54 Plots of the groups with Type 2 diabetes and control subjects with increase in flux and  
50% added pressure 
 
 
Figure 4.55 Percentage change from baseline flux for the groups with Type 2 diabetes and control subjects 
with increase in flux and 50% added pressure 
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4.7.4.8 Differences across the groups with the addition of 100% pressure 
The increase in flux with dose of ACh for the group with Type 2 diabetes climbed 
steadily to a maximum flux whereas with the control group there was a less steep 
increase (especially noted at lower doses) as can be seen in Figures 4.56 and 4.57. The 
flux values achieved by the group with Type 2 diabetes were again higher generally 
than the control group with a baseline flux of 56.90 ± 48.67 (AU) and for the control 
group 49.94 ± 59.35 (AU) and a maximum flux of 138.18 ± 112.91(AU) and for the 
controls 121.60 ± 101.42 (AU). A significant difference was found for the dose 
administered (F = 14.891, p < 0.0001) however, no significant interaction was found 
between the group and dose with 100% pressure added (F = 1.411, p = 0.251) and 
follow up analysis did not indicate a significant difference between the maximum flux 
levels achieved by the groups (p = 0.292 M.W.U). 
Figure 4.56 Plots of the groups with Type 2 diabetes and controls with increase in flux and 100% 
 added pressure 
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Figure 4.57 Percentage change from baseline flux against increase in dose of ACh with current strength for the 
groups with Type 2 diabetes and controls with increase in flux and 100% added pressure 
 
4.7.4.9 The impact of pressure on the blood flux values obtained during the process of 
iontophoresis with SNP 
For baseline flux prior to application of current, for the whole group n = 60 inclusive of 
subjects with Type 2 diabetes and the control group, the addition of both 50% and 100% 
of the simulated walking pressure had an impact on the flux values obtained with SNP. 
The mean and standard deviation for SNP delivery (for baseline flux) with no pressure 
added was 72.29 ± 89.29 (AU), with 50% pressure was 58.76 ± 61.45 (AU) and for 
100% of added pressure flux was 39.66 ± 37.08 (AU). With SNP delivery via 
iontophoresis and no pressure the response to increasing the dose took longer than with 
ACh to produce an increase in flux, but once a response was achieved, there was a 
steady increase to maximum flux. However, 50% and 100% pressure delivery impacted 
greatly in that the increase in flux was very much impeded with both, and the rise from 
baseline flux to the maximum flux achieved was small as illustrated in Figure 4.58. The 
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findings can be clearly seen in Figure 4.59 with the percentage change from baseline 
flux against increase on dose. The maximum flux mean and standard deviation for no 
pressure delivered being 123.40 ± 103.78 (AU), for 50% pressure was 66.07 ± 58.40 
(AU) and for 100% pressure was 53.52 ± 51.61(AU). There was a significant main 
effect within the participants for pressure (F = 16.752, p < 0.0001) and a significant 
effect of the dose of SNP administered (F = 9.223, p < 0.0001). There was also a 
significant interaction between pressure and dose of SNP delivered (F = 7.762, p < 
0.0001). ANOVA (repeated measures with post hoc Bonferroni) was used to analysis 
the data. Once again Mauchly’s test indicated violation of assumption of sphericity so 
Huynh-Feldt correction was used. Follow up analysis was carried out using the non-
parametric Mann-Whitney U test and a significant difference was noted for maximum 
flux achieved between no pressure and 50% pressure (p < 0.0001) and no pressure and 
100% pressure (p < 0.0001). There was no significant difference found in maximum 
flux achieved with 50% and 100% pressure added, however this result was marginal    
(p = 0.058). 
 
Table 4.23 Descriptive statistics for pressure and increased dose of SNP with 
iontophoresis 
Pressure 
applied 
Baseline flux(AU)  
Mean ± S.D. 
Max. flux(AU) 
Mean ± S.D. 
Sig. 
p values 
Sig. 
p values 
Sig.  
p values 
0 pressure 72.29  ± 89.29 123.40 ± 103.78 <0.0001 <0.0001  
50% pressure 58.76 ± 61.45 66.07 ± 58.40 <0.0001  0.058 
100% pressure 39.66 ± 37.08 53.52 ± 51.61  <0.0001 0.058 
There was a significant difference found within subjects with pressure (p < 0.0001, ANOVA) for the group. A 
significant difference was found for increase in dose (p < 0.0001, ANOVA) and for the interaction effect of 
pressure with increase in SNP dose (p < 0.0001, ANOVA). There was a significant difference found between 0 
pressure and 50% pressure application (p < 0.0001, M.W.U) and between 0 pressure and 100% pressure 
delivery (p < 0.0001, M.W.U) however although marginal, no significant difference was found between 50 and 
100% pressure (p = 0.058, M.W.U). 
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Figure 4.58 Plots of the whole group with no pressure, 50% and 100% pressure delivery with increasing SNP 
dose against blood flux 
 
Figure 4.59 Percentage change from baseline flux against increase in dose of SNP with current strength for the 
whole group with no pressure, 50% and 100% pressure delivery  
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4.7.4.10 The impact of pressure on the blood flux values obtained during the process 
of iontophoresis with SNP in the group with Type 2 diabetes 
With the group with Type 2 diabetes, on the application of SNP the baseline flux for 
pressure additions impacted on the flux values obtained with baseline flux mean and 
standard deviation when no pressure was added (91.32 ± 106.30 AU), with 50% 
pressure added 74.38 ± 76.11(AU) and with 100% pressure added 53.11 ± 46.56 (AU). 
Without any pressure added the flux increased to a maximum mean value of 128.51 ± 
110.86 (AU), however the impact of 50% pressure delivery in the group with Type 2 
diabetes was marked in that the final flux value on completion of the iontophoresis 
delivery of SNP resulted in a lower mean value than the starting flux at 72.98 ± 
65.01(AU). 100% pressure also impacted greatly in that there was a very small 
difference between the baseline flux and the maximum flux value achieved on 
completion of iontophoresis with a mean value of 59.61 + 57.71(AU). There was a 
significant main effect found within subjects for pressure (F = 8.532, p = 0.006 
ANOVA). No significant difference was found for the effect of dose administered       
(F = 0.608, p = 0.535 ANOVA) however there was a significant interaction between 
pressure and the dose of SNP administered (F = 2.424, p = 0.044 ANOVA). Follow up 
analysis indicated a significant difference between the final flux values between no 
pressure and the addition of 50% pressure (p = 002 M.W.U) and between no pressure 
and 100% pressure (p = 0.001 M.W.U). No significant difference was found between 
50% and 100% added pressure at the final flux value (p = 0.115 M.W.U). The impact of 
pressure addition to flux levels can be noted in Table 4.24 and is illustrated in Figure 
4.60 and the percentage change from baseline flux is clearly indicated in Figure 4.61. 
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Table 4.24 Descriptive statistics for pressure and increased dose of SNP with 
iontophoresis in the group of subjects with Type 2 diabetes 
Pressure 
applied 
Baseline flux(AU)  
Mean ± S.D. 
Max. flux(AU) 
Mean ± S.D. 
Sig. 
p values 
Sig. 
p values 
Sig. 
p values 
0 pressure 91.32 ± 106.30 128.51±110.86 0.002 0.001  
50% pressure 74.38 ± 76.11 72.98 ± 65.01 0.002  0.115 
100% pressure 53.11 ± 46.56 59.61 ± 57.71  0.001 0.115 
There was a significant difference found in the group with Type 2 diabetes within subjects with pressure (p = 
0.006, ANOVA) for the group. There was no significant difference found for increase in dose (p = 0.535, 
ANOVA) and for the interaction effect of pressure with increase in SNP dose there was a significant difference 
found (p = 0.044, ANOVA). There was a significant difference found between 0 pressure and 50% pressure 
application (p = 0.002, M.W.U) and between 0 pressure and 100% pressure delivery (p = 0.001, M.W.U) 
however no significant difference was found between 50 and 100% pressure (p = 0.115, M.W.U). 
 
Figure 4.60 Plots of the group with Type 2 diabetes with no pressure, 50% and 100% pressure delivery with 
increasing SNP dose against blood flux (AU) 
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Figure 4.61 Percentage change form baseline flux against increase in dose of SNP with current strength in the 
group with Type 2 diabetes with no pressure, 50% and 100% pressure delivery 
 
4.7.4.11 The impact of pressure on the blood flux values obtained during the process 
of iontophoresis with SNP in the group of control subjects 
The addition of pressure at 50 and 100% of simulated walking pressure did impact upon 
the baseline flux in this group as it did in the group with Type 2 diabetes. Baseline flux 
without pressure addition mean and standard deviations were 53.27 ± 64.82 (AU) with 
50% pressure were 43.13 ± 37.39 (AU) and with the addition of 100% pressure were 
26.74 ± 17.81(AU). With the control subjects and the iontophoresis of SNP it did take 
some time before the flux began to rise with no pressure however, once it started to 
increase it climbed steeply to a maximum value of 118.28 ± 98.02 (AU). There was an 
impact with both 50 and 100% pressure addition, with 50% maximum mean 59.41 ± 
51.62 (AU) and 100% pressure achieving 47.68 ± 45.42 (AU), however the control 
group did deal better with the pressure than the group with Type 2 diabetes in that an 
increase in flux values was recorded at the end of the iontophoresis process. A 
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significant difference was found for the main effect of pressure (F = 7.986, p = 0.004 
ANOVA), and for the effect of dose of SNP (F = 15.139, p < 0.0001 ANOVA) as well 
as for the interaction between pressure and dose of SNP (F = 5.911, p = 0.001 
ANOVA). There was a significant difference found between the maximum flux value 
for no pressure when compared with 50% pressure (p = 0.002 M.W.U) and between no 
pressure and 100% pressure (p = 0.0001 M.W.U), however no significant difference 
was found between the maximum flux obtained with 50% and 100% pressure added    
(p = 0.253 M.W.U). The impact of pressure can be seen in Table 4.25 and is illustrated 
in Figures 4.62 and 4.63. 
 
Table 4.25 Descriptive statistics for pressure and increased dose of SNP with 
iontophoresis in the control group 
Pressure 
applied 
Baseline flux(AU)  
Mean ± S.D. 
Max. flux (AU) 
Mean ± S.D. 
Sig. 
p values 
Sig.  
p values 
Sig. 
p values 
0 pressure 53.27 ± 64.82 118.28 ± 98.02 0.002 0.0001  
50% pressure 43.13 ± 37.39 59.41 ± 51.62 0.002  0.253 
100% pressure 26.74 ± 17.81 47.68 ± 45.42  0.0001 0.253 
There was a significant difference found in the control group within subjects with pressure (p = 0.004, 
ANOVA) for the group. There was a significant difference found for increase in dose (p < 0.0001, ANOVA) 
and for the interaction effect of pressure with increase in SNP dose (p = 0.001, ANOVA). There was a 
significant difference found between 0 pressure and 50% pressure application (p = 0.002, M.W.U) and 
between 0 pressure and 100% pressure delivery (p = 0.0001, M.W.U) however no significant difference was 
found between 50 and 100% pressure (p = 0.253, M.W.U). 
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Figure 4.62 Plots of the control group with no pressure, 50% and 100% pressure delivery with increasing SNP 
dose against blood flux 
 
Figure 4.63 Percentage change from baseline flux with increase in dose of SNP for the control group with no 
pressure, 50% and 100% pressure delivery 
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4.7.4.12 Differences found between the two groups in reaction to the pressure 
delivered under iontophoresis with SNP 
Without the addition of any pressure, there was a marked difference in the baseline flux 
found between the groups, with the group with Type 2 diabetes displaying a higher 
baseline flux (91.32 ± 106.30 AU) than the age matched control group (53.27 ± 64.82 
AU). However, the maximum value achieved by the control subjects (118.28 ± 98.02 
AU) was quite close to that of the subjects with Type 2 diabetes (128.51 ± 110.86 AU), 
thus displaying a greater overall response and this was achieved by a much steeper 
curve of the response as can be seen in Figure 4.64. No significant difference was found 
for the main effect of group measured with the increase in SNP dose (F = 0.855, p = 
0.365 ANOVA), however there was a significant difference found for dose administered 
(F = 18.138, p < 0.0001 ANOVA). No significant interaction between group and the 
dose of SNP was found (F = 1.468, p = 0.241 ANOVA). Follow up analysis of the 
resting flux (p = 0.130 M.W.U) and the maximum flux (p = 0.909 M.W.U) did not 
indicate a significant difference between the 2 groups which can be noted in Figure 4.64 
and indicated in the percentage change from baseline flux illustrated in Figure 4.65. 
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Figure 4.64 Differences found between the 2 groups with delivery of SNP with no added pressure 
 
Figure 4.65 The percentage change from baseline flux with increase in SNP dose between the groups with  
no added pressure 
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4.7.4.13 The impact of 50% pressure addition on the 2 groups with SNP delivery 
under iontophoresis 
Both groups reacted differently to the addition of 50% pressure. The group of control 
subjects started with a baseline flux lower than the group with Type 2 diabetes (43.13 ± 
37.39 vs 74.38 ± 76.11 AU), but then a gradual increase in flux was found up to the 
maximum flux of 59.41 ± 51.62 (AU), whereas the group with Type 2 diabetes while 
starting with a higher baseline flux actually achieved a slight lowering of flux to 72.98 ± 
65.01(AU), thus the impact of 50% pressure delivery was greater on the group with 
Type 2 diabetes than the control group as displayed in Figure 4.66. Despite the 
differences noted between the two groups as illustrated in Figure 4.67, no significant 
difference was found for the main effect of group on the dose of SNP (F = 1.194, p = 
0.286 ANOVA) or for the dose administered (F = 1.860, p = 0.161 ANOVA) or in fact 
for the interaction between group and the dose of SNP (F = 1.092, p = 0.354 ANOVA). 
Between participants did display a significant difference (F = 74.627, p < 0.0001 
ANOVA). There was no significant difference found either with resting flux (p = 0.189 
M.W.U) or with final flux values (p = 0.784 M.W.U) between the two groups. 
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Figure 4.66 Differences found between the 2 groups with delivery of SNP and 50% added pressure 
 
Figure 4.67 Percentage change from baseline flux with increase in dose of SNP displaying the differences 
found between the 2 groups with delivery of SNP and 50% added pressure 
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4.7.4.14 The impact of 100% pressure addition to the two groups with SNP delivery 
under iontophoresis 
Again a notable difference was found between the baseline flux of the two groups with 
the group with Type 2 diabetes having a higher baseline flux than the control group 
when 100% pressure was added (53.11 ± 46.56 versus 26.74 ± 17.81 AU). The group 
with Type 2 diabetes had a marginal increase in flux from baseline to maximum flux 
(53.11 ± 46.56 to 59.61 ± 57.71 AU) whereas the control group displayed a rise from 
baseline flux at 26.74 ± 17.81 (AU) to 47.68 ± 45.42 (AU) as displayed in Figure 4.68 
and 4.69. There was a significant difference found for the main effect of the group       
(F = 4.589, p = 0.045 ANOVA) but no significant difference for the dose administered 
(F = 0.942, p = 0.389 ANOVA). There was a significant difference for the interaction 
between the group and dose administered (F = 2.918, p = 0.047 ANOVA) and between 
the subjects (F = 46.096, p < 0.0001 ANOVA). On follow up analysis there was a 
significant difference found between the resting flux of the two groups (p = 0.017 
M.W.U) but not between the maximum flux (p = 0.575 M.W.U). 
Figure 4.68 Differences found between the 2 groups with delivery of SNP and 100% added pressure 
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Figure 4.69 Percentage change from baseline flux with increase in SNP dose for the 2 groups with delivery of 
SNP and 100% added pressure 
 
4.8 SUMMARY 
Investigation of the reaction to PORH in the two groups indicated that there was no 
significant difference found for baseline flux or the groups, and no significant 
interaction was found between baseline flux and the groups. On further analysis, there 
was no significant difference found between the groups for baseline flux at any of the 
six areas under study, being the plantar aspect of the 5th toe, 3rd toe, 1st toe, 5th MPJ, 3rd 
MPJ and the 1st MPJ areas. This was also the finding for the occlusive stage of reactive 
hyperaemia, for the time taken on release of the occlusion to achieve peak flux, and for 
2 minutes post peak flux measurements. One element of the PORH that did display a 
difference was the peak flux values achieved on release of occlusion. Generally values 
for the group with Type 2 diabetes were higher than the control group, and the main 
effect of peak flux produced a significant difference, as did the group and a significant 
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interaction was found between the peak flux and the groups.  On follow up analysis, all 
areas under study with the exception of the 1st toe displayed a significant difference 
between the groups. On investigating 5 minutes post peak flux values; although the 
main effects were not significant, on follow up analysis it was found that the 1st toe and 
5th MPJ areas were significantly different between the group with Type 2 diabetes and 
the control group. 
The actual pressure measured across the forefoot displayed no significant difference 
between the group with Type 2 diabetes and the control group. A significant correlation 
between the 6 areas under study was found for both groups with regard to pressure, but 
no association was noted between the plantar pressures and the baseline flux across the 
forefoot areas. 
There was an association for perfusion found between the six forefoot areas under study 
with the LSCI equipment, and also an association between the values obtained at 
baseline flux between the LSCI flux measurements and the LDF blood flux values 
obtained at the plantar aspect of the 3rd MPJ. 
Laser Doppler flowmetry was utilised in conjunction with iontophoresis with ACh and 
SNP to investigate endothelial function when placed under a known pressure. Findings 
with the analysis of blood flux using ACh as the endothelium-derived vasodilator 
indicated a significant difference within the whole group with pressure, increase in dose 
of ACh and a significant interaction effect of pressure with increase in ACh dose. 
Further analysis indicated a significant difference between the addition of no pressure 
and 50% added pressure, no pressure and 100% added pressure, but no significant 
difference between 50% and 100% added pressure. For the group with Type 2 diabetes 
as with the group as a whole, a significant difference was found for the effect of 
pressure and increases in dose, but there was no significant interactive effect of pressure 
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and dose. On further analysis, there was no significant difference with the group with 
Type 2 diabetes between no pressure and 50% pressure, or between 50% and 100% 
pressure, but there was a significant difference between no pressure and 100% pressure. 
The control group displayed no significant difference within subjects for pressure. There 
was a significant difference for increase in dose, but no significant interaction between 
the two elements of pressure and dose. There was a significant difference within the 
group between no pressure and 50% pressure as well as no pressure and 100% pressure, 
but again no significant difference between 50% and 100% pressure. Thus, the main 
impact on blood flux of pressure when exerted with ACh and iontophoresis occurred 
when 50% of normal walking pressure was exerted. 
When SNP was utilised as the endothelium-independent vasodilator with iontophoresis 
a significant difference was found for the group as a whole with pressure and for 
increase in dose as well as the interaction effect of both dose and pressure. There was 
also a significant difference found between no pressure and 50% pressure, no pressure 
and 100% addition but no significant difference was noted between 50% and 100% 
pressure. For the group with Type 2 diabetes, there was a significant difference found 
with pressure but not for increase in dose. The interaction effect of pressure and dose 
was significant and again on further analysis a significant difference occurred between 
no pressure and 50%, no pressure and 100% pressure but no significant difference was 
found between 50% and 100% pressure. The control group also displayed a significant 
difference for pressure, as well as for increase in dose and for the interaction between 
pressure and dose. Again a significant difference was found on further analysis between 
no pressure and 50%, no pressure and 100% but not between 50% and 100% added 
pressure. Increase in pressure with SNP was found to have a greater impact on the 
subjects with Type 2 diabetes than the control group. 
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5 DISCUSSION 
 
5.1 INTRODUCTION 
The key findings for this study relate to the design and development of equipment, and 
its utilisation to assess endothelial function by measuring blood flux during the process 
of iontophoresis on the plantar aspect of the forefoot simultaneously, with the addition 
of pressure. A pressure delivery system was specifically developed for this study, and 
repeatability of the system was found to be good during both in vitro and in vivo testing, 
thus enabling utilisation in conjunction with LDF on the 3rd MPJ during the process of 
iontophoresis using the developed and tested protocol.  
Inter-day repeatability was found to be good for the LSCI equipment when tested on the 
lower limb for assessment of PORH. Investigation of the 6 plantar areas under study 
(5th,3rd and 1st toes, 5th, 3rd and 1st MPJs), during PORH found no significant difference 
in blood flux between the group with Type 2 diabetes and the matched control group for 
any of the stages of PORH with the exception of the peak flux found on release of the 
occlusive stage. The group with Type 2 diabetes were found to have a significantly 
higher peak flux than the control group. A strong correlation was found amongst the 6 
plantar areas under study, and this association was stronger in the group with Type 2 
diabetes than in the control group. A strong correlation was also found between LDF 
and LSCI when used to measure baseline blood flux on the plantar aspect of 3rd MPJ.  
Actual plantar pressure values across the forefoot were not significantly different 
between the groups, and no association was found between plantar pressures and 
baseline flux in the forefoot. However, a significant association was found in both 
groups for the actual plantar pressure measured amongst the 6 forefoot areas.  
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Findings indicated that the main impact of pressure delivery on blood flux 
measurements during the process of iontophoresis with ACh occurred when 50% of 
simulated, normal walking pressure was exerted, and no significant difference was 
found between the groups. With the endothelium-independent vasodilator SNP, again 
the main impact of pressure was found at 50% of simulated normal walking pressure, 
however there was also a significant difference found between the groups with the 
delivery of 100% pressure. Thus, when the endothelium was stimulated to dilate with an 
endothelium-derived vasodilator there was no significant difference found between the 
subjects with Type 2 diabetes and the control group, whereas when the stimulation was 
delivered via a none-endothelium derived vasodilator, significant differences were 
found in the blood flux between the groups perhaps indicative of structural changes 
within the vessel or by a reduction in NO activity (Turner et al. 2008). 
 
5.2 EQUIPMENT DESIGN AND TESTING 
5.2.1 The pressure delivery system 
The pressure delivery system was specifically developed for this study as no system was 
available that could deliver pressure to the forefoot whilst investigating endothelial 
function simultaneously. Some preliminary experimental work had been carried out by 
several groups to investigate blood flow simultaneously with pressure application to the 
plantar aspect of the foot, but none of the systems developed enabled endothelial 
function assessment to be carried out (Abu-Own 1995; Meinders et al. 1996; Fromy et 
al. 2000; Cobb & Claremont 2001 and 2002; Santos et al. 2003; Hahn et al. 2007). For 
this current study, the pressure delivery system developed had to be robust, and able to 
produce repeatable results; as well as feasibly working in conjunction with the other 
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equipment necessary for endothelium function assessment such as an iontophoresis 
chamber and LDF probe. A stainless steel spring was decided upon to actually deliver 
the pressure, but much effort was given to how the pressure could be delivered to the 
same area as blood flux measurements were being undertaken. Eventually the DP2 
probe was utilised as the end point for pressure delivery and a housing case designed to 
firmly hold the probe in position while delivering the known pressure. The security of 
the probe within the housing was paramount as movement of the probe during use could 
have led to errors in the pressure actually delivered. During testing of the equipment, 
and throughout the data collection the probe housing proved highly successful with no 
movement of the probe observed. Repeatability testing with a universal testing machine 
over 14 sessions with known pressures as displayed in Table 3.1, and in vivo analysis 
carried out on the equipment (Table 3.3) found the system to display good repeatability 
with high ICCs obtained.  
However, the system was held in place with a modified post-surgical boot which had an 
adjustable metal baseplate to ensure that the system could be held in the correct position 
for all foot sizes. Whilst this modified boot held the equipment securely, there was some 
possibility for slight flexion of the foot to occur at the ankle joint which could have 
reduced the actual pressure being delivered. In hindsight perhaps a firmer based boot 
could have been utilised which would have held the foot in a fully secured position thus 
preventing any reduction in pressure delivery. However, this could have compromised 
the comfort for the subjects, and as such the mental stimulation caused by discomfort 
may have impacted on blood flux, or the subject might have asked for the process to 
stop. 
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5.2.2 Measurement of blood flux under pressure in a supine position 
Although perhaps not fully representative of the blood flux when the limb is dependent 
and loaded, as dependency of the limb has been found to lead to a decrease in cutaneous 
blood flow (Eun 1995; Santos et al. 2003), in this current study the decision was made 
to carry out measurements with the subject in a supine position. This allowed the 
collection of data to be carried out with minimal movement artefacts and pressure 
loading of the area to occur simultaneously with the process of iontophoresis and blood 
flux measurement. The possibility of carrying out simultaneous blood flux 
measurements during ambulation has proven impossible to date. Laser Doppler 
flowmetry was considered the most suitable method of assessing blood flow, and a 
prototype sensor was developed which could be housed within a ‘shoe’ and sit flush 
with the insole, thus allowing the individual to walk with the sensor in situ (Cobb & 
Claremont 2001). The shoe was based upon an orthopaedic insole made of plastazote 
foam with a cut out at the area of the 1st metatarsal head to house the sensor. A custom 
made shoe had to be manufactured for each subject, but the main problems were with 
movement artefacts which were found on movement of the probe in relation to the 
plantar tissue. There was an attempt made to overcome this by taping the probe to the 
skin surface as well as restraining it within the recess. However, a second type of 
artefact occurred with compression and decompression of the tissues when the foot was 
loading during the stance phase of gait and unloading during the swing phase. 
Eventually in a pilot study it was only possible to measure flux during the unloaded 
swing phase of gait, thus not truly measuring the blood flow during loading of the foot 
(Cobb & Claremont 2002). They also had to heat the foot prior to gathering data, as it 
was not possible to maintain temperature required for the analysis of blood flow in an 
open shoe during walking.  Meinders et al. (1996) also found that signal disturbances 
relating to the displacement of tissue cells with loading and unloading made it 
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impossible to observe blood flow during dynamic loading. They also found movement 
artefacts with subjects in a standing position, due to the small natural movements of the 
individual which would also cause a disruption to the LDF signal.  
 
5.2.3 Choice of LDF  
The requirement of a system which would allow a method of applying local pressure to 
the area under assessment of blood flux, coupled with the non-invasive methodology of 
LDF made the system an obvious choice for this study. It is a system which has been 
extensively validated for superficial blood flux assessment with the use of standardised 
protocols. It comes with a large variety of probes, and the DP2 probe was found to be 
durable enough to simultaneously measure flux as well as acting as the final component 
of the pressure delivery system. One of the issues generally noted about the use of LDF 
is that it is not possible to register measurements in absolute perfusion values which 
would be the blood flow in ml/min. relative to the tissue volume (Cracowski et al.2006). 
Most studies using LDF use arbitrary units (AU) or perfusion units (PU) and the term 
flux which is the product of average speed and concentration of the moving erythrocytes 
in the tissue sample volume rather than actual blood flow (Moor Instruments Ltd 1997), 
and this has been utilised in this study.  
 
5.2.4 Standardisation of PORH and iontophoresis protocols 
In order to ensure that this study was testing the aims and objectives set out, 
development work was carried out to obtain robust protocols which can be found in 
Chapter 3. Previous work has been carried out to ensure standardisation. Bircher et al. 
(1994) published a report with guidelines for cutaneous blood flow by LDF which most 
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studies adhere to regarding the environment and food, drugs and nicotine intake prior to 
assessment. Work carried out by Morris & Shore (1996) and Droog et al. (2004) 
suggested that protocols should be devised for iontophoresis which would minimise the 
nonspecific vasodilatory effects found. A protocol for PORH which suggested the 
parameters for analysis of baseline resting flux, occlusive flux, peak flux, time taken to 
reach peak flux and recovery times was devised by Morales et al. (2005), and was used 
in this current study. Cracowski et al.(2008) noted that there was no concensus around 
the parameters selected for analysis with PORH which is a complex microvascular 
response following a period of occlusion. It has been noted in a review article that while 
LDF in conjunction with iontophoresis has proven to be an easy to administer, validated 
and reproducible method of assessing endothelial function, standardisation of protocols 
would reduce controversy around the area (Turner et al. 2008). Thus, a lack of 
standardisation of protocols generally for both POHR and iontophoresis has posed 
difficulties in comparisons being made between this study and others in the areas of 
study. 
 
5.2.5 Spatial variation 
For the pressure and blood flux elements of this study the LDF probe had a dual 
purpose of measuring blood flux and acting as the final component with skin contact of 
the pressure delivery system. While this reduced any error in loading and measuring 
localities being in the same position for the individual, the size of the probe was fairly 
small and did require to be situated in the same place for each participant. The location 
of the probe and instrumentation was determined by one person (the researcher) on each 
occasion and location of the 3rd MPJ was carried out and carefully marked for each 
case; but it does mean that human error could have altered the positioning and site 
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slightly for some individuals.  However, at baseline flux measurement, good 
correlations were found amongst the 6 different forefoot sites thus indicating that the 
single point measurements were representative of other areas in the forefoot. 
As the probe has a small surface area, it is possible for the addition of high pressures to 
provoke pain or discomfort for the individual. While during this study, no subjects 
complained about pain or reported discomfort, pain does stimulate the sympathetic 
nervous system which also controls AVA blood flow so could have produced error in 
the flux readings obtained (Flynn & Tooke 1990). 
 
5.2.6 Iontophoresis chamber size 
As discussed in Section 3.2.3 the chamber size used for the process of iontophoresis of 
the vasodilators was small enough to be located in the area of the 3rd MPJ to ensure total 
contact and to house the LDF probe as well as holding enough solution for 
iontophoresis. Small chambers can elicit the ‘galvanic response’ i.e. a greater 
electrically induced hyperaemic response, which could have led to errors in the flux 
values measured, so the process was started off with relatively low currents to avoid any 
possible galvanic effect (Ferrell et al. 2002; Turner et al. 2008). 
 
5.2.7 Choice of vehicle for iontophoresis 
In this study 2% solution of methylcellulose was found to be a suitable vehicle being 
comparable with deionised water, and was used mainly because it provided a thickened 
solution which was found to be retained by the iontophoresis chamber in the vertical 
position on the foot, and was useful for ensuring contact on contoured sites. The impact 
of the vehicle for iontophoresis has been debated by several authors in relation to also 
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causing the ‘galvanic response’ (Morris & Shore 1996; Noon et al. 1998; Ferrell et al. 
2002; Droog et al. 2004; Turner et al. 2008). Several vehicles have been investigated 
with commonly deionised water, saline and methylcellulose being advocated. Deionised 
water was found to be a better vehicle for iontophoresis than NaCl (Khan et al. 2004) 
however, 2% methylcellulose, an inert gel, was found not to induce vasodilation so was 
a suitable vehicle for iontophoresis (Noon et al. 1998). Ferrell et al. (2002) could not 
confirm these findings when using 2% methylcellulose as the hyperaemic response still 
occurred, so the choice of vehicle in this study could be a source of error. Thickening 
the solution could also have led to the development of air pockets and bubbling which 
would prevent the uptake of the solution by the chamber which would also have an 
impact on the delivery of the vasodilator.  
 
5.2.8 Vehicle impact in this study 
During the iontophoresis protocol development work carried out prior to commencing 
this study, comparisons were made between deionised water and 2% methylcellulose as 
the vehicle, and methylcellulose was found to be a suitable vehicle in comparison to 
deionised water as can be found in Section 3.2.5. However this work was carried out 
with the vasodilators included in the solutions and in hindsight it could have been useful 
to also have investigated the impact of the vehicles alone by carry out iontophoresis 
with just the vehicles. Morris & Shore (1996) found that when utilising 3% mannitol in 
water as the vehicle for ACh and deionised water as the vehicle for SNP alone, without 
the addition of the vasodilators, a response was elicited which was thought to be caused 
by local nerve stimulation. This finding was established as when causing a local block 
with EMLA cream the vehicle induced vasodilation was inhibited. The impact was 
thought to be greater in response to the cathode current, and could be responsible for 
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inducing vasodilation with endothelium-independent SNP. Droog et al. (2004) noted 
that the way to eliminate nonspecific vasodilation during iontophoresis was to subtract 
the response to the vehicle alone from the overall response to the vasodilator in the 
vehicle. This did not change the outcome of their results as such, and there is some 
debate around the response actually being purely additive, so in this study the response 
to the vehicle was not subtracted.  Again, like Morris & Shore (1996), Droog et al. 
(2004) found that stimulation of the local sensory nerves could be responsible for the 
impact of the deionised water vehicles, and used EMLA cream as a local topical 
blocking agent. They did note that other mechanisms could also be involved, but did not 
specify.  
 
5.2.9 Utilisation of LSCI 
PORH is a non-invasive, but sensitive indicator for microvascular function, which 
requires a reliable method of detecting and recording parameters of the reactive 
hyperaemia.  Parameters of PORH have been noted as possibly providing early 
detection of vascular changes before clinical manifestations are detectable in diabetes 
mellitus, thus it is a useful investigative test for possible early microvascular 
manifestations (Humeau et al. 2002; Morales et al. 2005; Rossi et al. 2005). LSCI is a 
fairly recent development which can capture the perfusion from larger areas of tissue 
than LDF in near real time. On use in the upper limb it has proven to compare 
favourably with methods such as LDF for PORH assessment (Roustit et al. 2010; Tew 
et al. 2011), however it had not been used to measure perfusion in conjunction with 
PORH on the plantar aspect of the foot. In this study a strong correlation was found 
between LDF and LSCI when used to measure baseline flux on the plantar aspect of the 
3rd MPJ, thus validating its utilisation on the lower limb for PORH assessment. 
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It proved to be easy to use with good inter-day repeatability (ICC = 0.982). On occasion 
following deflation of the leg cuff providing the occlusion, the subject slightly moved 
which negated the available data. 
 
5.3 POST OCCLUSIVE REACTIVE HYPERAEMIA ASSESSMENT 
In this study there was no significant difference found in any areas of the forefoot with 
PORH using LSCI for resting or baseline flux, occlusive flux values, time to reach peak 
flux following release of occlusion, or flux values when measured two minutes post 
peak flux. There was a significant difference found between the group with Type 2 
diabetes and the healthy control group for peak flux, the group with Type 2 diabetes 
displaying higher peak flux values than the control group. Although generally in this 
current study flux values at 5 minutes post peak were not significantly different across 
all areas of the forefoot under study, both the hallux and 5th MPJ areas did display 
significant differences between the group with Type 2 diabetes and the controls in that 
the subjects with Type 2 diabetes displayed higher flux values, which may indicate a 
trend towards an extension of the recovery phase of the hyperaemia. As can be seen 
from the variety of findings noted below, a definitive pattern utilising PORH has not 
been established and generally conflicting findings have been reported. As yet no 
studies have been conducted utilising PORH on the lower limb with LSCI, thus a direct 
comparison with this current study is difficult. However, LSCI has generally been 
shown to display good comparative results with LDF when utilised in the forearm 
(Roustit et al. 2010; Tew et al. 2011), and in this current study was found to have a 
strong correlation with LDF baseline flux values in the forefoot, and as such some 
comparisons can be drawn between the utilisation of both systems in the lower limb. 
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The finding of a significant increase in peak flux values with Type 2 diabetes is in 
agreement with Schlager et al. (2012) who found peak perfusion to be higher in a group 
of 58 children with Type 1 diabetes in comparison with age and sex matched healthy 
controls when measuring PORH with LDF in the upper limb. They also found a 
significant difference between the group with Type 1 diabetes and the controls for the 
occlusive stage, but no significant differences were found for baseline perfusion, time to 
peak or recovery time. Yamamoto-Suganuma & Aso (2009) investigated the 
relationship between post occlusive forearm skin reactive hyperaemia and vascular 
disease in Type 2 diabetes when used in conjunction with LDF, postulating that this 
method could be a sensitive indicator of microvascular dysfunction. They found no 
significant difference in peak flux values between a group with Type 2 diabetes and a 
healthy control group, however while the group of subjects with Type 2 diabetes was 
made up of 104 subjects, the control group was a much smaller sample of 20 volunteers 
so limiting the power of the study. They also found no significant difference at 3 
minutes and 5 minutes post peak flux, but developed an index for the late phase 
prolonged total hyperaemia which was significantly longer in the group with Type 2 
diabetes. Pazos-Moura et al. (2008) noted a significantly lower peak flux in a group of 
16 subjects with Type 2 diabetes when compared with 15 healthy control subjects and 
also found the time to reach peak flux significantly longer with the group with diabetes. 
Rossi et al. (2005) utilised PORH with LDF for the assessment of patients with 
peripheral arterial obstructive disease (PAOD). They found no significant difference 
between the group and healthy controls at baseline flux, although the group with PAOD 
did display higher flux values, peak flux displayed no significant difference between the 
groups, however time to reach peak flux and recovery were significantly different being 
longer in the group with PAOD. There are several reasons why conflicting results have 
been reported, including subject numbers recruited and sample sizes, different 
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equipment utilisation, but also a lack of standardisation of protocols used.  A protocol 
for standardisation of PORH was developed by Morales et al. (2005) which included 
subject preparation i.e. subject positioned in a supine position and a 30 minutes 
acclimatisation period in a room of 25 ± 10 C, a recording session of 15minutes for 
referencing flux, 3 minutes occlusion and post occlusion recording for a further 15 
minutes with the LDF probe positioning on the dorsum of the foot between the 2nd and 
3rd MPJs. They investigated its use with 24 patients with PAOD and 30 healthy subjects 
in a 3 centred study. They found resting flux, as well as peak flux, were not significantly 
different between the groups, however the time elements such as time to reach resting 
flux, peak flux and recovery time were generally significantly longer for the PAOD 
group than in the healthy control subjects.  
 
5.3.1 Phases of PORH reaction-implications for this current study 
Although none of the subjects in this study presented with known neuropathy, it may be 
possible that early, clinically undetectable neurological alterations were developing, and 
as such could have impacted on the significantly higher peak flux detected in the group 
with Type 2 diabetes. The neuropathic changes in the lower limb are insidious in onset 
and can be present for some time prior to clinical manifestations, or symptoms 
occurring. Small muscle atrophy leading to altered toe position was found in subjects 
with Type 2 diabetes before any standard techniques noted the presence of clinical 
peripheral neuropathy (Greenman et al. 2005). 
Although PORH is a well-recognised method of assessing vascular reactivity following 
a period of occlusion, there is no real consensus regarding how the phases of the 
reaction occur other than a link with myogenic, neural and metabolic factors in addition 
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to endothelial function (Humeau et al. 2002; Koller & Bagi 2002; Cracowski et al. 
2006; Rossi et al. 2007; Yamamato-Suganuma & Aso 2009; Schlager et al. 2012). The 
debate concerning when and if NO activity is involved in the reaction is very pertinent, 
particularly for the study of those with diabetes. It would appear that the majority of 
studies have found that NO does not play a particular role in the early peak flow, but 
does have an involvement in the later extended hyperaemic phase (Larkin & Williams 
1993; Paniagua et al. 2001; Zhao et al. 2004; Cracowski et al. 2006; Joannides et al. 
2006; Yamamoto-Suganuma & Aso 2009; Schlager et al. 2012). Thus, the high peak 
perfusion observed in the group with Type 2 diabetes in comparison to the healthy 
control group in this study may not have been related to NO activity.  However, whilst 
NO is one of the major endothelium-derived dilators, there are other factors which may 
be altered or deficient with diabetes, and thought to play a role in the early peak flux 
such as prostaglandin as noted by Larkin & Williams (1993) and Paniagua e al.(2001).  
Vasoconstrictor prostaglandin H2 acts on smooth muscle and causes vasoconstriction to 
occur, but is normally released in small amounts and masked by prostacyclin 
production, NO and EDHF (Mombouli & Vanhoutte 1999). It is possible that the 
significant difference in peak flux found in this study could be related to reduction in 
prostaglandin production in the group with Type 2 diabetes i.e. it may be that the 
increased vasodilation found in this study was related to the impact of diabetes on 
vasoconstriction ability of the arterioles rather than on the release of dilatory mediators.  
Oxidative stress has also been implicated in endothelial dysfunction related to diabetes 
(De Vriese et al. 2000) and an increase in oxidative stress as well as raised serum levels 
of proinflammatory cytokines was thought to affect micro and macrovascular reactivity 
(Schlager et al.2012).  It was thought that it may also be linked with regulation of the 
tone of arteriolar smooth muscle cells ‘upstream’ being compromised thus impairing the 
regulatory ability of the precapillary arterioles, rather than being related to the release of 
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vasodilatory mediators. Again both oxidative stress and regulation ability of 
precapillary arterioles could be implicated in the higher peak flux found in the group 
with Type 2 diabetes in this present study. 
Mayer et al. (2003) found that arteriolar vasomotion could be an early index for 
sympathetic neuropathy in Type 2 diabetes. Impaired cutaneous blood flow in the 
microcirculation as well as an alteration in sweating, were thought to be amongst the 
first manifestations of peripheral sympathetic neuropathy and could often precede the 
detection of other manifestations (Sun et al. 2012). Pfutzner et al. (2001) also noted an 
association between small nerve fibre dysfunction and microvascular control in subjects 
presenting with diabetes.  
Given the complexity of the reactive hyperaemic response, and the many conflicting 
theories concerning how the elements of the reaction are brought about, it would seem 
quite possible that multiple mechanisms could be responsible for the differences found 
between the groups in this current study. This possibility is indicative that further work 
is required in this area. 
 
5.4 COMPARISON OF LDF AND LSCI FOR MEASURING PERFUSION 
The results from this study showed a good correlation between LDF and LSCI when 
used to compare baseline blood flux on the plantar aspect of the 3rd MPJ area of the 
forefoot, which corroborated the utilisation of LSCI for PORH in the lower limb. 
Further to this, LSCI offered a much more extensive perfusion map of the forefoot than 
was possible with the single probe LDF system, and in fact a strong association was 
found between the 6 forefoot areas under study.  Laser Doppler flowmetry has been 
extensively used to assess skin microvascular function for many years (Briers 2001; 
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Roustit et al. 2010), whereas commercial systems available for laser speckle contrast 
imaging are relatively new and so far LSCI in conjunction with PORH has not been 
used on the lower limb, although a small number of studies have utilised the system for 
assessing forearm perfusion successfully (Roustit et al. 2010; Mahe et al. 2012). Thus, 
it was important in this current study to assess the utilisation of the relatively new 
methodology of LSCI and to compare the system with the well-established LDF.  
Both LDF and LSCI are based upon the same fundamental principle, but with two ways 
of approaching the same phenomenon (Briers 2001). With LDF the light scattered from 
moving objects has its frequency shifted by Doppler. The light waves are combined 
with an un-shifted frequency as the frequencies of light waves are high, and a beat 
frequency is then produced from the difference between the two waves. Laser speckle 
on the other hand is a random interference effect between waves of the same frequency. 
A charge couple camera records fluctuations in the speckle pattern which is dependent 
upon the movement of the image. The level of blurring in the area of interest is then 
quantified by the speckle contrast. When the objects causing scatter are static the 
speckle pattern intensity is constant, with movement the pattern fluctuates with related 
path lengths from the different scatters (Tew et al. 2011). 
LDF provides a measurement of blood flux which is a product of average speed and 
concentration of the moving red blood cells within the sample area (Cracowski et al. 
2006). This measurement of velocity and concentration are linearly related which is 
preferable for physiological research. However, speckle contrast imaging has focussed 
on information regarding the velocity of the scattered particles, and this relationship 
between speckle contrast and velocity is non-linear, although more recent models have 
claimed to measure actual perfusion. Tew et al. (2011) in a study utilising PORH and 
LSCI on the forearm found that the cutaneous perfusion measured on the forearm was 
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non-linear and that LSCI was more sensitive to changes in the velocity of the red blood 
cells than to red cell concentration.  LSCI has recently been of interest as it offers a 
greater area of coverage ie wider area of interest with good resolution than is possible 
with single point LDF. Roustit et al. (2010) compared the inter-day reproducibility of 
PORH when using single point LDF in comparison to LSCI. They noted that while LDF 
was acceptable in some locations, because of the spatial variability between sites which 
was felt to be caused by the small size of the area of assessment, then on areas such as 
the forearm some problems with reproducibility had been noted. Two similar studies 
were carried out and both Roustit et al. (2010) and Tew et al. (2011) found LSCI 
compared favourably with LDF when used in conjunction with PORH for inter-day 
reproducibility. Roustit et al. (2010) noted that the full-field techniques of LSCI 
probably produced a better inter-day reproducibility due to lowering the inter-site 
variability. They also tried to standardise the temperature of the area prior to collecting 
baseline data which provided only moderate improvement in reproducibility.  Briers 
(2006) noted that laser speckle imaging was effective in real-time when the Doppler 
scanning with LDF actually took several minutes. The usefulness of LSCI was assessed 
on pressure induced ischaemic wounds in rats. It was found to more accurately assess 
the blood flow in that it could differentiate between the high and low loadings whereas 
the group found thermography could not, thus it could become a useful method of 
assessing skin blood flow (Nakagami et al. 2010). Further to this, as LSCI was known 
to be based upon the velocity of red blood cells, it was thought that it could have even 
further benefits in wound assessment as it could provide details about perfusion during 
the stage of infectious inflammation, providing monitoring of the possible increase in 
blood flow during this stage in wounds. Some caution must be added to this statement 
however, as it was not actually tested in the study.  
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Rousseau et al. (2011) investigated the impact of increasing the ‘region of interest ROI’ 
and ‘time of interest TOI’ with LSCI. As part of their study they utilised two skin areas 
situated 1cm apart. Both intra and inter-subject variability was recorded for the two sites 
and the intra-subject variability between sites a and b was also evaluated. Coefficients 
of variation were <35% which was found to be acceptable. Their findings indicated that 
moderate improvement was found when the TOI increased, but that increasing TOI did 
not have an impact on results. Their finding that there was an acceptable coefficient of 
variation between the two sites is in agreement with this current study, where there was 
a strong association found between the 6 areas under study when assessed across the 
whole group and also across the group with Type 2 diabetes and the control group. 
Also in agreement with work in this thesis, Roustit et al. (2010) found a significant 
correlation between LSCI and LDF data, although in the current study this was carried 
out on the foot rather than the forearm. In this study, the location for both LSCI and 
LDF was the plantar aspect of the forefoot under the 3rd MPJ, which is a specific area to 
palpate and as such reduced the special variability in this study. Royl et al. (2006) also 
carried out a comparison study with LDF and LSCI when assessing cerebral blood flow 
in animal studies. They also found LSCI to be a reliable method which compared well 
with the utilisation of LDF.  
Commercial LSCI systems are relatively new and as such there is little evidence 
available for their use, particularly for the lower limbs. Available evidence in the main 
concentrates on the upper limbs, and has provided valuable and supportive evidence 
which generally has found the equipment to compare well with the established LDF 
(Roustit et al. 2010, Tew et al. 2011). Further work and much more evidence is required 
with LSCI to establish the possibilities for accurate utilisation of the equipment. 
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5.5 THE IMPACT OF PRESSURE 
The current study found no significant difference between plantar pressure measured 
across the two groups, but with a greater range of pressure values found in the group 
with Type 2 diabetes in comparison with the control subjects. The group of subjects 
with Type 2 diabetes in this study did not display clinical signs of peripheral 
neuropathy. There is some debate in the literature regarding the levels of plantar 
pressure which has been reported in a group not displaying clinical signs of neuropathy, 
but the association generally found would suggest that unless there is some evidence of 
neuropathy, then as found in this study, the plantar pressures do not appear to be 
significantly raised in comparison to matched control subjects.  
Acharya et al. (2010) measured plantar pressure in subjects with Type 2 diabetes with 
and without assessed neuropathy, using the F scan in-shoe analysis system.  This was an 
attempt to find a method of early identification of lower limb neuropathy.  The group 
concluded that foot pressure distribution was an indicator for the health of the diabetic 
subject in relation to lower limb neuropathic involvement. Their study involved 34 
patients with Type 2 diabetes, 19 of which displayed indications of neuropathy and in 
addition 38 healthy control subjects. Findings from their study suggested that plantar 
pressures were significantly higher in the group with known neuropathy in comparison 
to the group without neuropathy, and suggested that this increase in plantar pressure 
could be utilised as an identification marker for the presence of early neuropathy. Tong 
et al. (2011) investigated in-shoe plantar pressures in a group of 35 non-neuropathic 
subjects with Type 2 diabetes and a control group of 38 control subjects without 
diabetes. They established that either sensory or motor neuropathic components were 
required to be present to impact upon plantar pressure, and in agreement with this 
current study, they also found no significant differences were noted in peak pressures 
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between the groups, although generally they did find higher pressures were recorded in 
the group with Type 2 diabetes. In agreement, Malloy et al. (1999) noted that limited 
joint mobility and motor neuropathy played an important pathogenic role in ulcer 
formation in diabetes by increasing forefoot plantar pressures. They studied a small 
cohort of 5 males and 5 females with no history of lower limb pathologies and restricted 
their ankle dorsiflexion. Neutral positioning of the foot without dorsiflexion was found 
to have no significant effect on plantar pressures, however limitation to 5 and 10 
degrees of plantarflexion was found to significantly alter the size, distribution and time 
frame of plantar pressures from the heel to the forefoot. While the results of their study 
were extrapolated to imply impact on the foot in diabetes with regard to limited joint 
mobility, they found significantly higher pressures with limited plantarflexion as well as 
distribution in a group of only 10 subjects, with none of the subjects actually having 
diabetes.  
In contrast, Bacarin et al. (2009) investigated plantar pressure distribution patterns 
during gait in patients with diabetes and neuropathy with an actual history of foot 
ulceration. Although they acknowledged that a strong association had been reported in 
the literature between diabetic neuropathy and high pressures, there was a lack of 
evidence linking pressure increase and the pathogenesis of ulceration. They studied 10 
subjects with diabetic neuropathy and a history of a least one healed ulceration within 
the last year, 17 subjects with known diabetic neuropathy but with no history of 
ulceration and 20 control subjects. They found peak pressure was significantly different 
among all of the groups at midfoot, with the two groups with neuropathy having 
statistically higher values than the control group, but the group with a history of 
ulceration presenting with the highest peak pressure values. They also noted a lateral 
shift of pressure in the neuropathic subjects.  Foot pressures were measured in a group 
of 200 subjects, with 160 patients with diabetes of which 50 did not present with 
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neuropathy, 90 with neuropathy and 20 with neuropathy and a history of ulceration and 
40 control subjects (Plank et al. 2000). Their findings indicated that peak plantar 
pressures were progressively higher in patients with diabetes and in those with 
neuropathy in comparison to subjects presenting without neuropathy, with the highest 
peak pressures recorded in the group with a history of ulceration. Although they 
included a control group in the study, little mention was given to the group in the results 
section, only an indication that plantar pressures were progressively higher in each of 
the four groups. It could be assumed from this that the control group displayed 
significantly lower peak pressures than the diabetic subjects. Whereas Bacarin et al. 
(2009) reported a lateral shift in pressures with neuropathy, Plank et al. (2000) found 
changes in pressures had a medial load shift, which was displayed in the neuropathic 
groups when retested some 12 months later. As early as 1987, Boulton et al., 
investigated foot pressures in a group of 44 subjects with diabetes, 20 Type 1 and 24 
Type 2 diabetes in a state of ‘early’ diabetic neuropathy which they defined as subjects 
having no clinical evidence of neuropathy with no history of neuropathic symptoms, 
normal clinical sensory examination, no obvious muscle wastage and normal ankle 
reflexes with no signs of peripheral vascular disease. Of the group 16 displayed 
abnormally high plantar pressures under the metatarsal heads whereas the other 28 
subjects had normal results, thus a mixed picture was presented with the majority of 
subjects displaying a normal plantar pressure pattern.  
Generally the findings suggest that there is a link with neuropathy and plantar pressures, 
but it should also be noted that other elements will increase plantar pressure such as foot 
deformity (Bus et al. 2005), joint mobility (Fernando et al. 1991) and structural changes 
in keratin in the skin, muscle, cartilage, tendons and ligaments (Abouaesha et al.2001; 
Kogler & Shorten 2001).  
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5.5.1 Plantar pressure and baseline blood flux values 
Additionally, no correlation was found in the present study between the natural walking 
plantar pressure values across 6 areas of the forefoot, and the baseline blood flux values. 
It would appear that plantar pressures per se did not influence the baseline resting 
perfusion, or that areas which experienced higher pressure during walking did not 
register lower or altered perfusion when unloaded. This is in agreement with an earlier 
study carried out by Newton et al. (2005) where their group of 16 subjects with 
diabetes, of which 2 had a history of ischaemic heart disease, 2 had a previous 
myocardial infarction, 2 had peripheral neuropathy and 3 had a history of foot 
ulceration, did display higher plantar pressures than a control group of 8 healthy 
matched subjects, but baseline skin blood flow using LDF was not significantly 
different between the 2 groups, thus pressure did not influence baseline blood flux 
values when the area was unloaded. 
 
5.5.2 Effect of diabetes on flux values under pressure and vasodilation with both 
ACh and SNP  
One of the main differences found between the two groups in this study was that the 
group with Type 2 diabetes displayed higher flux values throughout the delivery of 
pressure, at resting flux, 50% pressure and 100% pressure delivery with both 
vasodilators. The area under study was the plantar aspect of the 3rd MPJ, which was 
found to be one of the high pressure areas under the foot, and has commonly been the 
site for ulceration (Veves et al. 1992; Proano et al. 1992; Bowering 2001). Areas which 
displayed chronically raised plantar pressures i.e. over the 1st, 2nd and 3rd metatarsal 
heads were found to display an increase in blood flux when compared with sites of 
lower pressure on the same foot in the subjects with diabetes, whereas in the group of 
control subjects flow was found to be slightly decreased at the high pressure sites 
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(Newton et al. 2005). When investigating the differences between foot and forearm 
microcirculation with ACh and SNP delivered via iontophoresis, Arora et al. (1998) 
found that the baseline blood flow measurements were consistently higher in the non-
neuropathic group with diabetes in comparison to a neuropathic group and a control 
group. They were also found to be significantly higher in the non-neuropathic group at 
foot level (measured on the dorsum), and it was noted that this was an ‘unexpected 
finding’ and that further work would be needed to examine how this increase in blood 
flow could be explained in the absence of long term complications. Blood flux values 
on the plantar aspect of the hallux were also found to be substantially higher in the 
group with diabetes than for the control subjects (Cobb & Claremont 2002). Belcaro et 
al. (1989) when investigating skin blood flow in the distal foot found subjects with 
diabetes to have a significantly higher resting blood flow than control subjects. On 
standing, a higher skin blood flow was found in the group with diabetes which was not 
significantly different from resting blood flux indicative of an ineffective venoarteriolar 
response displaying an inability of the microcirculation to adapt to dynamic changes.  
However it should be noted that all 30 subjects with diabetes had peripheral neuropathy. 
The PIV response was found to be missing in the foot of subjects with diabetes (Koitka 
et al. 2004b), and Mayrovitz et al.(1997) when investigating heel blood perfusion 
responses to pressure loading and unloading found during loading a slight progressive 
increase in flux, but the trend was not significantly higher than when the heel was 
unloaded. 
Peripheral neuropathy present with diabetes was found to involve sympathetic fibres 
which could undergo damage relatively early in the disease process, thus damage could 
be sustained prior to clinical evidence of neuropathy (Tooke & Brash 1995). They 
found that the impact on foot microvascular haemodynamics included increased 
215 
 
arteriovenous shunt flow as well as increased nutritive capillary flow at rest. This could 
produce an increase in blood flux in a group with Type 2 diabetes in comparison to a 
control group as found in this current study. Perfusion pressure was noted to rise due to 
an increase in blood flow, and was thought to be possibly due to a reduction in pre-/post 
capillary resistance (Flynn & Tooke 1992). Tissue hypoxia which was related to 
increased demand or to altered oxygen transport was thought also to be a factor in the 
dilation of vessels. Capillary pressure as an indicator of capillary hypertension 
measured in nail-fold capillaries was found to be higher in a group of subjects with 
Type 1 diabetes in comparison to a control group (Sandeman et al. 1992). They 
hypothesised that nail-fold capillary hypertension could develop early in the course of 
diabetes again before microvascular disease became apparent and was found to be 
elevated less than one year after diagnosis, which could represent an early functional 
change. Clinical microvascular complications were found to differ between Type 1 and 
2 diabetes, and it was felt that care should be taken when extrapolating finds across the 
two groups (Shore et al. 1994) however, they did note that capillary pressure may have 
been raised in Type 2 diabetes and could be instrumental at an early stage of the disease 
process. 
The increased blood flux found in areas of high pressure was thought to be a 
physiological response to repeated tissue trauma from the pressure. With diabetes, this 
repeated trauma could lead to the development of a local inflammatory response which 
would produce local oedema and possible hypoxia resulting in tissue breakdown 
(Newton et al. 2005). Veves et al. (1998) noted that there appeared to be an interaction 
between peripheral neuropathy and endothelial dysfunction which resulted in an 
inability to increase blood flow in the diabetic foot in conditions of stress leading to the 
development of ulceration. As the blood flux was already raised in the locality, the 
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capacity of the microcirculation to respond to any further trauma could be limited as 
also suggested by Mayrovitz et al. (1999).  
Fromy et al. (2002) reported the opposite effect in that their findings have been 
indicative of a reduction in blood flow with diabetes, even without neuropathy being 
present to locally applied pressure on the internal ankle bone. They also found that the 
skin blood flow decreased significantly from baseline at a much lower pressure with 
diabetes. However, the internal ankle bone is not an area which should during normal 
foot function be subjected to pressure so would not have been expected to display 
higher pressure readings with diabetes.  
 
5.6 THE FLUX RESPONSE TO THE ENDOTHELIUM-DERIVED 
VASODILATOR ACH WHEN PRESSURE IS APPLIED    
The group was initially taken as a whole to investigate possible overall trends, and the 
main finding for this aspect of the study was that 50% of the normal walking pressure 
produced a significantly reduced blood flux measurement under the 3rd MPJ when using 
ACh as the vasodilating agent. When the pressure was increased from 50% to 100%, 
blood flux reduced slightly, but no significant difference was found between the 
addition of 50% and 100% normal walking pressure. Thus, the main damaging impact 
of pressure on blood flux when utilising an endothelium-derived vasodilator on the 
plantar aspect of the 3rd MPJ was found on application of only half of the measured 
normal pressure exerted. This finding was generally mirrored when taking the group 
with Type 2 diabetes and the control subjects as two individual groups thus, the impact 
of pressure on vasodilation with ACh delivered by iontophoresis in the group with Type 
2 diabetes was not significantly different from the control group. However, for the 
group taken as a whole and the group with Type 2 diabetes, the addition of pressure 
significantly reduced baseline blood flux, whereas with the control subjects there was 
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no significant impact from pressure delivery found. In fact with baseline flux 
measurements under pressure the control group displayed similar flux values with 0 
pressure and 50% pressure (56.88 ± 68.48 AU and 55.11 ± 77.83 AU). These findings 
would indicate that the control subjects could maintain their baseline flux values when 
placed under 50% of normal walking pressure, whereas those with Type 2 diabetes were 
unable to do so. 
Work has been carried out in the past on pressure and blood flow (Abu-Own 1995; 
Meinders et al. 1996; Fromy et al. 2000; Cobb & Claremont 2001, 2002; Santos et al. 
2003; Hahn et al. 2007) and on the effects of endothelium-derived and non-
endothelium-derived vasodilators on blood flux (Newton et al. 2001, 2005; Ferrell et al. 
2002; Khan & Newton 2003; Turner et al. 2008, Henricson et al. 2009),  but no studies 
have been found which have investigated the two elements concurrently so no direct 
comparison can be made with these findings. 
 
5.6.1 Mechanisms for ACh-mediated vasodilation 
Developing an understanding of how endothelium-derived vasodilation is derived is 
important for many reasons, not least being the inflammatory elements required for 
wound healing and the ability of the body to deal with local infection which can in turn 
lead to ulceration and gangrene. However there is much debate concerning the 
mechanisms involved (Morris & Shore 1996; Berghoff et al. 2002; Durand et al. 2004). 
The vascular response elicited from the administration of ACh may be dependent on 
several mechanisms the initial one being the release of NO, prostacyclin and 
endothelium-derived hyperpolarising factor, and the constrictor prostanoids (Morris & 
Shore 1996; Aso e al. 1997; Khan et al. 1997; Noon et al. 1998; Berghoff et al. 2002; 
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Durand et al. 2004; Newton et al. 2013). As well as the endothelium-dependent effects 
ACh has in the past been found to stimulate local sensory nerves leading to vasodilation 
near to the site of administration and inhibit the release of noradrenaline from nerves 
with high charge density (Walmsley &Wiles 1990; Morris &Shore 1996). This can be 
overcome by utilisation of lower currents and/or larger chambers for iontophoresis 
(Ferrell et al. 2002; Turner et al. 2008).  
 
5.6.2 Evidence of the impact of pressure on vasodilation with ACh 
In a sample of 16 patients, 5 with Type 1 diabetes and 11 with Type 2 diabetes and 8 
healthy matched control subjects, Newton et al. (2005) investigated the impact of 
pressure on blood flow to the plantar aspect of the foot. For both groups, the areas 
registering the highest pressures were 1st, 2nd and 3rd MPJ areas which are common sites 
for plantar ulceration in diabetes. They found that the subjects with diabetes had 
significantly higher pressures than the control group in the location of highest pressure 
(without the simultaneous application of pressure). This finding would be expected in a 
mixed group of subjects with both Type 1 and Type 2 diabetes, as several of the group 
presented with known complications such as peripheral neuropathy and ischaemic heart 
disease. There was a trend towards a reduction in ACh induced vasodilation at the sites 
which would generally be under high pressure in comparison with low pressure sites, 
this reached significance only in the sub group of those with diabetes who were 
recorded as ‘high risk’ due to the pressures noted during walking being higher than 
6kg/cm2, however the decision was made to avoid heavily callused areas. This could 
have impacted on the results in that plantar callosities are found in areas of high 
dynamic pressures, thus would be locate over the areas of high pressure (Young et 
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al.1992) and could have been reduced prior to iontophoresis to allow penetration of the 
solution through the epidermis.  
Using their developed system, Abu-Own et al.(1995) studied the blood flow in 30 
subjects, 10 elderly patients at risk of developing decubitus ulcers with a Norton scale 
score of 14 or less, and 10 sex and age matched healthy volunteers plus another group 
of 10 younger healthy volunteers. Resting flux in the ‘at risk’ group was significantly 
lower than both the age matched and younger control groups and no significant 
difference was found between the younger and older control groups. This was an 
interesting finding in that the ‘at risk’ group would have been expected to display lower 
values of resting flux, but it would appear that in this study, age did not impact on the 
flux measured in the other two groups. However, the addition of pressure caused similar 
results in all 3 groups; very low levels of compression caused no significant change in 
LDF values and higher levels of compression lead to a progressive decrease in flux with 
compression of 50mmHg or greater reducing the signal to a minimal value in all of the 
groups. Again this finding was interesting in that the ‘at risk’ group might have had a 
different response to the healthy volunteers to the addition of pressure, although the 
authors claimed that this was not surprising due to the higher pressures being delivered 
over a small area of the heel.  
Meinders et al. (1996) developed a system to investigate the effect of pressure delivery 
on the microcirculation of the sole of the foot in 11 healthy subjects. They noted that the 
area across the metatarsal heads and the heel was an area of high pressure which 
experienced compression of the skin and underlying tissues during walking, and the 
pressure would have an impact on the two parallel functioning microcirculation systems 
i.e. the surface capillary loops for nutrition as well as the deeper arteriovenous 
anastomoses for body temperature regulation. Although they did not include subjects 
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with diabetes in this study (using 11 healthy volunteers), they did note that a disturbed 
interaction between externally applied pressure and the microcirculation of the skin 
appeared to be important in diabetes, and that an understanding of this interaction even 
in healthy subjects was required to contribute to the understanding of the 
pathophysiology of diabetic foot problems. Each pressure load was applied for a period 
of 5 minutes with post pressure flux measured for a follow up period of 5 minutes. The 
11 subjects were divided into two groups; one group of 5 subjects underwent 
application of relatively low pressures, and the second group of 9 relatively high 
pressures (3 subjects participated in both). The numbers and grouping are somewhat 
puzzling, for example, if it was possible for 3 subjects to take part in both protocols why 
not all of the subjects. During loading there was an exponential decrease found in blood 
flux until pressure reached 40kPa. At levels higher than this there was minimal further 
effect found and release of the pressure resulted in a reactive hyperaemic response.  
In 2000, Fromy et al. developed a progressive calibrated pressure device which was 
used in a further study in 2002 where the group investigated skin blood flow in response 
to pressure in subjects with diabetes. They included 4 groups of subjects in the study, 
subjects with diabetes (no specification re Type of diabetes was included) and with 
clinical neuropathy, with subclinical neuropathy, diabetes without neuropathy and a 
control group without diabetes. The grouping of subclinical neuropathy was for those 
subjects who presented with a neuropathy symptom score and neuropathy disability 
score of >0 but <5 (where severe neuropathy would score between 17 and 28). The area 
under study was the middle of the internal ankle bone and an increase in pressure of 
5.0mmHg/min rate. The results were that the skin blood flow in the locality of the ankle 
bone decreased significantly from baseline with much lower pressure application in all 3 
of the groups with diabetes, regardless of their level of neuropathy, and even the group 
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of subjects with diabetes and no neuropathy displayed that a significantly lower 
pressure application caused reduction in skin blood flow than in the control group.  
When Cobb & Claremont (2001) developed a prototype of an in-shoe laser Doppler 
probe for assessing plantar blood flow in diabetes, their system was developed to 
actually measure the flux on the plantar surface during walking, and in 2002 they 
carried out a pilot study utilising the equipment with 9 subjects, 3 subjects with Type 2 
diabetes and known vascular complications, 3 with Type 2 diabetes and known 
neurological complications and 3 controls. Results were limited in that although both 
static and dynamic loading was assessed, during dynamic loading i.e. walking, only the 
swing phase of gait could be assessed rather than the stance phase due to movement 
artefacts. This was the first attempt to measure blood flow during loading in the 
dynamic state of walking rather than by simulation, however did prove to present 
difficulties. Subject numbers were so low in this pilot that no statistical analysis was 
possible; however the inference was that those subjects with Type 2 diabetes did have a 
reduced vascular response in comparison with the control subjects. 
 
5.6.3 Pressure application and vasodilation with ACh delivered via iontophoresis 
summarised 
In this current study, the impact of pressure delivered at 50% of normal walking 
pressure was enough to significantly reduce the vasodilator effect of ACh delivered with 
iontophoresis in both groups, and further addition to full walking pressure did not 
significantly reduce the blood flux from 50% pressure, in agreement with the findings 
from Meinders et al. (1996).  There was no significant difference found between the 
subjects with Type 2 diabetes and the control group with the exception that at baseline 
flux, 50% pressure addition did not significantly reduce the flux measured in the control 
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subjects, but did for the group with Type 2 diabetes. This could indicate that in 
agreement with Veves et al. (1998), Hamdy et al. (2001) and Brooks et al. (2008) that 
endothelium-derived vasodilation using ACh delivered via iontophoresis is not 
significantly altered in comparison with control subjects in a group with Type 2 
diabetes, without peripheral neuropathy.  
 
5.7 EFFECT OF PRESSURE ON FLUX USING THE ENDOTHELIUM-
INDEPENDENT VASODILATOR SNP AND IONTOPHORESIS 
The addition of both 50% and 100% of normal walking pressure had an immediate and 
significant impact on blood flux with SNP delivered using iontophoresis to the group as 
a whole as indicated clearly in the percentage change from baseline flux in Figure 4.59. 
Both 50% and 100% pressure addition markedly reduced resting flux and the rise to 
maximum flux was reduced greatly with both pressures. However, when investigating 
the response of the groups, both displayed different results with pressure additions when 
assessed separately. For the group with Type 2 diabetes, 50% pressure addition actually 
resulted in a final flux value following iontophoresis with SNP of a lower mean value 
than the resting flux, and with 100% pressure addition the flux values were markedly 
lower than with 50% pressure with the final flux value only marginally higher than the 
resting flux (Figure 4.60). Although the pressure application did impact upon the 
control subjects resulting in a significant reduction in flux with both 50 and 100% 
pressure, the group did deal better with the pressure in that an increase in flux was 
recorded, albeit significantly reduced in comparison to the value achieved without 
pressure (Figure 4.62). Thus, both groups reacted differently to pressure addition under 
the vasodilator SNP. From this finding it is possible to state that even without known 
complications being present, diabetes mellitus has an impact on the ability of the 
superficial blood vessels to react to the NO donor SNP when the vessels are placed 
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under pressure of up to 100% of normal walking pressure on the plantar aspect of the 
foot, which could influence the development of plantar complications such as 
ulceration. 
Sodium nitroprusside is an inorganic, potent peripheral vasodilator (Kaisserlian et al. 
2005). It reacts with tissue sulfhydryl groups to produce NO, therefore is considered an 
NO donor. The NO produced stimulates the smooth muscle cells causing relaxation, as 
SNP works on arterial and venous smooth muscle cells it is used frequently as an 
endothelium-independent vasodilator. A reduction in response to SNP could be 
interpreted as structural change within the vessel leading to the reduction in vasodilation 
with Type 2 diabetes, or by a reduction in activity of NO caused by e.g. a reduction in 
the release of NO due to oxidative stress (Turner et al. 2008). Brooks et al. (2008) noted 
that SNP bypasses the endothelium to directly relax the smooth muscle, thus measuring 
endothelium-independent vasodilation.  
 
5.7.1 Evidence of the effect of diabetes on SNP delivery with iontophoresis i.e. non-
endothelium-derived dysfunction 
Although no study has investigated the simultaneous impact of pressure delivery on 
blood flux, there appears to be a number of studies in agreement with this current study 
that endothelium-independent vasodilation has been found to be reduced with diabetes 
per se. (Arora et al. 1998; Caballero et al. 1999; Khan et al. 2000; Gomes et al. 2008; 
Beer et al. 2008; Brooks et al. 2008). Veves et al. (1998) found that there was a reduced 
dilator effect with both SNP and ACh delivery with diabetes found in conjunction with 
neuropathy, ischaemia or arthropathy. Vasodilation was more severely reduced with 
SNP in patients presenting with ischaemia than with iontophoresis and ACh, however 
no difference was noted between the subjects with diabetes and no complications, and 
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control subjects. In contrast Beer et al. (2008) found the response to SNP was equally 
blunt in diabetes with or without complications in comparison to control subjects.  
A similar response was found with SNP and ACh by Caballero et al. (1999) who found 
that the vasodilation was reduced not only in known cases of diabetes, but also in 
relatives of those with diabetes and IGT individuals. They noted that it was extremely 
difficult to discriminate whether the reduction in dilation was a result of decreased 
production of NO, an increase in destruction, inactivation or a decrease in vascular 
smooth muscle cell responsiveness from their results. Arora et al. (1998) found that 
vasodilation was reduced at foot level with ACh, however found no difference between 
the groups of subjects with diabetes with and without neuropathy and controls with SNP 
delivered via inotophoresis. They postulated in agreement with Hamdy et al. (2001) that 
the difference was probably down to SNP not having a direct stimulating effect on C 
fibres whereas ACh did. As a result Hamdy et al. (2001) went on to state that with SNP 
there was no significant difference in the percentage contribution of the nerve axon 
related response. Pitei et al. (1996) found that on the dorsum of the foot, vasodilation 
with ACh was reduced in patients with and without neuropathy, whereas with SNP it 
was only reduced in the group of 8 subjects with diabetes and peripheral neuropathy. In 
contrast Kelly et al. (2001) found no significant difference with the vasodilator response 
to SNP on the dorsum of the foot in subjects with diabetes, with or without peripheral 
neuropathy. However it must be noted that protocols are not standardised for the 
iontophoresis process, and there are many differences in subject numbers incorporated 
in the studies mentioned which does make direct comparisons quite difficult.  
Brooks et al. (2008) found that SNP and ACh both produced a reduced response with 
diabetes and this appeared to progress with complications. The questioned their own 
results by noting that if ACh reactivity was to be regarded as an index for endothelial 
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function, then SNP should not have produced similar results. As it had done so, they 
postulated that this must indicate an impairment in the ability of the vessels to respond 
directly to a vasodilator which could be due to a functional defect of the smooth muscle 
in the response to NO, excessive destruction of NO, or perhaps to changes in the 
structure of the vessel walls leading to increased stiffness. The process was thought 
likely to be a complex interaction of several structural and/or functional abnormalities 
and factors which have been mentioned as possible contributors are advanced glycation 
end products (AGEs) or increased oxidative stress (Khan et al. 2000; Brooks et al. 
2008). Sampathkumar et al. (2005) found serum levels of AGEs were significantly 
higher in subjects with diabetes than in control subjects, and even higher in those with 
diabetes and complications. While it was noted that a causal relationship could not be 
established between AGEs and microvascular complications, it was suggested that they 
may play a role in accelerating the process with diabetes. Although the formation of 
AGEs occurred as part of the natural ageing process, it was found to be accelerated with 
diabetes (De Vriese et al. 2000). Advanced glycosylation is known to modify tissue 
proteins in diabetes which is the precursor for early glycosylation products which in 
turn become AGEs. Among the outcomes found with an increase or early production of 
AGEs in animal studies has been a reduced vasodilator response to the NO donor 
nitroglycerine (SNP and nitroglycerine belong to the same family of drugs), which 
would suggest that the efficacy and or synthesis of NO may be affected (Tribe & Poston 
1996). In addition endothelial vasodilation dysfunction can also occur indirectly through 
AGR induced oxidation of low density lipoproteins (LDLs) which again results in 
reduced synthesis of NO (DeVries et al. 2000). Alp et al. (2003) found endothelial cell 
superoxide production was higher with impairment of NO mediated endothelial 
vasodilation in diabetes induced mice when investigating the role of tetrahydrobiopterin 
(BH4) in eNOS activity. Generally evidence has been increasing to establish a role for 
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oxidative stress and oxidised lipids in microvascular dysfunction and the endothelium 
and the derived vasodilators would appear to be central to this (Tribe & Poston 1996; 
Pacher et al. 2002; Kampoli et al. 2009).  
 
5.7.2 Pressure application and SNP delivery in combination summarised 
There is a lack of agreement between the studies investigating the effect of the delivery 
of SNP with iontophoresis in conjunction with diabetes. Some in agreement with this 
current study have found the response to SNP to be reduced regardless of complications 
being present or not (Khan et al. 2000; Beer et al. 2008; Gomes et al. 2008), other 
studies found no difference between subjects with diabetes and control subjects (Arora 
et al. 1998; Kelly et al. 2001) and others found that the vasodilator effect was reduced 
in conjunction with the presence of complications like neuropathy (Pitei et al.1996; 
Veves et al. 1998; Brooks et al. 2008).  
Again it should be emphasised that no other studies have investigated the response to 
SNP in conjunction with pressure delivery and as such a direct comparison of results 
found in this current study is not possible. In the current study there were some 
differences found between the groups caused by the application of pressure in 
conjunction with SNP and iontophoresis. The group with Type 2 diabetes showed a 
poor microvascular response with the addition of pressure in conjunction with 
iontophoresis of SNP compared with the response in the control group.  However, 
although not significant, both groups displayed a difference between the flux values 
obtained at 50% and 100% pressure delivery, unlike the delivery of ACh, where the flux 
values obtained at 100% pressure application were similar to those found with 50% 
pressure delivery.  
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5.8 LIMITATIONS OF THE STUDY 
5.8.1 Same day assessment for all elements of this study 
One of the major decisions concerning gathering of data for this study was the choice 
between gathering all data on the same day, and spreading the data gathering over two 
or more visits. By gathering all data in the same visit it ensured that for each element of 
the study, the pre-study background was absolutely identical with food and caffeine 
intake etc., however in order to allow recovery between each test it did make the visit 
quite lengthy. It also ensured that the actual testing could be completed for each subject 
without the need to return. Initial volunteers were questioned, and it was the general 
consensus that a single lengthy visit was preferable to returning on another occasion. 
However with this decision it has to be noted that although time was given for recovery 
between tests, and the results do not indicate any residual effects before the next 
element of the assessment, there may have been some impact in assessing all elements 
on the same day such as mental stimulation of the subjects due to possible boredom. 
 
5.8.2 Subject recruitment and implications for the study 
Recruitment of subjects with Type 2 diabetes was carried out by a written invitation 
sent out to a random sample of subjects located on the diabetes centre at Ninewells 
Hospital SCI-DC database system. The return rate was quick and good and of those who 
had agreed in writing, all of them following a telephone discussion agreed to participate 
with the exception of one individual who had a pacemaker fitted and who was unsure 
about the iontophoresis process. However, the group were generally free from 
complications and neuropathy, and it could be noted that those who do take an interest 
in their health issues are more likely to volunteer to help with studies than those who do 
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have some difficulties with either the management of their diabetes, or with 
complications. It may have been useful to target a group with known neuropathy as a 
comparison and perhaps this would be a useful follow up study in the future. 
 
5.8.3 Number of subjects included in the study 
The number of subjects included in this study was limited because of possible time 
allocation to a total of 60. As a result the two groups contained a mix of sexes which did 
reflect the mix normally found with Type 2 diabetes with a slightly higher number of 
male subjects than female. However, with a group number of 30 in total, it did preclude 
any analysis of the data with regard to gender. Eun (1995) noted that men have been 
reported as having slightly higher cutaneous blood flow than women, and it would have 
been interesting to see if gender had any influence on the findings in this study.  
 
5.8.4 Skin thickness variations 
It has been noted that skin thickness does vary between individuals, but Ferrell et al. 
(2002) found no significant correlation between the calculated resistance and skin fold 
thickness as measured with calipers and reported that subcutaneous fat did not affect 
resistance. More importantly for this study, they observed that there was no significant 
correlation between skin fold thickness and the ACh perfusion/time integral. There is a 
debate around how much the presence of plantar callus influences plantar pressure. 
Some authors argue that it leads to an increase in pressure (Boulton 1987; Young et al. 
1992; Masson 1992; Abouaesha et al. 2001), while others have found that it does not 
increase plantar pressure at all (Potter & Potter 2000). As a precaution, any overlying 
callus found in this study was removed using a sterile scalpel prior to the study being 
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carried out. However, Hashmi et al. (2006) found the epidermis itself to be thicker in 
Type 2 diabetes when compared to controls without diabetes, and to display a reduced 
plasticity when using high frequency ultrasonography. As this was a comparative study 
with Type 2 diabetes and healthy controls, it may have been useful to measure the 
thickness of the plantar epidermis. 
 
5.8.5 Choice of true pressure values rather than a set pressure value 
It would have proven much quicker and easier to select a set pressure value to use for all 
subjects in this study, rather than measuring their own maximum pressure for 
application with the process of iontophoresis and vasodilation. However, a meaningful 
single pressure value would have been very difficult to select and for some subjects 
would have been set either too high or too low in comparison with their own maximum 
pressure.  
 
5.8.6 Subject related movement artefacts 
Although the limb was held securely in a boot to stabilise and ensure that the foot did 
not move with the addition of pressure, it was still possible for small movements to 
occur during assessment which might have caused some movement artefacts. During 
PORH on release of the cuff it was also quite possible for the participant to move their 
foot slightly altering the actual area of interest pre and post occlusion. 
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5.8.7 Pre testing intake of food and beverage 
While clear, written instructions were provided for each participant concerning their 
intake of food and caffeine related drinks prior to the assessment, there is no guarantee 
that every participant remembered to follow the instructions carefully. A way of 
preventing this would have been to ask the participants to refrain from eating from 
midnight onwards i.e. fast overnight and on arrival early morning to provide a suitable 
breakfast as carried out by Beer et al. (2008). 
 
5.8.8 Mental stimulation during the assessment session 
As well as being a temperature controlled environment, the area was a quiet and 
peaceful room with no direct entry for anyone other than the participant and the 
researcher. Eun (1995) noted that mental stimulation could influence cutaneous blood 
flow. However, although every physical element was controlled in the environment, 
when the participant was in a supine position for a lengthy period of time there is no 
guarantee that they were not mentally doing shopping lists or other activities which may 
have influenced cutaneous blood flow.  
 
5.8.9 Possible human error on the part of the researcher 
It is very possible for human error to have occurred in several elements. The equipment 
was carefully positioned for continuity of positioning; however it is quite possible that it 
was not absolutely exact in every case. Utilisation of a single researcher to position the 
equipment who was very aware and well versed in the positioning required did help to 
reduce this possible error. Calculation and addition of the pressure values was also a 
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possible source of human error from the initial reading of the values obtained with the 
Emed-x/E system to transference of the values to the pressure delivery system for each 
individual. There is little room for human error in reading the flux values obtained ether 
by the LSCI system or the LDF system as both provide the readings clearly. However, 
the time taken to reach maximum peak pressure with the LSCI system is a judgement, 
and again limitation of possible error is by the single researcher carrying out all readings 
and standardising the readings with pre-tester training.  
The vasodilator substances and solutions were weighed and mixed by the researcher 
using an electronic balance, following training, and sterile syringes were used to ensure 
the correct amount of deionised water was added. A magnetic stirrer was also utilised 
for mixing the 2% solution of methylcellulose to ensure no bubbles were present in the 
mixture. Care was taken to ensure continuity of the solutions used which were freshly 
made for each session. Although every care was taken, it was still a possible source of 
human error. 
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Chapter Six  
Conclusions 
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6 CONCLUSIONS 
 
The aim of this study has been to investigate endothelial function in the superficial 
vessels situated in the plantar aspect of the forefoot, when placed under normal walking 
pressure. The initial focus was around the development of equipment as well as to 
ascertain the optimum protocols to allow meaningful investigations utilising the 
equipment to proceed.  
A pressure delivery system was successfully developed which could repeatedly deliver 
a known pressure to the area under study, while also acting as a housing unit for the 
LDF probe. This dual activity of the system meant that simultaneous delivery of 
pressure could be carried out along with assessment of endothelial function, in 
combination with measurement of the blood flux on the plantar aspect of the foot. With 
the LDF probe not only measuring blood flux, but also being the delivery point for 
pressure, it was possible to measure both in the same locality under study 
simultaneously. This study was centred on the plantar aspect of the foot, and as such it 
was paramount that time and effort was dedicated to ensuring that the equipment could 
be optimised for utilisation in the area. The most suitable vehicle for the endothelium-
dependent and independent vasodilators (ACh and SNP), given the position of the foot 
and the size of the preferred iontophoresis chamber, was fully investigated and 
considered, with a 2% solution of the vasodilator and methylcellulose in deionised 
water chosen. The optimum protocol for the delivery of the drugs via the process of 
iontophoresis was also fully explored, with the better test-retest reliability in 
combination with the shortest duration being the features of the favoured protocol for 
the study (Tables 3.4 and 3.5). 
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The utilisation of LSCI is a recent development in measuring endothelial function, but 
is thought to offer advantages such as measuring dynamic changes in blood flow over 
wider areas, coupled with good resolution, so ideal for investigating areas such as the 
forefoot. In this study it was successfully tested for suitability to investigate PORH in 
the forefoot, and was also compared with LDF. A strong, significant positive 
association was found between the established LDF for resting flux under 3RD MPJ and 
LSCI (Table 4.14. and Figures 4.31 to 4.36). Thus, LSCI was found to be suitable for 
assessing endothelial function in superficial vessels on the plantar aspect of the forefoot. 
 The equipment and protocols were then utilised in vivo for two groups with matching 
age and sex distribution, 30 subjects with Type 2 diabetes and 30 control subjects. Of 
the parameters tested with PORH, peak flux following release of occlusion was the only 
one displaying a significant difference between the groups. The subjects with Type 2 
diabetes displayed significantly higher peak flux value than the control subjects (Table 
4.4, and Figure 4.9). Published literature would suggest that this finding could be related 
to a reduction in prostaglandin production by the group with Type 2 diabetes, in that 
diabetes is thought to have an impact on the vasoconstriction of the arterioles rather 
than releasing mediators to dilate the vessels. 
Plantar pressure exerted on the areas of the forefoot across the groups in this study was 
found not to be significantly different (Table 4.17). As the group with Type 2 diabetes 
did not display any clinical signs of neuropathy this was not a surprising finding, and 
additionally no correlation was found between the natural walking pressure values 
across the 6 forefoot areas under study and baseline blood flux (Table 4.19). This would 
indicate that pressure did not influence baseline blood flux values in this study. 
A noticeable impact of Type 2 diabetes in this study was that the group displayed higher 
flux values than the control group throughout all stages of the study. There is some 
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evidence in the literature that this could be related to involvement of sympathetic fibres 
sustaining damage prior to clinical signs and symptoms of neuropathy, with increased 
arteriovenous shunting of blood flow combined with increased nutritive capillary flow 
at rest. It could also relate to a reduction in pre/post capillary resistance with tissue 
hypoxia related to increased demand or altered oxygen transportation. 
When the endothelium-derived vasodilator ACh was applied to the superficial vessels 
supplying 3rd MPJ using iontophoresis, a reduction in blood flux was found in both 
groups generally at 50% of normal walking pressure. No significant difference was 
found for either group between 50% and 100% pressure delivery, so the main impact on 
blood flux occurred in both groups at 50% application of normal walking pressure 
(Tables 4.21. and 4.22). A difference was found in the ability of the groups to deal with 
50% pressure with baseline flux. The control group displayed similar flux values with 0 
and 50% pressure addition (56.88 ± 68.48 AU and 55.11 ± 77.83 AU), which would 
indicate that they could maintain blood flux when placed under 50% normal walking 
pressure, whereas the group with Type 2 diabetes were unable to do so (79.72 ± 81.87 
AU and 63.01 ± 58.49 AU). 
When SNP, the NO donor vasodilator was applied to the superficial vessels, pressure 
was found to have a greater impact on blood flux on the subjects with Type 2 diabetes 
in comparison to the control group. Without the addition of pressure, with 50% pressure 
and 100% pressure addition, the control subjects responded better, and achieved higher 
blood flux values (Figure 4.65, 4.67 and 4.69). With this reduced capacity the group 
with Type 2 diabetes did not respond to pressure application as well under the 
vasodilator SNP as the control group could. The literature would suggest that this 
reduction in response by the group with Type 2 diabetes to SNP could be interpreted as 
structural change within the superficial vessels leading to a reduction in the capacity to 
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dilate, or a reduction in the activity of NO when e.g. high oxidative stress reduces the 
release of NO.  
 
6.1 CONTRIBUTION TO KNOWLEDGE 
The contribution to knowledge of this study has been to successfully develop and test 
equipment which has allowed for the first time simulated plantar pressure application to 
an area of the forefoot known to receive high pressure levels during walking, with 
simultaneous assessment of endothelial function. The development of a device which 
could deliver known pressure repeatedly to the chosen area was a vital element of this 
study. The novel utilisation of the DP2 probe as a component of that pressure delivery 
system ensured that the pressure delivered and blood flux measurements were both 
produced in the exact same location. Iontophoresis is a method of drug delivery which 
is normally carried out on the upper limbs or on occasion the dorsum of the foot where 
the skin is much finer. This study successfully utilised the process on the plantar aspect 
of the foot, and in a vertical position, which meant that 2% methylcellulose as a 
thickening agent was required. 
PORH is a well utilised method of assessing endothelial dysfunction in the lower limb 
in conjunction with LDF. However, the recent development of LSCI offered the 
possibility of measuring rapid changes in blood flux over a larger area, coupled with 
good resolution, particularly useful for an area like the forefoot. On examination of the 
literature, LSCI had not been used on the plantar aspect of the forefoot before, and 
published research indicated that further evidence of the comparability with LDF was 
also required. 
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6.2 UTILITY AND APPLICATION OF THIS KNOWLEDGE 
This knowledge adds to the understanding of two of the important elements, namely 
plantar pressure alteration and endothelial dysfunction known to be involved in the 
development of forefoot plantar ulceration associated with diabetes. As elevated plantar 
pressures and endothelial dysfunction are commonly cited as having a major role in the 
development of plantar ulceration and tissue viability in the foot with Type 2 diabetes, it 
is hoped that the development of this equipment may help with improving knowledge 
around the interaction of the two elements. 
 
6.3 SUGGESTIONS FOR FURTHER RESEARCH IN THE AREA 
On completion of this study there are some areas which have become apparent where 
further investigation would be beneficial. It would be useful to investigate further a 
group of subjects with diabetes who are known to present with neuropathy, thus 
elements like the effect of sensory nerve blocking could be investigated further, as well 
as the greater impact of increased plantar pressure on the forefoot.  
Further work should be undertaken regarding the higher blood flux found in areas of 
increased pressure with Type 2 diabetes, with perhaps a comparison study of areas 
which do not receive high pressure on the plantar aspect of the foot. 
Given the complexity of PORH and the debate concerning the elements of the test, it 
would be useful to investigate further the effect on the lower limb as well as carrying 
out further comparative work with LSCI and LDF.  
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Further work should be carried out regarding measurements of skin thickness and how 
this affects blood flux, as well as fully investigating the role that callus formation and 
removal may have on flux values. 
A larger group containing more subjects of each gender would allow further work on 
the impact of gender on blood flow.   
An interesting area of further study could be to investigate the impact of mental 
stimulation on peripheral blood flow during the assessment process.  
Finally, as there is so much variation found in the protocols used for iontophoresis 
delivery, further work in the development of protocols would be useful. 
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 Friends, students,colleagues
LEND ME YOUR FEET!
Participants required for Research
I am currently investigating the effect of foot pressure on microvascular function in the diabetic
foot and looking for healthy volunteers to constitute a control group for the study.
As a participant in this study, you will be invited to attend the podiatry clinic in QMU where blood
flowing through the superficial skin blood vessels will be measured on the sole of the foot. You will
be asked to sit comfortably and a cuff will be inflated around your calf for 4 mins. The reactive
hyperaemia will be measured using a laser speckle machine.
Your participation would involve the attendance of one session, lasting approximately 40 mins..
All information will be treated with the strictest confidence.
If you are
 Male/female aged 18 - 75
 In general good health
 Have no foot problems
 Would like to volunteer for this study 
and would like further information 
please contact: 
telephone Lynne Flynn on 07876762072
email  lflynn@qmu.ac.uk
QMU and Tayside Committee on Medical Research Ethics has examined this proposal and has raised no objections from the point of view of medical ethics
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Healthy Volunteer Information Sheet 
 
Study Title – The effect of pressure on microvascular function in the diabetic foot. 
 
You are being invited to take part in a research study which we believe will 
contribute to the explanation of why people with diabetes suffer with foot 
ulcerations. This study needs healthy volunteers so that we can compare the 
responses of their local blood flow to pressure in the feet, to the response in people 
with diabetes. Before deciding to take part, it is important that you understand why 
the research is being carried out and what the study will involve. Please make sure 
you take the time to read the following information carefully and talk to others about 
the study if you wish. 
• Part 1 tells you the purpose of this study and what will happen to you if you 
take part. 
• Part 2 gives you more detailed information about the conduct of the study. 
Please ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
Part 1 
What is the purpose of this study? 
Foot ulceration is a problem which can be found with diabetes. Two factors which 
are thought to contribute to foot ulcers are changes which occur to the small blood 
vessels found just under the skin surface, and the pressure placed on the sole of 
the foot when walking. The aim of this study is to investigate these 2 factors 
together to try to find out if there are differences in the way the small blood vessels 
respond under pressure with diabetes when compared to a group of people without 
diabetes. The component of the study you are being asked to help with is in 
assessing the reactive hyperaemia which occurs in the skin blood vessels following 
occlusion of the local vessels. 
 
What will happen to me if I take part? 
You will be invited to attend the podiatry clinic at Queen Margaret University for a 
single visit only.  
You will be seated in a chair with your feet up. A small box will be placed about 
30cms above your foot to measure the blood flowing through your skin. After 2 
minutes a pressure cuff will be inflated around your leg, just like the cuff used when 
you have your blood pressure measured. This will be inflated for 4-5 minutes and 
then removed. The small box will stay in place above your foot for a further 15 
minutes to measure your blood flow without contact with your skin, or causing any 
discomfort. During this process you will be asked to sit still with your feet up. The 
process will take approx. 40 mins. to complete.  
 
Are there any side effects? 
There are no known side effects or problems with the equipment used in this study. 
On occasion a mild tingling sensation can be felt at the start of the procedure, and 
if this should continue then the testing would be stopped. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this 
is given in Part 2. 
 
 
Will you taking part in the study be kept confidential? 
Yes, all the information about your participation in this study will be kept 
confidential. The details are included in Part 2. 
A contact point for further information about this study is 
Mrs Lynne Flynn, Subject Area of Podiatry, Queen Margaret University or Institute 
of Motion Analysis and Research, Ninewells Hospital, Dundee DD1 9SY. 
 
This completes Part 1 of the information sheet. 
If the information in Part 1 has interested you and you are considering 
participation, please continue to read the additional information in Part 2 
before making any decision. 
 
 
Part 2 
What if relevant new information becomes available? 
Sometimes during the course of a research project, new information becomes 
available about the study. If this happens the researcher will tell you about it and 
discuss whether you want to continue with the study. If you decide not to carry on 
then the procedure will be stopped and any data gathered from you will be 
destroyed. If you decide to continue in the study, you will be asked to sign an 
updated consent form.  
 
 
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any time and any data already gathered will be 
destroyed. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with 
the researcher Lynne Flynn who will do her best to answer your questions (contact 
number 0131 474 0000 email lflynn@qmu.ac.uk). If you remain unhappy need any 
further information or wish to complain formally, you can contact Dr Rami Abboud, 
Director of the Institute of Motion Analysis and Research  Ninewells Hospital 
Dundee DD1 9SY tel no. 01382 496276.  
In the event that something does go wrong and you are harmed during the 
research study there are no special compensation arrangements. If you are 
harmed and this is  
due to someone’s negligence then you may have grounds for a legal action for 
compensation against University of Dundee but you may have to pay your legal 
costs. 
 
Will my taking part in this study be kept confidential? 
If you join this study the data collected about you will be coded and anonymous 
and will be securely stored. It will be used only for this study and then destroyed. 
During the course of the study some parts of the data will be looked at by the 
supervisory team for the study to ensure that the study is being carried out 
correctly. All individuals with access to the data will have a duty of confidentiality to 
you as a research participant and nothing that could reveal your identity will be 
disclosed outside the research site. The procedures for handling, processing, 
storage and destruction of the data will be compliant with the Data Protection Act 
1998. 
 
What will happen to the results of the research study? 
The results of the study will be published in the form of a thesis for submission for 
PhD, and may also be published in one of the journals dedicated to diabetes. You 
will not be identified in any report or publication. 
 
 
Who has reviewed the study? 
The Tayside Committee on Medical Research Ethics, and Queen Margaret 
University Ethics committee have examined this proposal and have raised no 
objections from the point of view of medical ethics. It is a requirement that 
the research records are made available to monitors from NHS Tayside 
whose role is to check that research is properly conducted and the interests 
of those taking part are adequately protected.  
Thank you for considering taking part or taking time to read this information 
sheet. If you decide to take part in this study you will be given a copy of the 
information sheet and a signed consent form to keep. 
Information sheet for healthy volunteers version 2     
Date 19th Mar 10 
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Consent Form 
 
Study Title – The effect of pressure on micro vascular function in the diabetic foot. 
 
 
I have read and understood the information sheet and this consent form.  I have had an 
opportunity to ask questions about my participation. 
 
I understand that I am under no obligation to take part in this study. 
 
I understand that I have the right to withdraw from this study at any stage without giving 
any reason. 
 
I agree to participate in this study. 
 
 
 
Name of participant:  _____________________________________ 
 
 
 
Signature of participant: _____________________________________ 
 
 
 
Signature of researcher: _____________________________________ 
 
 
 
Date:   _________________ 
 
 
 
Contact details of the researcher 
 
Name of researcher: Lynne Flynn 
 
Address:             Subject Area Podiatry,  
   School of Health Sciences 
Queen Margaret University, Edinburgh 
   Queen Margaret University Drive 
                                    Musselburgh 
                                    East Lothian  EH21 6UU 
 
Email / Telephone: lflynn@qmu.ac.uk / 0131 474 0000 
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Research Participant Information Sheet 
Study Title- The effect of pressure on microvascular function in the 
diabetic foot. 
 
You are being invited to take part in a research study. Before deciding to take part, 
it is important that you understand why the research is being carried out and what 
the study will involve. Please make sure you take the time to read the following 
information carefully and talk to others about the study if you wish. 
• Part 1 tells you the purpose of this study and what will happen to you if you 
take part. 
• Part 2 gives you more detailed information about the conduct of the study. 
Please ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
 
Part 1 
 
What is the purpose of this study? 
Foot ulceration is a problem which can be found with diabetes. Two factors which 
are thought to contribute to foot ulcers are changes which occur to the small blood 
vessels found just under the skin surface, and the pressure placed on the sole of 
the foot when walking. The aim of this study is to investigate these 2 factors 
together to try to find out if there are differences in the way the small blood vessels 
respond under pressure with diabetes when compared to a group of people without 
diabetes. The activity of the blood vessels will be assessed by placing a substance 
on the skin surface which when absorbed causes the small local vessels to enlarge 
temporarily and the amount of blood flowing through the vessels to increase. This 
increase in local blood flow can be measured on the skin surface by placing a 
probe against the skin. This study is being carried out by a researcher who is 
studying towards a PhD. 
You have been chosen to take part in this study as you are on the diabetes centre 
database at Ninewells Hospital and Medical School and therefore have the type of 
condition which is required for this study. 
 
 
Do I have to take part in this study? 
No, it is up to you to decide whether or not to take part. If you do, you will be given 
this information sheet to keep and be asked to sign a consent form. You are still 
free to withdraw at any time and without giving a reason. A decision to withdraw at 
any time, or a decision not to take part, will not affect the standard of care you 
receive.  
 
What will happen to me if I take part? 
You will be invited to attend the vascular unit at Ninewells Hospital for a single visit 
only. Note that you should eat breakfast or lunch as usual before travelling to the 
hospital, but avoid eating or drinking for 1-2 hours before the tests are carried out. 
It is expected that this period of time will be taken up in the time it takes to travel to 
the hospital and in preparing you for the tests You will be asked to walk barefoot at 
your normal pace over a walkway which will measure the pressure you have on the 
sole of your foot. If you have any hard skin on the sole of your foot in the area 
under study this will be removed by the researcher who is a registered podiatrist. 
You will then be seated in a chair with your feet up. A small box will be placed 
about 30cms above your foot to measure the blood flowing through your skin. After 
2 minutes a pressure cuff will be inflated around your leg, just like the cuff used 
when you have your blood pressure measured. This will be inflated for 4-5 minutes 
and then removed. The small box will stay in place above your foot for a further 15 
minutes to measure your blood flow without contact with your skin, or causing any 
discomfort. Equipment will then be placed onto the sole of your foot just behind 
your toes which will allow the jelly like substance to be absorbed into your skin. A 
small pressure device will be placed against your skin and will place the skin under 
the same pressure measured when you were walking. A skin surface probe will be 
attached to your skin and will measure the amount of blood flowing through the 
surface blood vessels when they are under pressure.  
The pressure will be reduced to half and then to a quarter of your normal pressure 
and measurements will be repeated. This process will be repeated using a second 
jelly like substance also designed to expand your local small blood vessels. During 
this process you will be asked to sit still with your feet up. The process will take 
approx. 2 hours to complete. Time will be given between measurements for you to 
stretch or move around for your comfort. 
 
Expenses and payment 
As this visit will be for the study only and not for your normal treatment, expenses 
for attending will be reimbursed.  
 
Are there any side effects? 
There are no known side effects or problems with the equipment used in this study. 
On occasion a mild tingling sensation can be felt at the start of the procedure, and 
if this should continue then the testing would be stopped. 
 
What are the possible benefits of taking part? 
We cannot promise that this study will help you directly, but the information we get 
might help to prevent foot ulcers in the future for people with diabetes by providing 
us with a better understanding about why they happen. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this 
is given in Part 2. 
 
Will you taking part in the study be kept confidential? 
Yes, all the information about your participation in this study will be kept 
confidential. The details are included in Part 2. 
A contact point for further information about this study is 
Mrs Lynne Flynn, Institute of Motion Analysis and Research, Ninewells Hospital, 
Dundee DD1 9SY phone 07876762072. 
 
 
This completes Part 1 of the information sheet. 
If the information in Part 1 has interested you and you are considering 
participation, please continue to read the additional information in Part 2 
before making any decision. 
 
 
 
Part 2 
What if relevant new information becomes available? 
Sometimes during the course of a research project, new information becomes 
available about the study. If this happens the researcher will tell you about it and 
discuss whether you want to continue with the study. If you decide not to carry on 
then the procedure will be stopped and any data gathered from you will be 
destroyed. If you decide to continue in the study, you will be asked to sign an 
updated consent form. If the study is stopped for any other reason you will be told 
why, and this will have no effect on any future care for your condition. 
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any time and any data already gathered will be 
destroyed. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with 
the researcher Lynne Flynn who will do her best to answer your questions (contact 
number 07876762072). If you remain unhappy and wish to complain formally, you 
can contact Dr Rami Abboud, Director of the Institute of Motion Analysis and 
Research  Ninewells Hospital Dundee DD1 9SY tel no. 01382 496276.  
In the event that something does go wrong and you are harmed during the 
research study there are no special compensation arrangements. If you are 
harmed and this is due to someone’s negligence then you may have grounds for a 
legal action for compensation against University of Dundee but you may have to 
pay your legal costs. 
 
Will my taking part in this study be kept confidential? 
If you join this study the data collected about you will be coded and anonymous 
and will be securely stored. It will be used only for this study and then destroyed. 
During the course of the study some parts of the data will be looked at by the 
supervisory team for the study to ensure that the study is being carried out 
correctly. All individuals with access to the data will have a duty of confidentiality to 
you as a research participant and nothing that could reveal your identity will be 
disclosed outside the research site. The procedures for handling, processing, 
storage and destruction of the data will be compliant with the Data Protection Act 
1998. 
 
Informing the family doctor 
With your consent your own GP will be notified that you are participating in this 
study. 
 
 
What will happen to the results of the research study? 
The results of the study will be published in the form of a thesis for submission for 
PhD, and may also be published in one of the journals dedicated to diabetes. You 
will not be identified in any report or publication. 
 
Who has reviewed the study? 
The Tayside Committee on Medical Research Ethics, which is responsible for 
scrutinising proposals for medical research on humans, has examined this 
proposal and has raised no objections from the point of view of medical 
ethics. It is a requirement that the research records are made available to 
monitors from NHS Tayside whose role is to check that research is properly 
conducted and the interests of those taking part are adequately protected.  
Thank you for considering taking part or taking time to read this information 
sheet. If you decide to take part in this study you will be given a copy of the 
information sheet and a signed consent form to keep. 
Information sheet version 3       
Date 20.03.09 
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Healthy Volunteer Information Sheet 
 
Study Title – The effect of pressure on microvascular function in the diabetic foot. 
 
You are being invited to take part in a research study which we believe will 
contribute to the explanation of why people with diabetes suffer with foot 
ulcerations. This study needs healthy volunteers so that we can compare the 
responses of their local blood flow to pressure in the feet, to the response in people 
with diabetes. Before deciding to take part, it is important that you understand why 
the research is being carried out and what the study will involve. Please make sure 
you take the time to read the following information carefully and talk to others about 
the study if you wish. 
• Part 1 tells you the purpose of this study and what will happen to you if you 
take part. 
• Part 2 gives you more detailed information about the conduct of the study. 
Please ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
 
Part 1 
 
What is the purpose of this study? 
Foot ulceration is a problem which can be found with diabetes. Two factors which 
are thought to contribute to foot ulcers are changes which occur to the small blood 
vessels found just under the skin surface, and the pressure placed on the sole of 
the foot when walking. The aim of this study is to investigate these 2 factors 
together to try to find out if there are differences in the way the small blood vessels 
respond under pressure with diabetes when compared to a group of people without 
diabetes. The activity of the blood vessels will be assessed by placing a substance 
on the skin surface which when absorbed causes the small local vessels to enlarge 
temporarily and the amount of blood flowing through the vessels to increase. This 
increase in local blood flow can be measured on the skin surface by placing a 
probe against the skin. This study is being carried out by a researcher who is 
studying towards a PhD. 
 
What will happen to me if I take part? 
You will be invited to attend the vascular unit at Ninewells Hospital for a single visit 
only. Note that you should avoid eating or drinking for 1-2 hours before the tests 
are carried out. You will be asked to walk barefoot at your normal pace over a 
walkway which will measure the pressure you have on the sole of your foot. If you 
have any hard skin on the sole of your foot in the area under study this will be 
removed by the researcher who is a registered podiatrist. You will then be seated 
in a chair with your feet up. A small box will be placed about 30cms above your 
foot to measure the blood flowing through your skin. After 2 minutes a pressure 
cuff will be inflated around your leg, just like the cuff used when you have your 
blood pressure measured. This will be inflated for 4-5 minutes and then removed. 
The small box will stay in place above your foot for a further 15 minutes to measure 
your blood flow without contact with your skin, or causing any discomfort. 
Equipment will then be placed onto the sole of your foot just behind your toes 
which will allow the jelly like substance to be absorbed into your skin. A small 
pressure device will be placed against your skin and will place the skin under the 
same pressure measured when you were walking. A skin surface probe will be 
attached to your skin and will measure the amount of blood flowing through the 
surface blood vessels when they are under pressure. The pressure will be reduced 
to half and then to a quarter of your normal pressure and measurements will be 
repeated. This process will be repeated using a second jelly like substance also 
designed to expand your local small blood vessels. During this process you will be 
asked to sit still with your feet up. The process will take approx. 2 hours to 
complete. Time will be given between measurements for you to stretch or move 
around for your comfort. 
 
Are there any side effects? 
There are no known side effects or problems with the equipment used in this study. 
On occasion a mild tingling sensation can be felt at the start of the procedure, and 
if this should continue then the testing would be stopped. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this 
is given in Part 2. 
 
Will you taking part in the study be kept confidential? 
Yes, all the information about your participation in this study will be kept 
confidential. The details are included in Part 2. 
A contact point for further information about this study is 
Mrs Lynne Flynn, Institute of Motion Analysis and Research, Ninewells Hospital, 
Dundee DD1 9SY phone 07876762072. 
 
This completes Part 1 of the information sheet. 
If the information in Part 1 has interested you and you are considering 
participation, please continue to read the additional information in Part 2 
before making any decision. 
 
 
 
Part 2 
What if relevant new information becomes available? 
Sometimes during the course of a research project, new information becomes 
available about the study. If this happens the researcher will tell you about it and 
discuss whether you want to continue with the study. If you decide not to carry on 
then the procedure will be stopped and any data gathered from you will be 
destroyed. If you decide to continue in the study, you will be asked to sign an 
updated consent form. If the study is stopped for any other reason you will be told 
why, and this will have no effect on any future care for your condition. 
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any time and any data already gathered will be 
destroyed. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with 
the researcher Lynne Flynn who will do her best to answer your questions (contact 
number 07876762072). If you remain unhappy and wish to complain formally, you 
can contact Dr Rami Abboud, Director of the Institute of Motion Analysis and 
Research  Ninewells Hospital Dundee DD1 9SY tel no. 01382 496276.  
In the event that something does go wrong and you are harmed during the 
research study there are no special compensation arrangements. If you are 
harmed and this is due to someone’s negligence then you may have grounds for a 
legal action for compensation against University of Dundee but you may have to 
pay your legal costs. 
 
Will my taking part in this study be kept confidential? 
If you join this study the data collected about you will be coded and anonymous 
and will be securely stored. It will be used only for this study and then destroyed. 
During the course of the study some parts of the data will be looked at by the 
supervisory team for the study to ensure that the study is being carried out 
correctly. All individuals with access to the data will have a duty of confidentiality to 
you as a research participant and nothing that could reveal your identity will be 
disclosed outside the research site. The procedures for handling, processing, 
storage and destruction of the data will be compliant with the Data Protection Act 
1998. 
 
What will happen to the results of the research study? 
The results of the study will be published in the form of a thesis for submission for 
PhD, and may also be published in one of the journals dedicated to diabetes. You 
will not be identified in any report or publication. 
 
 
Who has reviewed the study? 
The Tayside Committee on Medical Research Ethics, which is responsible for 
scrutinising proposals for medical research on humans, has examined this 
proposal and has raised no objections from the point of view of medical 
ethics. It is a requirement that the research records are made available to 
monitors from NHS Tayside whose role is to check that research is properly 
conducted and the interests of those taking part are adequately protected.  
Thank you for considering taking part or taking time to read this information 
sheet. If you decide to take part in this study you will be given a copy of the 
information sheet and a signed consent form to keep. 
Information sheet for healthy volunteers version 2     date 20.3.09 
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Vascular Assessment and Microcirculation
in Lower Limb Wounds
A good blood supply is paramount to initiate healing of lower limb wounds regardless of whether these are in an acute or a
chronic phase, and it is vital that the method chosen for vascular assessment is accurate, user friendly and if possible non
invasive. Several methods of vascular assessment are currently available for both clinical as well as research use. Included
in this review are laser Doppler flowmetry and perfusion imaging with the utilisation of iontophoresis and reactive hyper-
aemia, laser speckle contrast imaging, photoplethysmography, thermal infra red imaging, transcutaneous oxygen tension
as well as the ankle brachial pressure index and nailfold capillaroscopy. Although the techniques function in a variety of
ways, the measurements offer an understanding of the role of microvasculature and endothelial function in the develop-
ment of lower limb ulcers, as well as in wound assessment and the determination of the possibility of healing as an outcome
of management strategies. This review outlines the techniques for assessment and given the important role microvascula-
ture plays in the repair and healing of wounds, examines the available evidence for the role of the various measurements
in this process.
Abstract
Keywords: Lower limb wounds, Microcirculation, Laser Doppler flowmetry, Laser Doppler perfusion imaging
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Introduction
Regeneration and repair of tissue in healing wounds involves
multiple complex and interrelated mechanisms, with the micro-
circulation playing a significant role. Initially, microvascular
perfusion in the wound is reduced to help limit blood loss, but
this is then superseded by an increase in microvascular perfu-
sion as inflammation ensues, which brings in immunological
cells, growth factors, and fibroblasts to the wound and pro-
vides it with nutrients. Accordingly, it can be appreciated that a
lack of perfusion to the lower limb can lead to ulceration and
gangrene, often with an outcome of amputation. Potential causes
of poor perfusion include peripheral arterial disease, venous
insufficiency and commonly, diabetes mellitus.1,2 Given the impor-
tant role of the microcirculation in wound healing, there is inter-
est in being able to assess this effectively in order to aid better
prediction of wound healing, to monitor progression of repair,
and also to understand underlying mechanisms. For example,
dysfunction of the vascular endothelium has widely been inves-
tigated in the pathogenesis of peripheral arterial disease.3,4
The vascular endothelium is responsible for several functions
including controlling the vascular tone and inhibiting platelet
aggregation, as well as modulation of the vascular wall per-
meability, however, in the main, endothelial function refers to
the ability of the endothelium to release compounds which
induce relaxation of smooth muscle within the vessel wall such
as nitric oxide, prostacyclin and endothelium-derived hyper-
polarizing factors.3 Several non-invasive methods are avail-
able to assess microvascular perfusion (Table 1), either indi-
rectly or directly and these can aid in the diagnosis, assessment
and management strategies for lower limb pathologies and
associated complications such as ulceration and gangrene.
The aim of this review is to evaluate some of the common meth-
ods currently in use.
Laser Doppler Flowmetry (LDF)
BACKGROUND
While many techniques can provide an indirect indication
of microvascular perfusion, laser Doppler flowmetry is one of
the few that can assess the microcirculation directly. Changes
in microvascular perfusion of the skin can be measured rela-
tively easily utilising the non invasive technique of laser Doppler
flowmetry.4-7 The technique utilises the motion generated from
a light source and captured by a detector, this is known as the
Doppler effect. With LDF the moving erythrocytes, or in fact
tissues, cause a scattering of the laser light, and the velocity
of this back-scattered light is detected providing the Doppler
frequency information.5,8,9 The density and speed of the red
blood cells when measured with a regular or constant haema-
tocrit within the sample tissue, is known to be proportional to
red blood cell flow, hence the utilisation of the term ‘flux’ as a
unit of flow measurement.
INSTRUMENT AND MEASUREMENT TECHNIQUES
Traditional LD flowmeters utilise a helium-neon laser light
source of wavelengths varying between 630nm and 670nm with
a fibre optic cable in contact with the skin surface. They pro-
vide an estimated perfusion depth of 1-1.5mm into the dermis
and detect dermal blood flow without influence from the flow
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to the underlying skeletal muscle.5,9-12 An issue had been noted
in that the optical fibres produce low frequency noise arte-
facts; further developments have ensued to overcome this prob-
lem.9
Semi conductor laser diodes operating with near infrared
light of 780nm to 820nm as a light source have been devel-
oped to replace the helium-neon lasers.5,9,11 The main advan-
tages over traditional flowmeters being deeper penetration
and better reproducibility.5,9
In contrast to single point measurements, laser Doppler
perfusion imaging affords non-contact assessments (there-
fore desirable for wound assessments) with the laser beam
TECHNIQUE FUNCTION ADVANTAGES/DISADVANTAGES
Laser Doppler Flowmetry Uses laser light.
Velocity of this back scattered light is 
detected providing Doppler frequency 
information.
Advantages
• Effective and reliable method for measu-
rement of blood perfusion in the micro-
vasculature.
• Provides continuous, noninvasive and real-
time measurement capabilities.
• Versatile and easy to use. 
Disadvantages
• Motion artefact noise, lack of quantitative
units for perfusion, lack of knowledge of
depth of measurement and the biological
zero signal. 
Laser Speckle Contrast Imaging Interference when laser light has been
reflected from different parts of an 
illuminated surface.
Advantages
• Rapid skin blood flow measurements over
wide areas coupled with good resolution. 
• Full-field imaging of skin perfusion in
near real time.
Disadvantages
• Relationship between speckle contrast
and velocity is highly non-linear, thus a
lack of quantitative units.
Photoplethysmography Optical reflection mode system measuring
scattering and absorption characteristics 
of tissue associated with changes in blood
flow, with near infrared spectroscopy.
Advantages
• Non invasive, Easy to use, cost effective
and portable.
Disadvantages
• Blood volume, movement of the vessel
wall and orientation of erythrocytes may
have an influence on the amount of light
received. 
• Cannot easily be calibrated.
Thermography Thermal infrared imaging for the 
measurement of cutaneous circulation.
Advantages
• Can be used over large areas.
• Allows for real time recording. 
Disadvantages
• If temperatures are very close in range,
infrared imaging camera may misread the
information and individual objects can
become indistinguishable.
• Current technology in thermography only
allows for imaging to be applied to surface
temperatures.
Transcutaneous Oxygen Tension
Transcutaneous oxygen and carbon dioxide
sensors directly measure tissue gas ten-
sions with a short sensor response times.
Advantages
• Non invasive and continuous.
Disadvantages
Measurements do not equate directly to
arterial blood flow due to skin perfusion.
Ankle Brachial Pressure Index Systolic pressure is measured at the ankle
using either the posterior tibial artery or
dorsalis pedis and the value in mmHg 
obtained here is divided by the brachial 
systolic pressure, utilising a pressure 
cuff and a hand held Doppler probe.
A normal index value at rest is equal or
higher than 1.
Advantages
• Easy to perform.
• Non invasive.
• Equipment is cheap and readily available.
Disadvantages
Not useful for small vessel disease or with
calcification of vessels. 
Nailfold Capillaroscopy Under 10x to 20x magnification has been
used to assess digital microcirculation, and
reproducibility measurements of capillary
width and number of loops/millimeter 
have been measured.
Advantages
• Simple to carry out and non invasive, safe
and cost effective.
• Allows direct observation of nail fold 
capillaries.
Table 1. Available techniques for the assessment of microvascular perfusion with advantages and disadvantages.
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position controlled by a system of mirrors. Currently, there are
two main commercial laser Doppler imaging systems, pro-
duced by Lisca Development AB, Sweden and Moor Instru-
ments Ltd UK. A digital image is produced, being developed as
the combination of many single-point recordings of a two dimen-
sional matrix of the blood flow over an extended skin surface,
and over a larger area, thus producing a detailed perfusion
map. 
Both LDF and LDPI have been found to be user-independ-
ent by utilising established protocols and maintaining external
factors which can influence the readings, such as controlling
environmental temperature, reducing movement as well as
reflection artifacts where possible, removal of topical agents,
as well as refraining from smoking and caffeine ingestion for a
period of at least 2 hours prior to assessments.5,10
UTILISATION OF LASER DOPPLER FLOWMETRY
LDF has been utilised for many applications including der-
matology, wound healing, diabetology and peripheral vascular
aspects.9,10 LDI and capillary microscopy have been used to
assess subpapillary and nutritive microcirculation in 17 patients
with arterial occlusive disease and chronic venous insufficiency
ulcers in 4 regions, a non-granulating tissue area, a granulat-
ing tissue area, an area of skin adjacent to the ulcers (within a
distance of 1-8mm), and a more distant area of 9-25mm.13 Laser
Doppler flux was significantly higher in granulating areas than
in areas without granulation tissue and intact skin. In scar tis-
sue flux was found to be higher than in both intact skin and in
ulcers without granulation tissue being present. Thus; ulcers
without granulation tissue had poor perfusion and did not dis-
play healing, whereas when granulation tissue was present,
high perfusion was found. They also noted that the blood sup-
ply in the intact skin adjacent to the ulcers was affected by an
altered microcirculation found in the ulcers. Thus, it was noted
that LDI flux measurement could provide information to aid
the optimum evaluation of microcirculation in ulcers of mixed
aetiology. Krupa (2003)14 investigated the relationship between
plantar pressure and skin perfusion on the foot of type 11 dia-
betic, peripheral neuropathic patients with a history of plantar
ulceration. Although the heel area was found to display high
pressures, in comparison to the forefoot areas in the study it
displayed a higher skin perfusion, thus findings indicated that
understanding of the skin vasculature response to plantar pres-
sures could add valuable insight into re-ulceration issues. 
Pressure ulcers were investigated as a complication of tis-
sue ischaemia resulting from diabetes. When comparison was
made between subjects with diabetes and controls, skin blood
flow decreased markedly in subjects presenting with diabetes
without neuropathy, as measured with single point LDF in
response to initial locally applied increasing pressure. This
inability of the microcirculation to respond to local pressure
was noted as a possible factor in ulcer development in this
group.2 Figoni et al. (2006)15 assessed the utility of LDI versus
transcutaneous gases (TcPCO2 and TcPO2) in cases with severe
ischaemia, for the assessment of limb perfusion in order to
determine the degree and progression of the pathological process
leading to possible amputation. They compared 31 patients
who required amputation with 29 age–matched non ischaemic
controls and found that LDI could detect a proximal to distal
gradient of perfusion of the lower limb which was not discernible
with TcPO2. LDI was also found to discriminate between
ischaemic and non ischaemic skin which was not possible with
TcPO2 thus overall LDI proved to perform better than TcPO2.
Skin perfusion in the hallux utilising LDI with 14 patients with
peripheral arterial occlusive disease was compared with 11
healthy volunteers.16 Significantly lower digital artery pressure
and skin perfusion pressure was found in the patient group.
They noted that LDI provided an easy and non-invasive method
of simultaneously assessing digital artery and skin perfusion,
enabling the severity of peripheral arterial occlusion to be
assessed thus predicting possible healing of foot ulcerations.
Laser Doppler Flowmetry and
Iontophoresis
Iontophoresis is a useful technique where small doses of
vasoactive substances are required to stimulate skin microves-
sels locally without systemic effects to gain a better under-
standing of mechanisms of vascular dysfunction. Utilising ion-
tophoresis with LDF provides a non-invasive method using a
small electric charge to aid migration of charged substances
across the skin surface.5,12,17-19 The polarity of the active elec-
trode used has to be the same charge as the substance itself.12,20
During the process of iontophoresis, the electric dose, which
is calculated from duration and current strength, is thought to
correlate with the amount of substance delivered across the
skin21.The most commonly utilised substances for this pur-
pose are those for investigating endothelial function, namely
acetylcholine (ACh) an endothelium-dependent agonist, and
sodium nitroprusside (SNP) an endothelium–independent
vasodilator, although other substances have also been used
such as bradykinin and substance P.5,12,17,19,21,22 However, when
using iontophoresis, several methodological issues need to be
considered, which have been reviewed elsewhere.12
UTILISATION OF IONTOPHORESIS
Iontophoresis in conjunction with LDI has been utilised to
investigate many pathological conditions, in particular dia-
betes mellitus and peripheral arterial disease, but only those
studies relating to factors potentially affecting wound micro-
circulation will be described below Sensory neuropathy is recog-
nised as a contributory factor to development of wounds. Kelly
et al. (2001)23 studied endothelial responses in the diabetic foot
with sensory neuropathy. Analysis of the ACh and SNP response
revealed no significant differences between groups of subjects
with diabetes and neuropathy, without neuropathy and con-
trols without diabetes. However this study utilised a protocol
with a higher current for a shorter duration of iontophoresis
than found in most other protocols and with a small number
of subjects in that n=6 in each of the groups with diabetes with
and without neuropathy, as well as the healthy controls stud-
ied.
Khan et al. (2000)24 studied children, adolescents and young
adults with type 1diabetes and measured skin microvascular
function using LDF with iontophoresis of ACh and SNP in the
feet, areas prone to development of ulcers and wounds. Find-
ings indicated that early reductions in the microvascular func-
tion in the form of endothelium-dependent and independent
vascular responses, as well as a reduction in maximal vasodila-
tor capacity, was present prior to any manifestation of clinical
presentation. 
Impaired pressure induced vasodilation (PIV) in young adults
with type 1 diabetes was investigated by Koitka et al. (2004)22
who noted that vascular and neurological mechanisms were
both likely to be involved in foot ulceration. They found an impaired
vasodilation to ACh but not to SNP between the group with dia-
betes and the control group with n=12 in each. Although Sigaudo-
Roussel et al. (2004)25 carried out their study on streptozo-
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tocin-induced diabetic mice and healthy control animals; they
also found that endothelial impairment was enough to severely
alter PIV. PIV suppression was noted as possibly leading to
complications such as foot ulceration in their study utilising
n=10 in both groups under study.
A pilot study to investigate the effects of local pressure on
microvascular function in the diabetic foot, with 16 patients
and 8 healthy controls was carried out.18 The subjects with dia-
betes displayed higher plantar pressures than the control group,
but no significant difference was found in basal skin perfusion
or in ACh response. Within the patient group, however, base-
line flow was increased (p=0.041) but the acetylcholine response
reduced (p=0.03) at the high-pressure compared with the low-
pressure site; this was most apparent in those who were par-
ticularly at risk of ulceration due to high plantar pressures.
The authors concluded that further work is required to deter-
mine whether, and under what conditions, this additional hyper-
aemia is protective or maladaptive.
LDF AND REACTIVE HYPERAEMIA
An additional tool for assessing the integrity of the microvas-
culature is to measure the reactive hyperaemic response, which
is defined as a temporary increase in skin and muscle blood
flow following an arterial occlusion.26,27 Post occlusive reactive
hyperaemia (PORH) has been specified as a useful, non-inva-
sive and sensitive indicator for microvascular dysfunction in
that the maximum peak blood flow and the time to reach this
point following release of the occlusion are related to nitric
oxide (NO) and as such are indicators of endothelial function.26
The ability to continuously monitor perfusion has made LDF
an important mode for study for post-occlusive reactive hyper-
aemia (PORH).27-29 Useful parameters for reactive hyperaemia
include time to peak flow and the value of peak flow. These
parameters have been found to provide early detection of vas-
cular alterations ie prior to the development of clinical symp-
toms in diabetes mellitus, and also to show the effects of smok-
ing and peripheral vascular disease.27,28,30 PORH was compared
in subjects with Fontaine classification of stage 11 PAOD ie
intermittent claudication occurring, but with no pain on rest-
ing, with healthy controls.30 In PAOD patient’s skin perfusion
was not impaired during baseline ie prior to occlusion, which
was thought to be a result of compensatory mechanisms related
to endothelial, myogenic and sympathetic activities. During
hyperaemia however, patients displayed reduced vasoreactiv-
ity suggesting perhaps an exhaustion of compensatory mech-
anisms. 
Although LDF is useful for monitoring the PORH response,
until recently this has only really been possible with single
point instruments (which have their inherent limitations as
mentioned in a previous section) since these instruments are
able to continuously monitor perfusion and capture the rapid
changes in perfusion post occlusion. A recent development,
however, has been the introduction of laser speckle contrast
imaging which has the capacity to perfusion from larger areas
of tissue in near real time.
Laser Speckle Contrast Imaging (LSCI)
BACKGROUND
In 1960s a ‘grainy’ pattern was discovered when laser light
was viewed on a matt surface such as glass, paper or dull metal,
and this speckle pattern lead to the term being adopted.31 It
has been described as an interference when light has been
reflected from different parts of an illuminated surface.31,32
With movement of an object, changes are noted in the speckle
pattern. When a solid object undergoes small movements the
speckles appear to move with the object, however with large
movements the pattern undergoes complete change and fre-
quency of the fluctuations is dependent on the velocity of the
motion. This phenomenon is known as ‘time-varying’ speckle
and Stern in 1975 was the first to note the potential for speckle
changes when assessing blood flow. Royl et al. (2006)32 noted
that ‘during increased blood flow the intensity variations of the
speckle pattern are more rapid’. The group found that in the
exposure time the contrast of the pattern was reduced and
quantification of the blurring effect was in fact possible with
analysis of adjacent areas within the illuminated area. The
speckle contrast K was then calculable thus; the mean veloc-
ity of moving elements could be calculated using this speckle
contrast. It was noted that this offered a faster way of signal
processing which allowed full-field imaging of skin perfusion
in near real time.29,31,33
UTILISATION OF LSCI IN BLOOD FLOW MEASUREMENT
The reproducibility of laser speckle contrast imaging (LSCI)
was compared with LDF as a method of assessing skin microvas-
cular reactivity when utilising PORH.29 It was found to offer
both rapid skin blood flow measurements over wide areas cou-
pled with good resolution. LSCI also displayed very good inter-
day reproducibility when assessing forearm PORH and local
thermal hyperaemia. Although the findings were positive, the
study had some limitations such as limited number of sub-
jects and the authors concluded that more data would be required
to clearly evaluate any linearity between LSCI and skin blood
flow.
A comparison of inter-day reproducibility utilising POHR
with single point LDF integrated probe LDF with LSCI was car-
ried out.33 In agreement with Roustit et al. (2010)29 they found
LSCI faired better than LDF due probably to the larger skin
area under measurement, however they did find that LDF was
more sensitive to changes in skin blood flow at lower levels
found on the finger pad area. It was also noted that the LSCI
signal was more sensitive to changes in red blood cell velocity
than concentration, and in agreement with Nakagami et al.
(2010)34 they found that the speckle contrast was not linear to
either velocity or perfusion, and in fact the relationship between
speckle contrast and velocity was highly non-linear. It was how-
ever concluded that this did not preclude the use of LSCI for
quantitative analysis of perfusion, but that careful calibration
and or interpretation would be required. However, the known
percentage change in velocity did produce the same change in
speckle contrast, thus LSCI was found to be more useful in
measuring changes in perfusion rather than absolute meas-
urements.33 The advantages over LDF are that it offers high
spacial and temporal resolution and is relatively user friendly
and cheap to use.35
An investigation into the use of LSCI for the assessment of
circulation in pressure ulcers was undertaken.34 Although this
work was utilising animal studies and small numbers were
used, nevertheless it was concluded that LSCI could have great
potential for assessing the severity of tissue damage in deep
tissue injury, although much more work would be required in
the area.
Photoplethysmography
BACKGROUND
Photoplethysmography (PPG) is an optical technique which
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measures blood volume changes in the microvascular bed in a
non invasive, portable and cost effective manner. Pioneered by
Alrick Hertzman in 1937, the first paper on PPG described the
use of a reflection mode system used to measure blood vol-
ume changes in the fingers. PPT requires only a few basic com-
ponents, a light source for the skin and a photo detector to
measure variations in light intensity.36 The light is initially
absorbed, then scattered and reflected in the skin and the blood
and some of the reflected light is detected by the photo detec-
tor.37 Depth of light penetration is dependent upon the wave-
length (red or near infrared) and the distance between the light
source and the detector. The signal can in fact be divided into
two separate parts, an AC and a DC signal. The AC signal relates
to blood flow in the vascular bed and DC reflects variations in
total blood volume. 
INSTRUMENT AND MEASUREMENT TECHNIQUES
PPG currently uses low cost semi conductor technology
with LED and matched photo detector devices working at red
and near infrared wavelength. There are two main operating
configurations, transmission where the skin sample is between
the light source and detector and reflection where the LED
and detector are side by side. Transmission provides more
restrictions on the location of the tissue under study than the
reflection mode.36 It should also be noted that blood volume,
movement of the vessel wall and the orientation of the ery-
throcytes may have an influence on the amount of light received.37
UTILISATION OF PPG
PPG was utilised as a clinically useful quantitative tool for
healing of diabetic wounds by measuring scattering and absorp-
tion characteristics of tissue with near infrared spectroscopy.38
Their study was carried out on 20 female hairless rats with 10
streptozotcin induced diabetic rats displaying 38 full thickness
wounds. Cross and parallel polaraisation pictures were taken
to evaluate the area and contraction of the wounds. Wound
healing rate was half that in the diabetic group in comparison
to the controls with the average absorption coefficient being
twice as high, and the scattering coefficient 30% higher in the
diabetic wounds. During healing both scattering and absorp-
tion coefficients increased faster with diabetes. The technique
was found to differentiate between healing diabetic and non-
diabetic wounds, however the study was carried out in ani-
mals, and a small sample size was utilised even though 38
wounds were assessed. 
PPG was suggested as useful for many clinical settings
including cardiovascular assessment of both arterial and venous
disorders.36 Arterial assessment such as vessel compliance
and ageing could be assessed effectively using PPG as well as
endothelial function, which was noted as an early event in ath-
erosclerosis that correlated well with major risk factors asso-
ciated with cardiovascular disease. The amplitude of the PPG
pulse was noted as often correlating with LDF in the assess-
ment of microvascular blood flow and the assessment of the
viability of tissues. The ability to assess the tissue perfusion
was suggested to be of particular importance for the clinical
assessment of tissue viability and the healing potential when
tissue breakdown had occurred. 
PPG and LDF were utilised in a single probe when assess-
ing blood flow at different tissue depths, in pressure ulcers on
17 individuals of both sexes, over 60 years of age.37 They noted
that blood flow was crucial in ensuring the tissue requirements
for nutrition and oxygenation, as well as for the removal of
waste products from the area, were fulfilled. Their dual probe
system was found to successfully detect the relevant blood
flow responses at different depths and when combining the
two methods of assessing blood flow, LDF complemented the
PPG. 
Thermography
Temperature measurement has commonly been utilised
for the assessment of cutaneous circulation, thus the use of
thermal infrared imaging has been indicated for assessing
microcirculation, and in fact skin temperature measurement
has become common practice for the assessment of the vas-
culature function in critical illness.39,40 The FLIR PM695 system
was used to assess chronic venous stasis ulcers before and
during treatment with water-filtered infrared-A ie a special
form of heat radiation with a high tissue penetration.41 This
afforded the group the opportunity to take image sequences at
1 second intervals during the treatment process, providing a
valuable visual impression of the heat distribution on and in
the skin around the ulcer. The results showed healing either
completely or near completion in 7 out of 10 patients (5 males
and 5 females with chronic venous stasis ulcers, and a reduc-
tion in size in another 2 patients.
Thermography was compared with LDI in the assessment
of primary Raynauds phenomenon (PRP) and secondary to
systemic connective tissue disorders like systemic sclerosis
(SSc) in a group of 7 subjects with PRP, 33 with SSc and 17
control subjects.42 Patients with SSc are known to present with
structural microvascular disease which can lead to ulceration
and gangrene often resulting in amputation, therefore assess-
ment and thus early indication of irreversible tissue damage is
vital. They found a poor correlation between flux and tempera-
ture gradients along fingers. This was thought to be due to the
fact that LDI is a more direct measurement of blood flow, thus
more sensitive to changes in flow. It was noted that despite
this poor correlation, neither technique was negated, rather
that the different parameters of measurement with each sys-
tem was required to be emphasised. 
Transcutaneous Oxygen Tension TcPO2
TcPO2 is carried out with probes positioned on the leg and
foot and a chest probe acting as a reference site, the probe
uses an electrochemical technique. It has a gold cathode sur-
rounded by an anode and a heater ring. Normal levels are approx.
60mmHg with values of 20mmHg or less indicative of severely
reduced blood flow, and values may be used to predict vascu-
lar disease, the need for revascularisation, as well as provid-
ing an indication for successful healing following amputation.43
Zimny et al. (2004)44 utilised TcPO2 to assess the skin oxygen
supply in 21 patients with type 2 diabetes who were at risk of
ulceration, but with no previous history of ulceration and com-
pared this group with 20 subjects with diabetes with no foot
lesions or neuropathy and 21 healthy controls. They found TcPO2
to be significantly reduced in the at risk group in comparison
to the other two groups and noted that TcPO2 was a useful tool
in the identification of the foot at risk in diabetes.TcPO2 and
TcPCO2 (transcutaneous partial pressure of carbon dioxide)
were compared with LDI in 31 subjects displaying severe leg
ischaemia and 29 healthy control subjects as a method to com-
pare pre-amputation assessments. The findings indicated that
TcPO2 could be considered an index of skin perfusion only when
blood flow was reduced, and there was a lack of correlation
between TcPO2 and LDI in the normal controls.15
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When TcPO2 was compared with ankle brachial pressure
index (ABPI) for the evaluation of percutaneous transluminal
angioplasty in 60 subjects, it was found to display a positive
correlation with ABPI both before and 4 weeks after angio-
plasty. However, 24 hours after the intervention, there was a
lack of correlation, thus they concluded that ABI was still the
most favorable method to indicate success of this revascular-
ization procedure, and the use of TcPO2 was not recommended
as a predictor to success on account of it being representative
of the microcirculation of a volume of tissue rather than the
macrocirculation supplying a digit or a limb.45
TcPO2 was evaluated with toe pressure in the management
of chronic critical leg ischaemia. Neither method displayed
any advantages over the clinical judgment of vascular sur-
geons, and thus was found not to lead to a better clinical out-
come.46
Ankle Brachial Pressure Index (ABPI)
This method is often used in the initial stage of non-inva-
sive vascular assessment43 and is described as a simple, accu-
rate and reproducible method.47 The systolic pressure is meas-
ured at the ankle using either the posterior tibial artery or the
dorsalis pedis and the value in mmHg obtained here is divided
by the brachial systolic pressure, utilising a pressure cuff and
a hand held Doppler probe.43 A normal index value at rest is
equal or higher than 1. This value decreases in relation to the
severity of vascular disease with subjects with ulcers and gan-
grene displaying rest pain and tissue loss with an ABPI of less
than 0.5.43 If the ABI is found to be abnormal, segmental pres-
sures can be used to define the level of the disease, with the
cuff placed at upper and lower thigh, upper calf and ankle lev-
els. Toe pressures utilising cuffs around the toes can be use-
ful. A toe to brachial index of 0.75 is considered normal with
0.25 being found in association with sever arterial disease.43,47
Nailfold Capillaroscopy (NFC)
Capillaroscopy of the nailfold with less than 10x to 20x mag-
nification has been used to assess digital microcirculation,
and reproducibility measurements of capillary width and num-
ber of loops/millimeter have been measured. Nailfold capil-
laroscopy (NFC) was compared with fingertip lacticemy and
LDI when assessing digital microcirculation in 44 patients pre-
senting with systemic sclerosis and 40 controls.48 There was a
lack of correlation found with functional and morphological
microvascular abnormalities measured by fingertip lacticemy
and NFC. However, they concluded that it was appropriate to
consider LDI and NFC as complementary tools for evaluating
different aspects of microcirculation, with early detection of
changes being paramount as microvascular abnormalities could
result in reduction in the vessel lumen, decreased blood flow
and hypoxia resulting in digital ulceration and ultimately in
severe cases gangrene of the extremities. 
Conclusion
In this review we have discussed the current and frequently
used methods of vascular assessment that can be utilised for
the evaluation of lower limb wounds. In the main the tech-
niques can be useful for both clinical as well as for research
purposes. LDF and LDPI both offer relatively user friendly,
quick, non invasive and with LDPI, non contact direct meth-
ods of measuring blood flow. Multiple studies have utilised
LDF and LDPI in the analysis of ulceration in the limbs, and
have combined iontophoresis as well as reactive hyperaemia
to investigate the mechanisms of vascular dysfunction, par-
ticularly for wounds resulting from diabetes mellitus and periph-
eral arterial disease. The more recent development of LSCI
has added the possibility of full-field imaging of skin perfu-
sion in near real time, and although studies are not yet abun-
dant, do display this as a development with useful possibili-
ties for the future. PPG is an optical technique which uses low
cost, semi conductor technology and matched photo detector
devices to measure blood volume changes in the microvascu-
lar bed. This makes it very cost effective as well as being portable
and non invasive. Thermal infra red imaging has become com-
mon practice as a method of assessing vascular function in
critical illness; it can be used over larger areas and in com-
mon with LSCI allows real time recording. TcPO2 has proven
particularly useful for the identification of the foot at risk in
diabetes; it is another non invasive method which provides a
continuous measurement. ABPI continues to be simple, effec-
tive, reproducible, user friendly and cost effective and is very
much utilised as a quick clinical tool for the assessment of
the arterial supply to the lower limb, as does NFC for the assess-
ment of digital perfusion as it affords direct observation of the
nailfold capillaries. Non of the methods discussed offer a
panacea for vascular assessment related to the formation of
ulceration in lower limbs as each measure different compo-
nents (compartments) of the vasculature, either tissue O2,
macro or microcirculation, however each have strengths as
well as drawbacks for the practitioner to evaluate prior to
considering their utilisation.
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